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Abstract 
Neisseria gonorrhoeae is a human-specific pathogen that causes gonorrhea. It is defined as a super 
bacterium by the WHO due to the emergence of gonococci that are resistant to a variety of 
antibiotics and a rapidly increasing infection incidence. Genome-wide investigation of neisserial 
gene essentiality and novel virulence factors is urgently required in order to identify new targets 
for anti-neisserial therapeutics. To identify essential genes and new virulence factors, a 
high-density mutant library in N. gonorrhoeae MS11 was generated by in vitro transposon 
mutagenesis. The transposon library harbors more than 100,000 individual mutants, a density that 
is unprecedented in gonococcal research. Essential genes in N. gonorrhoeae were determined by 
enumerating frequencies of transposon insertion sites (TIS) with Illumina deep sequencing 
(Tn-seq). Tn-seq indicated an average distance between adjacent TIS of 25 bp. Statistical analysis 
unequivocally demonstrated 781 genes that were significantly depleted in TIS and thus are 
essential for Neisseria survival. A subset of the genes was experimentally verified to comprise 
essential genes and thus support the outcome of the study. The hereby identified candidate 
essential genes thus may constitute excellent targets for the development of new antibiotics or 
vaccines.  
In a second study, the transposon mutant library was applied in a genome-scale 
“negative-selection strategy” to identify genes that are involved in low phosphate-dependent 
invasion (LPDI). LPDI is dependent on the Neisseria porin subtype PorBIA which acts as an 
epithelial cell invasin in absence of phosphate and is associated with severe pathogenicity in 
disseminated gonococcal infections (DGI). Tn-seq demonstrated 98 genes, which were involved in 
adherence to host cells and 43 genes involved in host cell invasion. E.g. the hypothetical protein 
NGFG_00506, an ABC transporter ATP-binding protein NGFG_01643, as well as NGFG_04218 
encoding a homolog of mafI in N. gonorrhoeae FA1090 were experimentally verified as new 
invasive factors in LPDI. NGFG_01605, a predicted protease, was identified to be a common 
factor involved in PorBIA, Opa50 and Opa57-mediated neisserial engulfment by the epithelial cells. 
Thus, this first systematic Tn-seq application in N. gonorrhoeae identified a set of previously 
unknown N. gonorrhoeae invasive factors which demonstrate molecular mechanisms of DGI.
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Zusammenfassung 
Neisseria gonorrhoeae ist ein human-spezifisches Pathogen, das die Krankheit Gonorrhoe 
verursacht. Aufgrund der steigenden Anzahl antibiotikaresistenter Gonokokken und der damit 
verbundenen, rapide zunehmenden Anzahl von Infektionen erklärte die WHO Gonokokken 2012 
zum Superbakterium. Daher ist eine genomweite Untersuchung der neisseriellen 
Genessentiatialität und neuer Virulenzfaktoren dringend erforderlich, um neue Ziele für die 
antineisserielle Therapie zu identifizieren. Hierzu wurde eine high-density Mutantenbibliothek in 
N. gonorrhoeae MS11 durch in vitro Transposonmutagenese generiert. Die Transposonbibliothek 
enthält mehr als 100.000 individuelle Mutanten - eine Dichte, die in der Gonokokken-Forschung 
beispiellos ist. Essentielle Gene von N. gonorrhoeae wurden durch die Ermittlung der Häufigkeit 
von Transposon insertion sites (TIS) mit Hilfe von Illumina deep sequencing (Tn-seq) bestimmt. 
Tn-seq ergab eine durchschnittliche Distanz von 25 Basenpaaren zwischen benachbarten TIS. Die 
statistische Analyse zeigte eindeutig 781 Gene, die signifikant weniger TIS aufwiesen und deshalb 
als essentiell für das Überleben der Neisserien verstanden werden können. Für ausgewählte Gene 
wurde experimentell bestätigt, dass sie essentielle Gene beinhalten, wodurch das Ergebnis der 
Tn-seq unterstützt wird. Die hierbei identifizierten essentiellen Gene könnten exzellente Targets 
für die Entwicklung neuer Antibiotika oder Impfstoffe darstellen. 
In einer zweiten Studie wurde die Transposon Mutanten Bibliothek für eine genomweite „negative 
Selektionsstrategie“ bereitgestellt. Es sollten Gene identifiziert werden, die an der phosphatfreien 
Invasion (low phosphate-dependent invasion = LPDI) beteiligt sind. Die LPDI ist vom 
neisseriellen Porin Subtyp PorBIA abhängig, welches bei Epithelzellen in Abwesenheit von 
Phosphat als Invasin fungiert und mit einer schweren Pathogenität in disseminierenden 
Gonokokkeninfektionen (DGI) assoziiert ist. Tn-seq ergab 98 Gene, die an der Adhärenz an die 
Wirtszelle, und 43 Gene, die an der Wirtszellinvasion beteiligt waren. Zum Beispiel wurden das 
hypothetische Protein NGFG_00506, ein ABC Transporter, das ATP-bindende Protein 
NGFG_01643, wie auch NGFG_04218, das für ein Homolog von mafI in N. gonorrhoeae FA1090 
kodiert, experimentell als neue Invasionsfaktoren in der LPDI verifiziert. NGFG_01605, bei dem 
angenommen wird, dass es sich um eine Protease handelt, wurde als ein allgemeiner Faktor 
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identifiziert, der an der PorBIA-, Opa50- and Opa57-vermittelten Einstülpung der Membran von 
Epithelzellen beteiligt ist. Die erste systematische Anwendung von Tn-seq in N. gonorrhoeae 
identifizierte eine Reihe bisher unbekannter Invasionsfaktoren von N. gonorrhoeae, die 
molekulare Mechanismen der DGI zeigen. 
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1 Introduction 
1.1 Neisseria gonorrhoeae 
1.1.1 Pathogenesis of Neisseria gonorrhoeae 
Neisseria gonorrhoeae (also named as gonococcus or GC) is a Gram-negative, aerobic or 
facultative anaerobic diplococcus [1,2]. It is coffee bean-shaped with a diameter of 0.6–1 µm and 
was discovered by German physician Albert Neisser in 1879. The gonococci belong to the big 
genus Neisseria, commensal bacteria that colonize the mucosal surfaces of many animals. Among 
eleven species that colonize humans, two are pathogens, N. gonorrhoeae and N. meningitidis 
which cause bacterial meningitis and meningococcal septicemia.  
The obligate and human-specific pathogenic bacterium N. gonorrhoeae is the causative agent of 
the second most common sexually transmitted disease, gonorrhea, which is colloquially known as 
“the clap”. With more than 106 million of the estimated 498 million new cases of curable sexually 
transmitted infections (STIs) that occur globally every year, the gonococcal infections remain a 
serious threat to world health [3]. The gonococci usually infect the urogenital tract and 
preferentially colonize the mucosal surface of the male urethra and the female cervix, but the 
rectum, pharynx and the conjunctiva of the eye can also be infected. The infection in men mostly 
causes urethritis, epididymitis, and prostatitis. While many infected women are asymptomatic. But, 
occasionally they have symptoms of vaginal and pelvic discomfort of dysuria and these infections 
may develop to ascending gonococcal infection and subsequently pelvic inflammatory disease 
(PID) which increases the risk of infertility and ectopic pregnancy [4,5]. One in ten women suffers 
from PID, of which N. gonorrhoeae contributes to 40% of all reported cases [4]. If the urogenital 
gonococcal infections are undiagnosed or untreated, N. gonorrhoeae will spread in the host body 
and cause disseminated gonococcal infection (DGI) which can lead to some serious conditions 
such as arthritis, endocarditis and meningitis. The gonococci transmit from person to person via 
intimate contact, especially sexual contact, and the most common transmission are sexual 
transmission and mother-to-child transmission during birth which may cause gonococcal 
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conjunctivitis of the neonate [6]. In addition, 10–30% of patients with gonorrhea were found with 
a concomitant Chlamydia infection [7]. The gonococcus is also found to be one of the significant 
cofactors for human immunodeficiency virus (HIV) transmission and gonococcal urethritis 
increases the risk of acquiring and transmitting HIV infection about three-fold [8]. 
1.1.2 Diagnosis and therapy 
Urogenital gonococcal infections are usually diagnosed by culture tests, but other tests which are 
less labor-intensive have similar accuracy. For example, the new nonculture technique is the 
nucleic acid amplification test with 92–96% sensitivity and 94–99% specificity when compared 
with culture tests [9]. For the therapy strategy, the uncomplicated local gonococcal infections are 
usually treated by antibiotics, but reinfection is a common occurrence with gonorrhea. It may 
result from a lack of protective immune response to Neisseria enormous variations. The 
experimental infection in male human volunteers confirmed the initial infection would not protect 
against reinfection with the same Neisseria strain [10]. Many studies show that gonococcal 
mucosal infections can result in an immune response although very weak. Serum antibodies 
against different GC antigens are readily detected, decrease with time and disappear several 
months after infection treatment [11]. The sera obtained at the time of mucosal infection or from 
the convalescent-phase were bactericidal but did not prevent infection [12]. There are almost no 
naturally acquired immunity responses to gonococci after uncomplicated infection [13,14]. It was 
suggested that GC might be able to suppress the host immune response by as yet unknown 
mechanisms [14]. GC inhibit human CD4 T cells or B cells by binding to human CEACAM1 
(carcinoembryonic antigen cellular adhesion molecule 1) on lymphocytes with gonococcal 
opacity-associated (Opa) proteins [15-17]. Mucosal infections with gonococci are characterized by 
the abundant influx of polymorphonuclear leukocytes (PMNs) to the inflammation site [18]. GC 
can resist non-oxidative antimicrobial factors secreted by adherent, IL-8-primed PMNs [19], 
suppress oxidative burst of PMNs [20], and also delay apoptosis in PMNs [21]. Furthermore, 
antigenic and phase variation of gonococcal outer membrane structures such as 
lipooligosaccharide (LOS), pili and Opa proteins constitutes an efficient mechanism to escape 
recognition by the host immune system.  
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1.1.2.1 Vaccine development 
With no evidence for naturally acquired immunity after infection by the gonococcus, it is difficult 
to develop an effective vaccine for GC. In the 1970s, Greenberg et al. tried a crude whole cell 
vaccine made from killed gonococci in small but well controlled clinical trials. The vaccine gave 
an antibody response in over 90% of vaccine recipients and good tolerance with only mild 
reactions in humans but no efficacy in preventing gonorrhea [22]. The other vaccine which had 
entered into clinical trials was a pilus vaccine. Brinton et al. found that it protected human male 
volunteers against the experimental urethral infection by the homologous strain with parenteral 
immunization of isolated and purified pili [23]. The antibody response was detected in the serum 
and genital secretions, but the pilus vaccine failed to prevent infections with heterologous strains 
expressing antigenically variant pili [24]. Also it did not show resistance in a clinical trial [25] 
which might have been caused by antigenic variation of pili expressed in the gonococcus. 
Intranasal immunization of female mice with a gonococcal outer membrane vesicle (OMV) 
vaccine resulted in reduced colonization on the vaginal surface in infections with the homologous 
N. gonorrhoeae strain MS11 [26]. However, protection was not observed in subsequent infections 
with either MS11 or FA1090 OMV [13]. The individual outer membrane proteins are considered 
as promising vaccine targets, for example PorB (outer membrane porin protein B) [27] and TbpB 
(transferrin receptor protein) [28]. Immunization of BALB/C mice by intramuscular needle 
injection or epidermal gene gun bombardment with a DNA vaccine encoding N. gonorrhoeae 
PorB produced detectable levels of antigen-specific antibodies. The anti-PorB antibody levels are 
significantly increased with a boost of renatured recombinant (rr) PorB from E. coli or PorB 
expressed from viral replicon particles (VRPs) [27]. The resulting antibodies were shown to partly 
recognize the surface of the homologous strain in vitro but further experiments in mouse models 
will be required.  
1.1.2.2 Antibiotic resistance 
In the absence of effective vaccines, timely diagnosis and efficient antibiotic therapy remain the 
principal method to prevent epidemics and cure infections. The history of antibiotic treatment of 
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gonorrhea and evolution of resistance in N. gonorrhoeae in the United States demonstrates that 
Neisseria acquires antibiotic resistances (Fig. 1-1) [29]. For example, penicillin was introduced in 
the treatment of gonorrhea in 1943 [30] when sulfonamide-resistant gonococci became 
widespread. Penicillin was very effective in the treatment in the first 10-15 years after introduction. 
Then doses of penicillin had to be gradually increased due to developing resistance by sequential 
accumulation of chromosomal mutations [31]. In 1976, the plasmids containing β-lactamase were 
first reported in gonococci isolated from patients in Asia and Africa [32]. Alternative antibiotics, 
such as erythromycin, spectinomycin, tetracycline and fluoroquinolones were introduced in the 
treatment regimen, but resistant strains emerged soon due to chromosomal mutations or gene 
acquisitions. Today, the first-line antibiotics for treatment are third-generation cephalosporins 
(cefixime and ceftriaxone). Unfortunately, the first gonococcus with high-level resistance to 
ceftriaxone was identified in 2011 in Japan [33] and another clinical failure with cefixime 
treatment was recently reported in Europe [34]. N. gonorrhoeae thus evolved into a super bug and 
gonorrhea may become untreatable. 
 
Fig. 1-1 History of antibiotic treatment of gonorrhea and evolution of resistance in N. 
gonorrhoeae in the United States. Figure modified from Unemo M and Shafer WM, 2011 [29].  
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1.1.3 Neisseria virulence factors  
Neisseria gonorrhoeae expresses a set of virulence factors required for successful human infection, 
immune evasion, intracellular survival and transmission to a new host. Type IV pili (Tfp) induce 
the initial attachment to mucosal cells and enable the gonococci to form efficient colonization on 
the cell surface. Subsequently different Opa proteins trigger intimate binding and invasion into 
host cells, as well as transcellular transcytosis across polarized epithelial cell monolayers. Further, 
Neisseria Porin subtype PorBIA efficiently mediates bacterial attachment and internalization under 
the low phosphate condition mimicking the bloodstream. Porin is also capable to translocate from 
the bacterial outer membrane into host cell membranes and/or mitochondrial outer membranes of 
infected cells and modulates various cell processes, for example promotion of apoptosis and 
inhibition of phagosome maturation. Additionally, LOS, immunoglobulin A1 (IgA1) protease and 
factor H binding protein are important determinant to support the pathogenic potential of GC. 
1.1.3.1 Type IV Pili 
Pili are long filamentous structures on the surface of Neisseria and many other bacterial species. 
Type IV pili are important Neisseria virulence factors that mediate a set of functions, such as 
initial attachment to host cell, bacterial aggregation, twitching motility, microcolony formation 
and DNA uptake during natural transformation [35]. Neisseria pili are formed by non-covalent 
homopolymerization of major pilus subunit proteins, pilins, which are encoded by the gene pilE. 
Many pilus-associated proteins are involved in pilus assembly, extension and retraction. PilD, a 
bifunctional enzyme with peptidase and transmethylase activity, is responsible for pilus precursor 
maturation [36]. PilF is an ATPase that supplies the energy for pilus formation in the periplasm 
[37]. PilT is required for pilus disassembly and is dependent on ATP hydrolysis [38]. PilC is 
located at the tip of the pili and essential for pilus-mediated epithelial cell adherence and DNA 
transformation [39,40]. In addition, there are some minor pilus proteins, such as PilQ which forms 
a gated channel on the outer membrane for pilus extension [41]; PilV, which is found to be 
essential for adherence to the epithelial cells [42]; PilU and PilX, which are important for bacterial 
aggregation [43]. 
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The antigenic and phase variation of Neisseria pili is one of the most effective strategies to evade 
host immune responses. N. gonorrhoeae possesses one pilin expression locus (pilE) but multiple 
silent pilin loci (pilS) located in the discrete locations in the genome [44]. The nonreciprocal 
homologous recombination between any silent pilS copy and the expressed pilE results in the 
expression of a new variant pilin leading to pilus antigenic variation [45]. The new variants can be 
fully functional, poorly expressed or not expressed and the last two situations exhibit the 
non-piliated colony morphology thus causing the pilus phase variation [46]. The guanine quartet 
(G4) structure on the upstream of pilE locus is required for the recombination [47] and regulated 
by a small non-coding RNA (sRNA) [48] and RecQ DNA helicase [49]. Additionally, the 
recombination is RecA-dependent and utilizes the RecF-like mechanism instead of RecBCD 
[50,51]. Besides the variation of PilE, the pilus adhesin PilC also has effects on pilus phase 
variation. Most gonococcal strains carry two copies of pilC, pilC1 and pilC2. These two genes are 
not identical and thus produce two different forms of PilC. Usually pilC1 is out of frame and pilC2 
is expressed. The expression of pilC is altered by frequent frameshift mutations within a series of 
guanine residues in the signal peptide encoding region. Since PilC is required for pilus assembly, 
the switch in the expression of PilC results in gonococcal pilus phase variation [52,53]. 
Neisserial pili mediate initial attachment of the bacteria to human cells, but the pilus receptor on 
the host cell surface is still controversial. Human CD46 (also termed membrane cofactor protein, 
MCP) is proposed as Neisseria pilus receptor [54]. Piliated, but not non-piliated gonococci bound 
to hamster cells expressing human CD46. The binding of piliated Neisseria to epithelial cells 
further was blocked by CD46 antibodies and a purified recombinant CD46 competitor [54]. 
However, Kirchner et al. found that the different binding efficiencies of piliated gonococci on 
human epithelial cells did not correlate with the level of surface-expressed CD46 and 
pilus-mediated binding was not reduced when CD46 expression was down-regulated by siRNA 
[55]. Alternatively, complement receptor 3 (CR3) was proposed as gonococcal pilus receptor on 
cervical epithelial cells [56] whereas an I-domain-containing integrin was demonstrated as pilus 
receptor on urethral epithelial cells (UECs) [57]. Recent research showed that after attachment, 
Neisseria pili prevented bacterial internalization by forming microcolonies and inducing 
anti-invasive signals trigged by caveolin-1 phosphorylation [58]. The natural loss of piliation 
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switches gonococcal local infection to a porin/scavenger receptor-triggered invasive infection [59] 
(1.1.3.3). 
1.1.3.2 Opacity-associated (Opa) proteins  
Neisseria encodes a family of phase-variable and antigenically distinct Opa proteins which 
mediate aggregation of gonococci by binding to LOS and bacterial intimate attachment to and 
efficient invasion into host cells during infection. In strain MS11, eleven different opa gene alleles 
have been identified and each of them has its own promoter [60]. Opa genes are constitutively 
transcribed but the expression is regulated by pentameric CTCTT repeat sequences within the 
leader peptide-coding sequences. The number of CTCTT determines if the coding regions are 
either in or out of frame [61,62]. The expression of each opa gene can be independently switched 
on or off, so bacteria derived from a single colony actually represent a mixture with respect to Opa 
proteins expression [60]. 
All Opa proteins are integral outer membrane proteins with different surface-exposed loops which 
show different host cell receptor binding specificities [62,63]. Opa proteins are grouped into two 
classes binding either i) heparan sulfate proteoglycans (HSPGs) or ii) carcinoembryonic 
antigen-related cellular adhesion molecules (CEACAMs; previously CD66). The first class 
represented by Opa30/Opa50 (encoded by opaC gene, for nomenclature of Opa proteins, see [63]) 
mediates invasion into epithelial cells by binding to HSPGs on the cell surface [64], but the 
subsequent host signaling pathway is dependent on cell line [64]. For example, the binding of 
Opa50 to the human conjunctiva epithelial cell line Chang cells stimulates two lipid hydrolysis 
enzymes, phosphatidylcholine-specific phospholipase C (PC-PLC) and acidic sphingomyelinase 
(ASM), which results in cytoskeletal rearrangements and bacterial uptake [65]. However, in other 
epithelial cell lines, like Chinese hamster ovary (CHO) cell, HeLa and Hep-2, the serum-derived 
extracellular matrix proteins vitronectin or fibronectin serve as a molecular bridge between an 
Opa-proteoglycan complex and host cell integrins [66-68].  
The second class including most Opa proteins Opa51-60 interact with CEACAMs [69]. Among 
twelve different human CEACAMs, CEACAM1, 3, 5 and 6 have been described as Opa receptors 
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[70-73]. The interaction triggers various important cellular functions, such as neisserial 
engulfment by the epithelial cells [74], transcellular transcytosis across polarized epithelial cell 
monolayers [75], entry into endothelial cells [76], suppression of lymphocyte response [15] and 
bacterial engulfment and killing by neutrophils [70]. Opa-dependent phagocytosis is mediated by 
CEACAM3, a CEACAM family member exclusively expressed on polymorphonuclear 
granulocytes. Upon bacterial engagement, the cytoplasmic domain of CEACAM3 is 
phosphorylated by Src family kinases and then the phosphorylated cytoplasmic domain recruits 
the small GTPase Rac followed by actin rearrangements [77-80]. However, internalization of N. 
gonorrhoeae in epithelial cells via CEACAMs (CEACAM1, CEACAM5 or CEACAM6) is 
independent of cytoplasmic domain of epithelial CEACAMs but the endocytosis is involvement of 
cholesterol-rich membrane microdomains, phosphatidylinositol-3’ kinase (PI3K) and 
phosphatidylinositol 3, 4, 5-phosphate [PI(3,4,5)P] [79,81,82]. 
1.1.3.3 Pore-forming proteins (Porin) 
Porins are the major outer membrane proteins in Neisseria and account for over than 60% of the 
total proteins on the outer membrane. In N. gonorrhoeae, the dominant outer membrane protein is 
PorB, encoded by a single gene por. PorB has two related serotypes PorBIA and PorBIB encoded 
by alleles of por gene, porA and porB respectively. Most clinical isolates express PorBIB and only 
20% express PorBIA. Among the PorBIA expressing strains, 80% are isolated from disseminated 
infection cases [83-85]. Further, PorBIA but not PorBIB triggers efficient bacterial internalization in 
many different cell lines under low phosphate conditions. This invasion is independent of pili and 
Opa proteins [86]. The study of Zeth K et al. demonstrated that in PorBIA the amino acid at 
position 92 was conserved either as arginine or histidine, whereas PorBIB encoded a serine at the 
same position. Arg/His92 in PorBIA of disseminating gonococci was critical for 
phosphate-sensitive adherence and invasion [87]. Recently, the human heat shock glycoprotein 
Gp96 and the scavenger receptor expressed on endothelial cells I (SREC-I) were found as host 
receptor for Neisseria PorBIA. The study indicated that the binding of PorBIA to Gp96 initiated a 
rapid and massive adherence in a phosphate-sensitive manner but blocked the invasion. The entry 
of gonococci to the host cell is trigged by the interaction of PorBIA with SREC-I [88]. 
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PorBIA-dependent bacterial uptake into epithelial cells requires the formation of membrane rafts 
and caveolin-1 phosphorylation. The underlying signaling cascade involves PI3K and 
phospholipase C ɣ1 (PLC ɣ1) [59].  
PorB forms an anion-selective ion channel that is essential for neisserial viability. In addition, 
porin is able to translocate from the bacterial outer membrane into host cell membranes where it 
modulates the infection process and affects various cell functions. PorB pore formation is 
modulated by cytosolic purine nucleoside triphosphates, especially by ATP/GTP [89]. The 
translocation of neisserial porin causes rapid calcium influx from the extracellular milieu into 
target cells. The increase in cytosolic calcium subsequently induces apoptosis by activation of the 
calcium-dependent protease calpain as well as proteases of the caspase family [90]. Porins share 
similarity with mitochondrial voltage-dependent anion channels (VDAC) with respect to structure, 
function and the mechanism of ion flow across mitochondria membrane [89-92]. Porin can be 
selectively transported to the mitochondrial outer membranes of infected cells causing efflux of 
cytochrome c and loss of the mitochondrial membrane potential thus ultimately resulting in 
apoptosis [91,92]. By contrast, Binnicker MJ et al. demonstrated NF-κB activation by PorBIB and 
increased expression of host anti-apoptotic factors in UEC cells [93]. PorB is further supposed to 
inhibit phagosome maturation as was evidenced by the experimentation that more early endocytic 
markers and less late endocytic markers were detected in isolated phagosomes from macrophages 
incubated with purified PorB [94]. 
1.1.3.4 Other virulence factors 
LOS is one of the important virulence determinants of N. gonorrhoeae. It contains three short 
oligosaccharide chains covalently linked through ketodeoxyoctonoic acid to a lipid A component 
which anchors in the outer membrane [95]. Contrasting lipopolysaccharide (LPS), which is often 
found in Gram-negative bacteria, LOS contains only a short oligosaccharide instead of 
polysaccharide o-chain repeats. LOS plays several key roles in gonococcal infection, immune 
evasion, tissue damage and the stimulation of bactericidal antibodies [96-98]. One Neisseria strain 
usually produces two to six different LOS molecules and the antigenic variation of LOS is mainly 
due to the types and numbers of carbohydrates in their LOS which are modulated by a frameshift 
  Introduction 
13 
 
on the poly (G) tract of the coding sequence of the gene lsi-2 [99]. 
Pathogenic Neisseria further can express an extracellular serine protease, the so called IgA1 
protease, which specifically cleaves the principal mucosal antibody, immunoglobulin A1 (IgA1) 
[100]. IgA1 protease contains an amino-terminal leader, the protease and a carboxyl-terminal 
“helper” domain. The leader and the “helper” domains are required for the transport through the 
inner and outer membranes [101]. Neisseria IgA1 protease was shown to promote intracellular 
survival within epithelial cells by degradation of LAMP1 (lysosomal-associated membrane protein 
1), a major integral membrane glycoprotein of late endosomes and lysosomes [102,103]. 
1.1.4 Disseminated gonococcal infection (DGI) 
In most cases, Neisseria gonorrhoeae cause uncomplicated gonococcal infections, such as 
cervicitis and urethritis, but rarely, in 1–3% of patients infected with N. gonorrhoeae, the 
gonococci spread from the local infection sites to other organs of the host body and cause 
disseminated gonococcal infection (DGI) which commonly leads to joint pain, skin lesions and 
polyarthritis. If untreated, DGI may develop to some serious conditions, such as bacterial 
endocarditis, meningitis, and pneumonia [104]. 
DGI is three or four times more common in women than men. The higher frequency among 
women may be due to many infected women are asymptomatic which gives the gonococci the 
opportunity for systemic spread. Besides, menstruation, pregnancy or the initial postpartum period 
increases the risk of dissemination from the genitourinary tract. The congenital or acquired 
complement deficiencies of the complement C5-C8 are less common risk factor [105]. The 
complement-dependent bactericidal effect of normal human sera can efficiently prevent the 
dissemination of serum-sensitive gonococci. However, the gonococci develop many strategies to 
evade the killing by host immune responses. Sialylation of gonococcal LOS results in conversion 
of previously serum-sensitive strains to unstable serum resistance allowing the gonococci escape 
from bactericidal activity of the serum [106]. Besides, Neisseria porins play an important role in 
stable serum resistance of nonsialylated gonococci by binding to factor H or C4b-binding protein 
(C4bp) to inhibit complement activity [107,108]. In addition to resist the bactericidal activity of 
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the serum, the gonococci can utilize the component in the serum for invasion into the host cell. 
For example, Neisseria Opa50 mediates internalization in some epithelial cell lines with assistance 
of the serum-derived extracellular matrix proteins vitronectin or fibronectin as a molecular bridge 
of Opa-proteoglycan complex [66-68].  
It is reported most gonococci isolated from patients with DGI are serum-resistant and AHU 
auxotype (Arg-Hyx-Ura auxotype) which means the gonococci require arginine, hypoxanthine, 
and uracil for growth on chemically defined medium [109]. Further, PorBIA expressing gonococci 
are frequently isolated from patients with disseminated infection [83-85]. It is found Neisseria 
PorBIA can trigger efficient invasion under a phosphate-sensitive condition mimicking the 
bloodstream [86]. In this process, the heat shock protein Gp96 and scavenger receptor SREC-1 
serve as the host receptors for PorBIA [88]. The formation of membrane rafts, caveolin-1 
phosphorylation and a series of activation of PI3K, PLCγ1, Rac1 (ras-related C3 botulinum toxin 
substrate) and PKD1 (PKCμ, protein kinase C μ) are involved in the subsequent signal 
transduction pathway which result in cytoskeletal rearrangements for membrane ruffling and then 
uptake of the gonococci [59]. However, little is known about Neisseria factors involved in this 
invasion process so far. It is likely that some other additional gonococcal factors may participate in 
PorBIA-triggered invasion and these factors may be new targets for the development of 
anti-infectives against gonococci. 
1.2 Transposon mutagenesis 
1.2.1 Transposons 
A transposable element (TE) or “transposon”, is a DNA sequence that can move from one 
genomic location to another. Transposons first were described as jumping genes in maize by 
Barbara McClintock in 1948 [110,111]. TEs have been identified in almost all the prokaryotic and 
eukaryotic organisms and comprise a large proportion of the genome. For example, TEs make up 
approximately 12% of Caenorhabditis elegans genome [112,113], 37% of the mouse genome 
[114] , 50% of the human genome [115] and up to 90% of the maize genome [116]. Thus they play 
a significant role in changes of genome size during evolution and in genetic plasticity of 
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organisms [117-119]. The mobilization of TEs can cause insertion, excision, duplication or 
translocation at the site of integration and thus may positively or negatively influence gene 
expression and also induce gene deletions and illegitimate recombination. TEs are considered as 
selfish DNA and tend to widely spread throughout the whole genome. Since deleterious effects of 
transposons in essential genes will ultimately lead to a reduction in the fitness of the affected 
organism, most transpositions are identified in the nonessential regions of the genome [120,121]. 
Besides, transpositions are frequently found in the germ line or embryonic cell as the harmful 
mutations can be selected during the development [122,123]. On the other hand, the host have 
evolved several strategies to curtail TEs spread, such as DNA methylation to reduce the 
expression of TEs [124,125], RNA interference (RNAi) [126] or specific proteins mediated 
inhibition mechanism [127]. So the distribution of TEs in the genome is the balance result of host 
cells’ defense against TE’s expansive spread. 
TEs are classified into two major groups. Class I TEs, also known as retrotransposon such as 
retroviruses, propagate through an RNA intermediate via a “copy and paste” mechanism. A 
reverse transcriptase is necessary for the transposition, which is encoded by the class I TE itself. 
Class I TEs produce RNA transcripts and the RNA transcripts can be reverse transcribed to DNA 
which is inserted into a new location of the genome. There are two major types of class I TEs: 
LTR retrotransposons with long terminal repeats (LTRs) and non-LTR TEs lacking these repeats 
such as long-interspersed nuclear elements (LINEs) or short-interspersed nuclear elements 
(SINEs). Classes I TEs occupy nearly 40% of the mammalian genome (reviewed in [117,118]). 
By contrast Class II TEs are DNA transposons. Most class II TEs are excised from one position 
and reintegrated into another position within the genome using a “cut and paste” mechanism. 
Transposition of class II TE is catalyzed by transposase. Class II TEs are further characterized by 
9 to 40 base pairs terminal inverted repeats (TIRs). The transposases recognize these TIRs and cut 
the whole DNA transposon from the excision site. Some transposases recognize and bind to 
specific DNA sequence as target site for insertion of the transposon. For example, the transposase 
of the Tc1/mariner element specifically recognizes TA dinucleotide in the genome and catalyzes a 
random insertion in any TA target site. Other transposases catalyze nonspecific transpositions in 
any target site. Transposases cut their respective target sites and generate sticky ends for the DNA 
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transposon. Subsequently, the two gaps of target site are filled up and closed by DNA polymerase 
and DNA ligase. Target site duplications (TSDs) comprise a unique hallmark of DNA transposons 
containing flanking direct repeats (LTRs in class I or TIRs in class II). After excision, these repeats 
are left behind as “footprint”. Class II TEs are also classified into different families depending on 
their sequences, such as Tc1/mariner, P elements, hAT superfamily (hobo/Ac/Tam3) and so on. 
Only few transposons utilize a replicative transposition mechanism instead of the “cut and paste” 
pattern. These include, for example, Helitron and Maverick transposons (reviewed in [119]). 
Both class I and class II TEs contain autonomous and non-autonomous elements. The autonomous 
transposons encode the proteins required for their transposition and can move on their own. 
Non-autonomous transposons lack genes encoding reverse transcriptase or transposase and thus 
are dependent on autonomous transposons for their mobilization. For example, activator element 
(Ac) is an autonomous TE and dissociation element (Dc) is a non-autonomous TE which requires 
the presence of Ac for transposition [128]. 
Transposons can regulate gene expression and contribute to genome evolution, but they are used 
as a powerful molecular tool for both, single gene analysis and a wide variety of genomic studies 
in microorganism and higher eukaryotes. Transposon-based strategies for microbial functional 
genomics include gene sequencing, gene fusions, signature-tagged mutagenesis, and genetic 
footprinting (reviewed in [129]). Transposons have been rediscovered as efficient genetic tools in 
higher eukaryotes and even in vertebrates and are used, for example, for the generation of 
transgenic cells in tissue culture and transgenic animal models and even for therapy of genetic 
disorders in humans (reviewed in [130]). 
1.2.2 DNA Transposon Tn5 
Tn5 is one of the first identified transposons [131] and today one of the most frequently used 
transposition systems. It was isolated from Gram-negative bacteria and comprises a composite 
transposon which contains three antibiotic resistance genes, kan (kanamycin), ble (bleomycin) and 
str (streptomycin) flanked by two inverted insertion sequence IS50 elements. Each IS50 element is 
defined by two 19 bp end sequences (ES), the outside end (OE) and inside end (IE), which are 
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critical binding sites for transposase (Tnp). IE is methylated by deoxyadenosine methylase (Dam) 
in some bacteria, and this methylation strongly inhibits recognition by the transposase [132]. 
Moreover, both OE and IE are suboptimal for transposition. So the hyperactive version of the ES, 
which is called mosaic end (ME, CTGTCTCTTATACACATCT), is usually introduced in 
synthetic Tn5 transposon systems, which drastically increases the transposition efficiency. IS50R 
encodes the functional Tnp and the transposition inhibitor (Inh). Whereas IS50L is almost 
identical to IS50R, it only encodes truncated, inactive versions of Tnp and Inh (Fig. 1-2A, 
reviewed in [133,134]).  
Tn5 utilizes a “cut and paste” mechanism for its transposition during which Tn5 is excised from 
the original site and then inserted into the target site. The whole transposition process requires 
three macromolecules, the donor DNA-containing transposon, the target DNA sequence and the 
476 amino acid residues Tnp. In brief, the transposition process contains three steps: (1) Tnp 
recognizes and binds to the ES of Tn5 and a Tnp-transposon DNA synaptic complex is formed by 
dimerization of Tnp; (2) In the presence of Mg
2+
 or Mn
2+
, the synaptic complex is catalytically 
cleaved off the donor DNA; (3) The released synaptic complex captures the target DNA sequence 
and Tnp catalyzes strand transfer (Fig. 1-2B, reviewed in [133,134]). The strand transfer leaves 
two 9 bp gaps on either end of the inserted Tn5 which are likely filled in and sealed by host. 
However, some details of these three steps are still unclear. The analysis of the target sequence 
from thousands of inserts indicates the preferred target sequence contains 19 bp with a 9 bp core 
sequence surrounded by 5 bp on either side [135]. The consensus 9 bp core sequence is 
A-GNTYWRANC-T (N = A/G/C/T , Y = T/C, W = A/T and R = A/G) [136]. Although there is a 
slight sequence bias of Tn5 insertion sites, almost any sequence can be chosen at some frequency, 
so the randomness is sufficient for most applications and the impact of the bias is negligible.  
Tn5 transposition has been used as a powerful tool for molecular genetics by enclosing cargo 
DNA, such as antibiotic markers, genes for fluorescent proteins or therapeutic genes with ME 
[137]. Wild-type Tnp is low active because frequent transpositions easily lead to lethal genetic 
mutation of the host which will cause the loss of Tn5. Goryshin et al. greatly increased the 
transposition efficiency of Tnp by introducing mutations that render Tnp hyperactive and enable 
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an in vitro Tn5 transposition system [138]. Transposition can be conditionally regulated by the 
providing Tnp for the transposition reaction. 
 
Fig. 1-2 Tn5 structure and transposition mechanism.  
(A) Tn5 structure. Two IS50 elements bracket three antibiotic resistance genes. IS50R encodes 
transposase (Tnp) and transposase inhibitor (Inh). IS50L encodes C-terminal truncated, inactive 
versions of Tnp and Inh. IS50 elements are defined by transposon end sequences (ES), outside 
end sequence (OE) and inside end sequence (IE).  
(B) Tn5 transposition mechanism. Tnp recognizes and binds to ES to form a Tnp-DNA synaptic 
complex which is cleaved from the donor DNA. The released complex captures the target DNA 
and Tn5 is then inserted into target DNA by strand transfer. The 9 bp gaps at both ends of the 
insertion site are repaired by host cell proteins. 
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1.3 Next generation sequencing (NGS) technologies 
Next generation sequencing [NGS; also called second generation sequencing, deep sequencing, or 
massively parallel sequencing (MPS)] became available only a few years ago, but since then the 
technology has been broadly applied in genomics, transcriptomics and epigenomics. 
The first-generation sequencing, known as Sanger sequencing, applies chain-termination method 
for DNA sequencing [139] (Fig. 1-3A). Briefly, during primer elongation, the random insertion of 
fluorophores labeled ddNTPs (dideoxynucleotides) instead of dNTPs terminates the synthesis of 
the chain. The products including all possible lengths of chains are separated on the capillary gel 
where the fluorophores are detected by an imaging system to identify the base and then the 
sequence is analyzed by computer. Compared with Sanger dideoxynucleotide terminator 
sequencing, NGS can perform massively parallel sequencing of millions of DNA fragments in a 
single sequencing run and thus is much cheaper, about one hundred thousandth of the expenses of 
the traditional sequencing technologies, and faster, since hundreds of Gbp can be readily acquired. 
Another advantage of NGS is that the sequencing library can be constructed and amplified in vitro 
rather than in E. coli [140].  
Several NGS platforms have been developed, such as Illumina HiSeq 2500, NextSeq and MiSeq, 
Life Technologies SOLID4 and Ion Torrent Personal Genome Machine (PGM), Roche 454 
GS-FLX and GS Junior [141]. One of the most commonly used platforms is Illumina HiSeq 2000. 
Illumina sequencing is performed by synthesis (Fig. 1-3B). Bridge amplification of DNA 
fragments enclosed by specific adapters generates up to 1,000 identical copies of each single DNA 
template in a very small area (diameter of 1 micron or less) on a flow cell. Sequencing is 
performed by chain synthesis with fluorescently-labeled nucleotides (FI-dNTPs) that contain a 
removable terminator. After FI-dNTP incorporation, the emitted fluorescence from each cluster is 
imaged to identify the incorporated nucleotide. Then the fluorescent dye terminator is 
enzymatically cleaved from the nucleotide exposing a hydroxyl group that enables the 
incorporation of the next labelled nucleotide base and reinitiating the procedure. With additional 
repeats of the sequencing cycles, the base sequence in the DNA amplicon is determinated. 
Subsequently, the image-based raw data is transformed into sequence reads by several 
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computational analysis steps mainly including removing adaptor sequences and low quality reads, 
mapping to the reference sequence and bioinformatics analysis of the compiled sequence [142]. 
 
Fig. 1-3 Schematic diagram of sequencing process.  
(A) Sequencing process of the first generation sequencing Sanger sequencing 
(http://en.wikipedia.org/wiki/File:Sanger-sequencing.svg). 
(B) Sequencing process of Illumina sequencing, an example of the next generation sequencing 
(http://openwetware.org/wiki/BioMicroCenter:Sequencing). 
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1.4 Transposon insertion sequencing (Tn-seq) 
With the advent of NGS, the microbial genomes have flooded the database; however, the 
knowledge of gene function has greatly lagged behind gene discovery. Approximately 30-40% of 
genes are unknown in a new sequenced microorganism [143-145]. In order to reveal 
genotype-phenotype relationships in a high-throughput manner, the techniques combined NGS 
with traditional transposon mutagenesis has been recently developed, such as transposon 
sequencing (Tn-seq), high-throughput insertion tracking by deep sequencing (HITS), insertion 
sequencing (INSeq) and transposon-directed insertion site sequencing (TraDIS) [146-150]. In 
these similar approaches, a high-density transposon mutant library in which nearly all the 
non-essential genes contain insertions is applied to grow in a defined condition, in vitro growth 
conditions or in vivo infection of the host. The contribution of each gene in this condition is 
determined by comparing the relative frequency of each mutant in the population during the 
growth which can be quantified by massively parallel sequencing (MPS) of the transposon 
junctions. Such methods had been used to identify essential genes in different bacteria including 
Salmonella Typhi [147], Salmonella Typhimurium [151], Caulobacter crescentus [152], 
Mycobacterium tuberculosis [153], Porphyromonas gingivalis [154], Streptococcus pneumonia 
[148] and so on. Besides, these approaches were applied to identify virulence genes in some 
pathogens, such as Haemophilus influenza genes required in mouse lung infection model [146] 
and Pseudomonas aeruginosa genes for resistance functions [155]. In addition, the emerging 
applications of this technique are for the identification of sRNAs required for pathogenesis [156] 
and for the elucidation of genetic interactions [157] in Streptococcus pneumonia. Owing to the 
wide activity of the Mariner and Tn5 transposons which were used in the studies mentioned above, 
the transposon insertion sequencing (Tn-seq) has the potential to contribute to the exploration of 
complex pathways across many different species [158]. 
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1.5 Aims of this study 
The human-specific pathogen Neisseria gonorrhoeae might develop to an untreated super 
bacterium in the near future. It is urgent to develop novel strategy to control the infections and 
cure the disease as recently appealed by WHO (World Health Organization) [3]. Therefore, 
identification of essential genes and virulence factors will be an effective approach to find out 
promising targets for vaccine or drug development. 
Genome sequencing and preliminary annotation have been completed for some N. gonorrhoeae 
strains, but little is known about gene essentiality and the contribution of genes to neisserial 
virulence. This is in part due to the lack of straight forward transposon mutagenesis as transposons 
are usually inactive in gonococci. The first aim of this study thus was to construct a high-density 
transposon mutant library in N. gonorrhoeae. Then the distribution of transposon insertion sites 
(TIS) was to be analyzed by deep sequencing (Tn-seq) in order to identify the essential genes 
required for gonococcal survival and growth. Further, the transposon mutant library was to be 
used to screen for virulence factors involved in gonococcal disseminated infection (DGI), a severe 
systemic infection that occurs in about 1-3% of gonococcal infections. 
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2 Material and methods 
2.1 Material 
2.1.1 Bacterial strains 
All the gonococcal strains used and constructed in this study are derived from Neisseria 
gonorrhoeae MS11 and are listed in Table 2.1. Escherichia coli strains XL1 Blue and DH5α were 
used for amplification of plasmids. E. coli strains BL21 and soluBL21 (a gift from Dr. Rosalia 
Deeken, Department of Botany I, University of Wuerzburg) were used for protein expression. 
Table 2.1 N. gonorrhoeae strains used in this study 
 
Stain 
Identifier 
Phenotype Genotype/Plasmid Source 
MS11 PorBIB, P
+
, Opa
-
 porB Our lab 
N2009 PorBIA, P
+
, Opa
-
 MS11, porB::porA [159] 
N219 PorBIB, P
-
 MS11-B1 (P
s
) [160], ptetM25.2 [161] [162] 
N220 N219, pTH10a N219, pTH10a Our lab 
N931 N219, Opa50 N219, pTH6a (Opa50) [63] 
N313 N219, Opa57 N219, pTH6a (Opa57) [63] 
N2020 N2009 Δ01605, Opa50 N2009, NGFG_01605::Kan
R
, 
pTH6a(Opa50) 
[163] 
N2021 N2009 Δ01605, Opa57 N2009, NGFG_01605::Kan
R
, 
pTH6a(Opa57) 
[163] 
N2022 N2009, Opa50 N2009, pTH6a(Opa50) This study 
N2023 N2009, Opa57 N2009, pTH6a(Opa57) This study 
N2024 MS11, Kan-Ptrc-00442 MS11, (promoter of 
NGFG_00442)::(Kan
R
-Ptrc) 
This study 
N2025 MS11, Kan-Ptrc-00442, 
lacI
q
 
MS11, (promoter of 
NGFG_00442)::(Kan
R
-Ptrc), (pTH10a) 
This study 
N2026 MS11, Kan-Ptrc-04144 MS11, (promoter of 
NGFG_04144)::(Kan
R
-Ptrc) 
This study 
N2027 MS11, Kan-Ptrc-04144, 
lacI
q
 
MS11, (promoter of 
NGFG_04144)::(Kan
R
-Ptrc), pTH10a 
This study 
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N2028 MS11, Kan-Ptrc-02103 MS11, (promoter of 
NGFG_02103)::(Kan
R
- Ptrc) 
This study 
N2029 MS11, Kan-Ptrc-02103, 
lacI
q
 
MS11, (promoter of 
NGFG_02103)::(Kan
R
- Ptrc), pTH10a 
This study 
N2030 MS11, Kan-Ptrc-00007 MS11, (promoter of 
NGFG_00007)::(Kan
R
- Ptrc) 
This study 
N2031 MS11, Kan-Ptrc-00007, 
lacI
q
 
MS11, (promoter of 
NGFG_00007)::(Kan
R
- Ptrc), pTH10a 
This study 
N2032 N2009Δ00599 N2009, NGFG_00599::Kan
R
 This study, done 
by Weitner, H 
N2033 N2009Δ00859-00860 N2009, NGFG_00859-00860::Kan
R
 This study, done 
by Weitner, H 
N2034 N2009 Δ01489 N2009, NGFG_01489::Kan
R
 This study 
N2035 N2009 Δ01393 N2009, NGFG_01393::Kan
R
 This study 
N2036 N2009 Δ02032 N2009, NGFG_02032::Kan
R
 This study 
N2037 N2009 Δ00042 N2009, NGFG_00042::Kan
R
 This study 
N2038 N2009 Δ01836 N2009, NGFG_01836::Kan
R
 This study 
N2039 N2009 Δ04218 N2009, NGFG_04218::Kan
R
 This study 
N2040 N2009 Δ01605 N2009, NGFG_01605::Kan
R
 [163] 
N2041 N2009 Δ00072 N2009, NGFG_00072::Kan
R
 [163] 
N2042 N2009 Δ01266 N2009, NGFG_01266::Kan
R
 [163] 
N2043 N2009 Δ01643 N2009, NGFG_01643::Kan
R
 [163] 
N2044 N2009 Δ00506 N2009, NGFG_00506::Kan
R
 [163] 
N2045 N2009 Δ00827 N2009, NGFG_00827::Kan
R
 This study 
2.1.2 Cell lines  
Table 2.2 Cell lines 
Cell line Properties Media Source 
Chang T Human conjunctiva epithelial cells RPMI 1640, 10% FCS ATCC CCL-20.2 
HFF Human Foreskin Fibroblast cells DMEM, 10% FCS ATCC SCRC-1041 
NIH 3T3 Mouse embryonic 
fibroblast cell line 
DMEM, 10% FCS ATCC CRL-1658 
HeLa 229 Human epithelial cervical 
carcinoma cells 
RPMI 1640, 10% FCS ATCC CCL-2.1 
HeLa 
CEA 
Human cervix carcinoma epithelial 
cell expressing CEACAM 1 
RPMI 1640, 10% FCS Our lab 
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2.1.3 Plasmids 
Table 2.3 Plasmids used in this study 
Plasmid Properties Source 
pGEM
®
-T-Easy Cloning vector Promega 
pGEM-T-Ptrc Ptrc promoter cloned in pGEM-T-Easy  This study 
pGEM-T-kan-Ptrc Kanamycin cassette cloned in 
pGEM-T-Ptrc (SpeI/SacI) 
This study 
pCR2.1
®
-Topo Cloning vector Invitrogen 
pCR2.1-Tn5 Tn5 cassette cloned in pCR2.1
®
-Topo This study 
pCR2.1-Tn5-DUS DUS sequence inserted in 
pCR2.1-Tn5 by site-directed 
mutagenesis 
This study 
pET28b Expression vector, mutation in 
244-239 from GGCAGC to GGATCC 
Novagen, Lab of Dr. Rosalia 
Deeken, Department of Botany I, 
University of Wuerzburg 
pET28b-AIF1 ORF of NGFG_01605 cloned in 
pET28b (BamHI/HindIII) 
This study 
pET28b-AIF1185-451aa DNA sequence encoding AIF1185-451aa 
cloned in pET28b (BamHI/HindIII) 
This study 
2.1.4 Oligonucleotides 
Table 2.4 Oligonucleotides for generation and sequencing of the libraries 
Primer name Oligonucleotide Sequence (5’ 3’) Comment 
Adaptor sense p-GATCGGAAGAGCGGTTCAGCAGGAATGCCGAG Y-type 
adaptor Adaptor antisense ACACTCTTTCCCTACACGACGCTCTTCCGATC*T 
EZ-Tn5-Kan2-DUS-F TGGCGGATGCCGTCTGAAGATCCTCTAGAGTCGAC
C 
Insert DUS 
in the Tn5 
EZ-Tn5-Kan2-DUS-R GGATCTTCAGACGGCATCCGCCACGGTTGATGAGA
GC 
Ez-Tn5 Amplify 
primer 
CTGTCTCTTATACACATCTCAACC Amplify 
Tn5-DUS 
P5-ME biotin-AATGATACGGCGACCACCGAGATCTACGGTT
GAGATGTGTATAAGAGACAG 
 
Antisense Input CAAGCAGAAGACGGCATACGAGATACACGTCGGT
CTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
Library 1 
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TnSeq-PE-Index-YX1 CAAGCAGAAGACGGCATACGAGATACACGTCGGT
CTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
438_C 
TnSeq-PE-Index-YX2 CAAGCAGAAGACGGCATACGAGATGTACACCGGT
CTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
438_D 
TnSeq-PE-Index-YX3 CAAGCAGAAGACGGCATACGAGATCATGACCGGT
CTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
438_E 
TnSeq-PE-Index1 CAAGCAGAAGACGGCATACGAGATCGTGATCGGT
CTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
438_F 
TnSeq-PE-Index2 CAAGCAGAAGACGGCATACGAGATACATCGCGGT
CTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
Library 2 or 
438_A 
TnSeq-PE-Index3 CAAGCAGAAGACGGCATACGAGATGCCTAACGGT
CTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
Library 3 or 
438_B 
TnSeq Primer ACCGAGATCTACGGTTGAGATGTGTATAAGAGACA
G 
Sequencing 
TIS 
TnSeq Index SP GATCGGAAGAGCGGTTCAGCAGGAATGCCGAGAC
CG 
Sequencing 
barcode 
p: phosphorylation; *: phosphothioate bond; biotin: biotin-TEG modification; the Neisseria DNA 
Uptake Sequence (DUS) is underlined; bold: library specific barcode. 
Table 2.5 Oligonucleotides for conditional knockout assays 
Primer name Oligonucleotide Sequence (5’3’) 
Kan-SpeI-F CGACTAGTATCATCGATGAATTGTGTCTC 
Kan-SacI-R TAGAGCTCCTGAAGCTTGCATGCCTG 
Ptrc-F GCGCCGACATCATAACGGTTCTG 
Ptrc-R CATGGTCTGTTTCCTGTGTGAAATTG 
Kan-cassette-R CTGAAGCTTGCATGCCTGCA 
rib-up-f GTGCGTTTAATCAGTGAGTCAGGC 
rib-up-r TGCAGGCATGCAAGCTTCAGGCAATCGGAGTAAGCGGAAAA 
rib-down-f CACACAGGAAACAGACCATGCCTAAAATGAAAACCAAGTCTAGCG 
rib-down-r CGGCTTTATCGAACACGGCC 
PorB-up-f CTTCGCCGCACTGATTCAAGAAC 
PorB-up-r TGCAGGCATGCAAGCTTCAGGATGTGCATTTTGAAGGACGG 
PorB-down-f CACACAGGAAACAGACCATGAAAAAATCCCTGATTGCCCTGAC 
PorB-down-r GCGTATTGTACGCTGCCGCTG 
01315-up-F ATTGTTTGCCTACGAACCGCCG 
01315-up-R TGCAGGCATGCAAGCTTCAGCGTTACTTCAAACCGGCTTGC 
01315-down-F CACACAGGAAACAGACCATGTTTATCCCTGCCGCCCTGC 
01315-down-R CAGCATATTCCTCAATCCGGCACG 
04144-up-F GAAGCCGTTGACCGGTGGATAC 
04144-up-R TGCAGGCATGCAAGCTTCAGTTAATCTCCTAAACCTGTTTTAACAATG
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CC 
04144-down-F CACACAGGAAACAGACCATGGCATCATATGTTTCCATCAAAGGATGG 
04144-down-R GCCAACCTACGCTTACTGAAAACCA 
02103-up-F GAAGACGAAGCGGGCAAGC 
02103-up-R TGCAGGCATGCAAGCTTCAGCGGATTTGTTCTTTAACCCATTGGG 
02103-down-F CACACAGGAAACAGACCATGAACCCAACCAAACAATCCAAAAAAAG
C 
02103-down-R CATACACCCTTCAGGGAACTCTTATC 
00007-up-F ACCAAACTGTAACTTATCCTGCGACT 
00007-up-R TGCAGGCATGCAAGCTTCAGCGAGCCTGTTTTACTTTTATTCCG 
00007-down-F CACACAGGAAACAGACCATGAACATCGTTAAAAAATACGCTGTAAAA
GC 
00007-down-R GAACAGAATTAGAACCGTCGAACCGA 
00686-up-F CCGTTTCCCATACCGTCTGAATC 
00686-up-R TGCAGGCATGCAAGCTTCAGGATTTAAGAAGGAAGGTCAGCAGC 
00686-down-F CACACAGGAAACAGACCATGTCCGAACAACCCGAAAAACACC 
00686-down-R CGCCGATGTGGATGGGTTCTTTA 
Table 2.6 Oligonucleotides for genetic footprinting assays 
Primer name Oligonucleotide Sequence (5’3’) 
01048-up-f GCCGTCTGAACAGCCGATTCATAGACGAAATGCC 
01052-down-r CTTCGTATGCTTGGCGGTGGC 
1063-up-f GCCGTCTGAACGGCATAAAAGTCAGTGAGTTGGCG 
1068-down-r GAGTGACGAAAGGCGGGAACAAC 
Tn ME sequence GGTTGAGATGTGTATAAGAGACAG 
Neisseria DNA Uptake Sequence (DUS) is underlined. 
Table 2.7 Oligonucleotides for construction of genes knockout mutants 
Primer name Oligonucleotide Sequence (5’3’) 
00599-up-forward GCCGTCTGAATTTGGGCGCAAACCGTTTC 
00599-up-reverse TGAGACACAATTCATCGATGATGTTTCATGGCGGTGGTGTTC 
00599-down-forward TGCAGGCATGCAAGCTTCAGAATCAGGACAAGGCGACGAA 
00599-down-reverse GGATTTGGCGAGGTGGGAGAG 
01674-up-forward GCCGTCTGAAACTTGAACGACAAAACCCGC 
01674-up-reverse TGAGACACAATTCATCGATGATCTCATGATAACCTCGCTGTTGG 
01674-down-forward TGCAGGCATGCAAGCTTCAGTGATTCCGCAAAGCCGC 
01674-down-reverse TGACGACGGGTTGGACGAACA 
01912-up-forward GCCGTCTGAAGCGAAGCCGAAGTAGATGCT 
01912-up-reverse TGAGACACAATTCATCGATGATCTGTGTCATGGGATACCTTGC 
01912-down-forward TGCAGGCATGCAAGCTTCAGGATGATTGACCATAGGGTCGG 
01912-down-reverse CGCGAGAGTGCAGGGGCATTAA 
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01489-up-forward GCCGTCTGAATTCCTCAACGGCTACCGTTT 
01489-up-reverse TGAGACACAATTCATCGATGATGAGCGAGTTCATGTAGCCGT 
01489-down-forward TGCAGGCATGCAAGCTTCAGAACCATGCCGTCTGAAAAATACC
TG 
01489-down- reverse GGTGTGGCAGCGTAGGTAATGCTG 
01393-up-forward GCCGTCTGAAACCTCCAGCTTCCCTATGTC 
01393-up-reverse TGAGACACAATTCATCGATGATGTATAAGGCGGGTTTCAGCC 
01393-down-forward TGCAGGCATGCAAGCTTCAGTAATCGGCTCGCGATGCC 
01393-down-reverse GACGGTATCCAGCCCGCAC 
02032-up-forward GCCGTCTGAAGGGAAACGGAAGAAGCCAT 
02032-up-reverse TGAGACACAATTCATCGATGATCTTCGCTGTCGATAAAGTCGG 
02032-down-forward TGCAGGCATGCAAGCTTCAGCCGAATCCATGCCCGAAA 
02032-down-reverse AATCGGGCCGCAATCCAGCT 
00042-up-forward GCCGTCTGAATTCCAAGCGTTTGACGACGA 
00042-up-reverse TGAGACACAATTCATCGATGATCGTCCTTTTGAGTGTATGAAGG
G 
00042-down-forward TGCAGGCATGCAAGCTTCAGAACGCACATCCCGAAAAAATGC 
00042-down-reverse CCGATGATGATGAGCTGCGGC 
01836-up-forward GCCGTCTGAAAAACGCTCTCCAAACCTTCG 
01836-up-reverse TGAGACACAATTCATCGATGATAAAAAGATGGTTTCGGGCGG 
01836-down-forward TGCAGGCATGCAAGCTTCAGAACCGGCAAAACAATGCCG 
01836-down-reverse TGTCGAACGCAGGCGGTATGTG 
00860-00859-up- 
forward 
GCCGTCTGAACCCGTCTCTTCAGGATAAGC 
00860-00859-up- 
reverse 
TGAGACACAATTCATCGATGATGGGTTGGTTGATACTACTCAGA
GA 
00860-00859-down- 
forward 
TGCAGGCATGCAAGCTTCAGTCTAATCGCGGCGATATGCC 
00860-00859-down- 
reverse 
GGCACGAAGCGCGCGATGAT 
04218-up-forward GCCGTCTGAACTACGCCGGTCTGCAAAAAC 
04218-up-reverse TGAGACACAATTCATCGATGATCCGTTTGAAGTGGCGTTCAG 
04218-down-forward TGCAGGCATGCAAGCTTCAGATCCTAGTTGTCCAGGACGG 
04218-down-reverse CGATAATCCCCCATCCCGCC 
00072-up-forward GCCGTCTGAAGTGTTGGCGGCGATTCTGTTTG 
00072-up-reverse TGAGACACAATTCATCGATGATTCCTTGAATATCCGATGTTCCGC 
00072-down-forward TGCAGGCATGCAAGCTTCAGAGCCGCAGAATAAACATACACAT
CC 
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00072-down-reverse GCGGTACACGGTAACCAGGCTC 
01605-up-forward GCCGTCTGAACGCCATCATGTCCCTGAC 
01605-up-reverse TGAGACACAATTCATCGATGATGGCGGGCAATAAGAGTTCGG 
01605-down-forward TGCAGGCATGCAAGCTTCAGGAACCCCTGAGCCACAATG 
01605-down-reverse TGCCAAAGTAGCTGTGGAAGCCG 
01266-up-forward GCCGTCTGAACAACCTCAGCAAACAAAGCACG 
01266-up-reverse TGAGACACAATTCATCGATGATCTTGATGGTTGCGTACTCGGTT 
01266-down-forward TGCAGGCATGCAAGCTTCAGCGGACGGTATTTCCACAACAG 
01266-down-reverse GGCCCGCCAATTCTTTTGACAGG 
01643-up-forward GCCGTCTGAATTATTTGGTTTTGCCACTGCGGA 
01643-up-reverse TGAGACACAATTCATCGATGATCGGGACTCGAACCAGGAAAAT
A 
01643-down-forward TGCAGGCATGCAAGCTTCAGCTCAGCGAACACGTCGAGT 
01643-down-reverse GATTTGCCCATACCGCTTTGTCCG 
00506-up-forward GCCGTCTGAAGATGCGGGCGACAAGATTTTC 
00506-up-reverse TGAGACACAATTCATCGATGATGTTACGCCCGACATTATAAAAT
CCC 
00506-down-forward TGCAGGCATGCAAGCTTCAGCCAAAAATGTTTGCTCTTGCCGC 
00506-down-reverse TAATGCCCTGCCAGCGGTCG 
00827-up-forward GCCGTCTGAATGATGTTTCAAGTCGCTTTCG 
00827-up-reverse TGAGACACAATTCATCGATGATTGAAATGAAGCATCATAATCTA
AAGG 
00827-down-forward TGCAGGCATGCAAGCTTCAGGAAATGCCGTCTGAAACACCT 
00827-down-reverse GGCTTCAGACGGCATTTTGCC 
op_kan_s ATCATCGATGAATTGTGTCTCAAAATCTCTGAT 
op_kan_hfq-mut_as CTGAAGCTTGCATGCCTGCA 
01393-seq2 GGTTCGCTGATTCTGACCGC 
02032-seq2 GCAACTGCCGCTCTTTGAAACC 
01836-seq2 ACGGGAATAAGGTACAGCAGCC 
00042-seq2 GCCCAAGGTTACGCGCAC 
00860-00859-seq2 TCTCTTCCTGCGTCCACTGA 
00599-seq2 CCGGCTTCAAACTCAGCC 
01674-seq2 CGTATCATCGCGTCGATGCC 
01912-seq2 AGGCAACTTCGACAAAGCCG 
01489-seq2 GTCCGCTGAAGGCAAACAGC 
seq2-04218-f GGCGAGGCGATGATGGCATTC 
seq-01605-sense TCAAGCCTTCCCGTTCCACA 
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seq-01266-sense TTCTTTCCCTTTTCGCCTCC 
seq-00072-sense ATCCTTCGGCAGTATCACGCTG 
seq-01643-sense CGAAATCGTCAAAAACGGACAGGA 
seq-00506-sense GACCTGATTCCGACTGCCAA 
seq-00827-f ATCTGGTCGAATACGCTTCGTGG 
Neisseria DNA Uptake Sequence (DUS) is underlined. 
Table 2.8 Oligonucleotides for RT-PCR 
Primer name Oligonucleotide Sequence (5’3’) 
RNase P-F CGGAAAGTGGAACAGAAAGC 
RNase P-R GTTTGGTCTTGCTCCGAATG 
Rt-00506-forwards AGAAAAGTTACGAAGTGCCCA 
Rt-00506-reverse GTTTCGTTGCTCTCGTTCCTC 
Rt-01605-forwards TTCGTTGCCGACATGGAGCC 
Rt-01605-reverse TTTGAGGCTGTCCACACCG 
Rt-00072-forwards CGGTTGCCTTTCTCGCTTTC 
Rt-00072-reverse CCCTCAGCGTTTTTCTCGGC 
Rt-01266-forwards CACCGATACAAACGGGCTGC 
Rt-01266-reverse GATGTCCCACGGCATTTCGG 
Rt-01643-forwards TGGGCAAAATCGTAGAGTGGC 
Rt-01643-reverse GACTGCTTGGCATAGACGG 
Table 2.9 Oligonucleotides for NGFG_01605 
Primer name Oligonucleotide Sequence (5’3’) 
01605-BclI-F CGTGATCAATGAAAGCACCCGAACTCTTATTGC 
01605-HindIII-R CCCAAGCTTTCAGGGGTTCAACACGCG 
01605-HindIII-flag-R CCCAAGCTTTTACTTATCGTCGTCATCCTTGTAATCGGGGTTCA
ACACGCGTGC 
01605-BamHI-185-F CGGGATCCAACCACCGCGATCCCAAC 
L-01605-rt CCGATCCATCTGTCCGTACA 
R-01605-rt ATCGCGGTGGTTGAAATAGC 
Bold: restriction enzyme cutting sites 
Table 2.10 siRNA Oligonucleotides 
Primer name Sequence source 
siLuciferase ON-TARGETplus Non-targeting Pool, D-001810-10-05, Thermo Fisher 
Scientific
TM
 Dharmacon
TM
 
siGp96 ON-TARGETplus HSP90B1 siRNA, LU-006417-00-0002, Thermo 
Fisher ScientificTM DharmaconTM 
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2.1.5 Buffers, solutions and media 
Table 2.11 Media and solutions for cell culture  
Medium/Chemical  Source  
RPMI 1640  GIBCO  
DMEM  Sigma Aldrich  
Opti-MEM
®
 I Reduced Serum Medium GIBCO  
DPBS  GIBCO or Sigma Aldrich  
Tryple
TM
 Express  GIBCO  
Fetal calf serum (FCS)  PAA  
Table 2.12 Bacterial culture media and buffers 
Medium/Buffer  Ingredients  
Cell Stocking Medium 70% FCS, 10% DMSO, 20% cell medium (DMEM or RPMI 1640) 
LB Medium (1L)  10 g tryptone, 5 g yeast extract, 10 g NaCl  
LB Agar (1L) 10 g tryptone, 5 g yeast extract, 10 g NaCl, 15 g agar  
SOC medium 2% (w/v) bacto-tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose 
GC Agar (1L) 36.23 g GC agar base, after autoclaving add 1% vitamin mix  
PPM Medium (1L) 15 g proteose peptone, 5 g NaCl, 0.5 g soluble starch, 1 g KH2PO4, 4 
g KH2PO4. Adjust to pH 7.2. Sterilize by sterile filtration  
Vitamin Mix combine Vitamin Mix Solution I and II (add dH2O up to 2 L) 
Vitamin Mix Solution I  200 g D(+)-glucose, 20 g L-glutamine, 0.026 g 4-aminobenzoic acid, 
0.2 g cocarboxylase, 0.04 g iron(III) nitrate nonahydrate, 0.006 g 
thiamine hydrochloride (vitamin B1), 0.5 g NAD, 0.02 g vitamin 
B12, 52 g L-cysteine hydrochloride monohydrate; add 1 L dH2O  
Vitamin Mix Solution II  2.2 g L-cystine, 0.3 g L-arginine monohydrochloride, 1 g uracil, 0.06 
g guanine-hydrochloride, 2 g adenine hemisulfate, add 600 mL dH2O, 
30 mL 32% HCl 
Neisseria Growth or 
Conjugation Medium 
PPM medium supplemented with 1% vitamin mix and 0.5% NaHCO3 
Neisseria Transformation 
Medium 
PPM medium supplemented with 1% vitamin mix, 0.5% NaHCO3, 10 
mM MgCl2 
HEPES Medium 
(phosphate free medium)  
50 ml solution I, 10 ml solution II, 200 μl solution III, 3 ml solution 
IV/V, 5 ml solution VI, 50 ml solution VII, 50 ml solution VIII 
Up to 500 ml H2O, regulate pH 7.3, filter sterilization 
HEPES -Solution I 0.1% L-Alanine, 0.15% L-Arginine, 0.025% L-Asparagine, 0.025% 
Glycine, 0.018% L-Histidine, 0.05% L-Lysine, 0.015% 
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L-Methionine, 0.05% Proline, 0.05% L-Serine, 0.05%L-Threonin, 
0.061% L-Cysteine, 0.036% L-Cysteine, 0.05% L-Glutamine, 
0.046% reduced Glutathione (GSH), 0.0032% Hypoxanthine, 0.008% 
Uracil, 0.004% D-Biotin, add 18% 1 N NaOH and 82% H2O 
HEPES -Solution II 375 g/L Glucose 
HEPES -Solution III 10 g/L Fe(NO3)3·9H2O 
HEPES -Solution IV/V 
 
0.33% Nicotinamide adenine dinucleotide (NAD), 0.33% 
Carboxylase, 0.33% Thiamin, 0.33% Ca-Pantothenate, 0.188% 
CaCl2·2H2O, 4.17% Na-Lactate, 15.33% Glycerin, 3.33% 
Oxaloacetate 
HEPES -Solution VI 50 g/L MgCl2·7H2O 
HEPES -Solution VII 50 g NaCl, 34 g Na-Acetat in 1 L H2O 
HEPES -Solution VIII 23.8 g/L Hepes 
Table 2.13 Buffers for agarose gel electrophoresis, SDS-PAGE, western blotting, 
Immunofluorescence 
Buffers Ingredients/Source 
10x TAE (1L) 48.5 g Tris, 11.4 mL glacial acetic acid, 20 ml 0.5 M EDTA (pH 
8.0) 
10x TBE (1L) 54 g Tris, 27.5 g Boric acid, 20 ml 0.5 M EDTA (pH 8.0) 
4x SDS upper buffer (1 L)  0.5 M Tris/HCl (pH 6.8), 0.4% (w/v) SDS  
4x SDS lower buffer (1 L)  1.5 M Tris/HCl (pH 8.8), 0.4% (w/v) SDS  
8% SDS lower gel solution for 10 mL: 2.7 mL 30% acrylamide, 2.5 mL 4x lower buffer, 4.8 mL 
H2O, 100 μL 10% (w/v) APS, 10 μL TEMED 
10% SDS lower gel 
solution  
for 10 mL: 3.3 mL 30% acrylamide, 2.5 mL 4x lower buffer, 4.1 mL 
H2O, 100 µL 10% (w/v) APS, 10 µL TEMED  
12% SDS lower gel 
solution  
for 10 mL: 4 mL 30% acrylamide, 2.5 mL 4x lower buffer, 3.6 mL 
H2O, 100µL 10% (w/v) APS, 10 µL TEMED  
3% SDS upper gel solution  for 3.3 mL: 330 µL 30% acrylamide, 825 µL 4x upper buffer, 2.1 
mL H2O, 40 µL APS, 4 µL TEMED  
2x Laemmli buffer 4% (w/v) SDS, 20% (v/v) glycerol, 120 mM Tris/HCl (pH 6.8), 0.2 
mg/mL bromophenol blue, 0.1 M DTT 
10x SDS Electrophoresis 
buffer (1 L)  
30.25 g Tris, 144 g glycine, 10 g SDS 
Coomassie Staining 
solution 
44% methanol, 11% acetic acid, 0.2% Coomassie blue R250 
Coomassie Destaining 
solution  
20% methanol, 7% acetic acid 
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10x semi dry buffer (1 L) 24 g Tris, 113 g glycine, 2 g SDS 
Semi dry transfer buffer  1x semi dry buffer, 20% (v/v) methanol 
10x TBS-T (1 L)  48.5 g Tris, 175 g NaCl, 10 mL Tween-20, adjust to pH 7.5 with 
HCl  
Blocking solution for WB 1x TBS-T, 3% (w/v) BSA  
Restore
TM
 Plus Western 
Blot Stripping Buffer 
Thermo Fisher Scientific 
4% paraformaldehyde 
(PFA, 400 mL) 
40 ml 10x PBS, 16 g PFA, 80 µL 10 N NaOH, 320 mL H2O, 
regulate pH to 7.4 
Blocking solution for IF 1x PBS, 1% (w/v) BSA 
Permeabilization solution 1x PBS, 0.1% (v/v) Triton X-100 
Mowiol mounting medium 2.4 g Mowiol 4-88, 6 g glycerol, 6 mL H2O, 12 mL 0.2 M Tris/HCl 
(pH 8.5) 
Table 2.14 Buffers for neisserial RNA and DNA isolation 
Buffers Ingredients/Source 
GTE buffer  50 mM glucose, 25 mM Tris/HCl (pH 8.0), 10 mM EDTA (pH 8.0)  
TE buffer 10 mM Tris/HCl (pH 8.0), 1 mM EDTA (pH 8.0) 
Lysis buffer for RNA 
isolation 
TE buffer + 1 µL/10 mL Ready Lyse 
3M Sodium acetat solution 
pH 5.2 
Sigma 
Table 2.15 Buffers for protein purification, antibody purification and inclusion bodies’ 
isolation 
Buffers Ingredients 
Binding buffer 50 mM NaH2PO4, 300 mM NaCl, pH 8.0 
Lysis buffer Binding buffer, 10 mM imidazol, 1% Triton X-100, 1% NP40 
Washing buffer Binding buffer, 20 mM imidazol 
Elution buffer for protein 
purification 
Binding buffer, 250 mM imidazol 
0.2 M Carbonate buffer 
pH8.9 
10 mL 0.1 M Na2CO3, 90 mL 0.1 M NaHCO3 
Elution buffer for antibody 
purification 
0.2 M acetic acid (pH 2.7), 500 mM NaCl 
Lysis buffer for isolation 
of inclusion bodies 
10% saccharose, 50 mM Tris/HCl (pH 8.0), 1 mM EDTA (pH 8.0) 
NTE buffer 50 mM NaCl, 50 mM Tris/HCl (pH 8.0), 1 mM EDTA (pH 8.0) 
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Table 2.16 Annealing buffer for adaptor oligonucleotides 
Buffers Ingredients 
10x Annealing buffer 100 mM Tris/HCl (pH 7.5), 1 M NaCl, 10 mM EDTA (pH8.0) 
2.1.6 Antibodies 
Table 2.17 Primary antibodies for western blotting (WB) and immunofluorescence staining 
(IF) 
Antibody Origin Application/Dilution Source 
N. gonorrhoeae polyclonal rabbit IF 1:100 US Biological N0600-02 
PorB1A polyclonal mouse WB 1:500 Our lab  
AIF1 
(NGFG_01605) 
polyclonal rabbit WB 1:500 This study, ImmunoGlobe 
Hsp60 monoclonal mouse WB 1:500 Santa Cruz sc-57840 
Table 2.18 Secondary antibodies 
Antibody  Origin Application/Dilution  Source  
ECL
TM
 anti-mouse IgG HRP linked  Goat  WB 1:3000  Santa Cruz sc2005  
ECL
TM
 anti-rabbit IgG HRP-linked  Goat  WB 1:3000  Santa Cruz sc2004  
Anti-rabbit IgG Cy2-linked  Goat  IF 1:100  Dianova  
Anti-rabbit IgG Cy3-linked  Goat  IF 1:100  Dianova  
2.1.7 Kits 
Table 2.19 Kits 
Kit  Manufacturer  
Agilent High Sensitivity DNA Kit Agilent Technologies 
AxyPrep
TM 
Plasmid Miniprep Kit  Axygen  
EZ-Tn5
TM
 <kan> insertion Kit Epicentre Biotechnologies 
GeneJet
TM
 Gel Extraction Kit  Fermentas  
NEBNext
®
 dA-Tailing Module New England BioLabs 
NEBNext
®
 End Repair Module New England BioLabs 
NucleoSpin Tissue Kit Machery-Nagel 
QIAquick Gel Extraction Kit Qiagen 
RevertAid
TM
 First Strand cDNA Synthesis Kit  Fermentas  
  Material and methods 
35 
 
2.1.8 Chemicals 
2.1.8.1 Antibiotics 
Table 2.20 Final antibiotic concentrations used in this study 
Antibiotics E. coli (μg/mL) N. gonorrhoeae (μg/mL) 
Ampicillin 100 ---- 
Chloramphenicol 30 15 
Gentamicin ---- 50 
Kanamycin 50 40 
Erythromycin 250 7 
Tetracycline ---- 10 
Ampicillin and kanamycin were dissolved in H2O and sterile-filtered. Chloramphenicol, 
erythromycin and tetracycline were dissolved in 100% ethanol. 
2.1.8.2 Markers 
Table 2.21 DNA and protein markers used in this study 
Size standard Application  Manufacturer 
GeneRuler
TM
 100 bp plus DNA ladder DNA agarose gels Fermentas 
GeneRuler
TM
 1 kb DNA ladder DNA agarose gels Fermentas 
GeneRuler
TM
 50 bp DNA ladder DNA agarose gels Fermentas 
O’GeneRuler
TM
 100 bp DNA ladder DNA agarose gels Fermentas 
PageRuler™ Prestained Protein Ladder Protein PAGE Thermo Fisher Scientific 
2.1.8.3 Enzymes 
Table 2.22 Enzymes 
Enzyme Manufacturer 
DNase I Fermentas 
Klenow Fragment Fermentas 
Phusion Polymerase Thermo Fisher Scientific 
Restriction enzymes Fermentas 
RNase A Fermentas 
T4 DNA ligase Fermentas 
T4 DNA Polymerase Fermentas 
Taq Polymerase Genaxxon 
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2.1.8.4 Fine chemicals 
Table 2.23 Fine chemicals 
Chemicals Supplier 
Acrylamid Rotiphorese Gel 30 (37.5:1) Roth 
Ammonium persulfate (APS) Merck 
Bacto
TM
 Proteose Peptone No. 3 BD 
Bovine serum albumin (BSA) Roth 
Coomassie R250 Roth 
GC Agar base Oxoid 
GlycoBlue Ambion 
Lipofectamine
TM
 2000 Invitrogen 
PerfeCTa
TM
 SYBR
®
 Green FastMix
TM
, ROX Quanta Bioscience 
Phalloidin 555 Invitrogen 
Ready Lyse Epicentre® Biozym 
Roti
®
Aqua Phenol (pH 4.5-5) Roth 
Roti
®
Phenol/Chloroform/Isoamylalcohol (pH 7.5-8) Roth 
Saponin Sigma 
Sodium deoxycholate (DOC) Merck 
Soluble starch Riedel-deHaen 
Tetramethylethylenediamine (TEMED) Fluka Analytical 
Trichloroacetic acid (TCA) Roth 
All other chemicals were purchased from Roth, Sigma Aldrich, Serva or Merck Chemicals if 
not stated otherwise. 
2.1.9 Technical equipment 
Table 2.24 Technical equipment used in this study 
Equipment Supplier 
Agilent 2100 Bioanalyzer Agilent Technologies 
Automated Colony Counter New Brunswick Scientific 
Avanti
TM
 J-25T centrifuge Beckman Coulter 
Balance ABS-80-4  Kern 
Balance EW 1500-2M Kern 
Binocular SMZ-168 Motic 
C6 Flow Cytometer  Accuri 
Centrifuge CT15RE VWR 
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Chemiluminescence camera system  Intas 
DMIL light microscope Leica 
Hera Cell 240i incubator Thermo 
Hera Safe sterile bench Thermo 
Magnetic stirrer RMO Gerhardt 
Megafuge 1.0R centrifuge Heraeus 
MicroPulser
TM
 Electroporation Apparatus Biorad 
NanoDrop 1000 spectrophotometer Peqlab Biotechnology 
Optima Max-xp Ultra centrifuger Beckman Coulter 
PerfectBlue Semi-Dry Elektroblotter Peqlab Biotechnology 
Plate reader infinite 200  TECAN 
Scanjet G4010 HP 
SenTix pH Electrode WTW 
Shaker TR125 Infors HT 
Sonifier 250 Branson 
Sonorex RK 255S Bandelin 
Step One Plus real-time PCR system Applied Biosystems 
TCS SPE confocal microscope Leica 
Thermal cycler 2720  Applied Biosystems 
Thermal cycler GS1 G-STORM 
Thermo mixer comfort Eppendorf 
Ultrospec 3100 pro Spectrophotometer Amersham Bioscience 
Vortex shaker Reax 2000 Heidolph 
2.1.10 Software 
Office 2010 (Microsoft), NCBI blast (http://blast.ncbi.nlm.nih.gov), ClustalX2 [164], CorelDraw 
X6 (Corel Corporation), ABI StepOne v2.3 (Applied Biosystems), DNAMAN 6.0 (Lynnon 
Corporation), LAS AF confocal microscopy software (Leica), ChemoStar Imager software (Intas), 
ImageJ (http://imagej.nih.gov), Notepad++ (http://notepad-plus-plus.org/), ApE v2.0 (A plasmid 
Editor by M. Wayne Davis), Artemis 14.0 (Wellcome Trust Sanger Institute), Integrated Genome 
Browser (IGB) v7.0.4 (BioViz), Vector NTI (Life Technologies), Agilent 2100 Bioanalyzer Expert 
Software (Agilent Technologies) and Primer3web (http://primer3.ut.ee/) and EndNote X7 
(Thomson Reuters). 
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2.2 Methods 
2.2.1 Bacterial culture methods 
2.2.1.1 Cultivation of Neisseria gonorrhoeae 
Neisseria gonorrhoeae MS11 derivatives and transposon mutant library used in this study were 
grown on GC agar base plates supplemented with 1% vitamin mix at 37 °C in 5% CO2 in a 
humidified incubator. Neisseria were grown on GC agar plates for no longer than 16–18 h to avoid 
Neisseria autolysis. The appropriate antibiotic (Table 2.20) was added to the GC agar plates for 
selection of antibiotic resistant Neisseria mutants. The piliation and opacity phenotypes were 
distinguished and selected by colony morphology under a stereo microscope [165]. 
2.2.1.2 Determination of Neisseria gonorrhoeae growth curves 
Neisseria grown on GC agar plates for 16–18 h were inoculate in 10 ml pre-warmed (37 °C) 
Neisseria growth medium at an optical density (OD550) of 0.15. For equalization of the growth 
stages of different strains, the primary culture was grown at 190 rpm at 37 °C to an OD550 of 0.4–
0.5. Then the pre-culture was inoculated in 20 ml Neisseria growth medium at an OD550 of 0.1. 
Neisseria were then shaken at 190 rpm at 37 °C and the OD550 was measured every 30 min for a 
total of 180 min. 
2.2.1.3 Cultivation of Escherichia coli 
Escherichia coli strains were cultured overnight on LB agar plates supplemented with appropriate 
antibiotics (Table 2.20) at 37 °C and 5% CO2 in a humidified incubator. For plasmid DNA 
preparation or recombinant protein expression, E. coli strains were grown overnight in LB 
medium containing appropriate antibiotics under agitation on a rotary shaker (190 rpm) at 37 °C. 
  Material and methods 
39 
 
2.2.1.4 Bacterial stocks 
Neisseria strains grown on GC agar plate for 16–18 h were suspended in 1 mL PPM medium in a 
2 mL cryo tube whereas for E. coli stocks, 1 ml of overnight culture was transferred to cryo tubes. 
The bacterial cultures were then mixed with 350 µL 100% glycerol to a final concentration of 25% 
(v/v) and stored at −80 °C. 
2.2.2 Transformation of bacteria 
2.2.2.1 Neisseria transformation 
Piliated gonococci are naturally competent and readily take up DNA fragments containing 
Neisseria DNA uptake sequence (DUS) [166,167]. For transformation, piliated gonococci were 
selected and grown on GC agar plate for 16–18 h. Bacteria were collected in pre-warmed 
Neisseria transformation medium. OD550 was determined. 5×10
6 
bacteria were suspended in 50 µL 
Neisseria transformation medium and mixed with 10 ng PCR product by gentle pipetting. The 
mixture was dropped on a GC agar plate and incubated at 37 °C and 5% CO2 for 24 h. The 
resulting colony was resuspended in PPM medium and plated on antibiotics-supplemented GC 
agar plates for selection (Table 2.20). 
2.2.2.2 Neisseria conjugation 
Neisseria strains were grown on GC plates for 16–18 h and collected in pre-warmed Nesseria 
growth medium. 10
7
 donor and recipient Neisseria were mixed in 50 µL Nesseria growth medium 
and dropped on GC agar plate for incubation at 37 °C for 6–8 h until forming a visible colony. 
Colonies were collected in 1 mL PPM medium, and then serial dilutions were plated on selective 
GC plates and incubate for 24 h at 37 °C. 
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2.2.2.3 Transformation of E. coli 
Preparation of chemically competent E. coli DH5α 
E. coli DH5α was inoculated in 4 mL LB medium and cultured at 37 °C, 190 rpm overnight. The 
E. coli overnight culture was diluted 1:100 in 120 mL of LB medium and grown at 37 °C and 250 
rpm to an OD600 of 0.4. Bacteria were incubated on ice for 15 min and split into pre-cooled 50 ml 
Polypropylene tubes (Greiner) and collected by centrifugation at 4000 rpm and 4 °C for 10 min. 
The bacterial pellet was washed with 10 mL of ice-cold 0.1 M CaCl2 twice, and resuspended in 10 
mL of ice-cold 0.1 M CaCl2 and incubated on ice for 30 min. Subsequently, the bacteria were 
centrifuged at 4 °C at 4000 rpm for 5 min. The pellet was resuspended in 2 mL ice-cold 0.1 M 
CaCl2 containing 20% (v/v) glycerol. 100 µL aliquots were stored at −80 °C. 
Transformation of chemically competent E. coli  
An aliquot of chemo-competent E. coli strain was thawed on ice followed by addition of 0.68 µL 
β-mercaptoethanol and additional 10 min incubation on ice. DNA was added and incubated for 30 
min on ice. The cells were heat-shocked for 90 s at 42 °C, and incubated for 2 min on ice. 
Immediately 800 µL of pre-warmed SOC medium was added to the mixture and the bacteria were 
incubated for 1 h at 37 °C and 150 rpm. Bacteria were plated on selective LB agar plates 
supplemented with appropriate antibiotics (Table 2.20). 
Preparation of electro-competent E. coli BL21 
200 mL LB medium was inoculated with 1/100 volume of a fresh overnight E. coli culture and 
grown at 37 °C and 250 rpm to an OD600 of 0.5. The bacteria were chilled on ice for 20 min and 
harvested by centrifugation at 4000 g for 15 min at 4 °C. Afterwards, the bacterial pellet was 
washed with 200 mL ice-cold 10% glycerol, followed by 80 mL ice-cold 10% glycerol and 20 mL 
ice-cold 10% glycerol. Finally, the bacterial pellet was resuspended in 2 mL ice-cold 10% glycerol 
and stored at −80 °C in aliquots of 100 µL. 
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Electroporation of electro-competent E. coli  
An aliquot of electro-competent E. coli strain was thawed on ice, mixed with 5 µL DNA and 
incubated on ice for 1 min. The mixture was transferred to the bottom of the pre-cooled 0.2 cm 
electroporation cuvette. The electroporation setting “Ec2” of the MicroPulser™ Electroporation 
Apparatus was used. Immediately, 1 mL pre-warmed SOC medium (37 °C) was added to the 
cuvette, the cells were gently resuspended, transferred to a sterile tube and incubated at 37 °C at 
225 rpm for 1 h. Afterwards, the bacteria were plated on selective LB agar plates supplemented 
with appropriate antibiotics (Table 2.20).  
2.2.3 Cell culture methods 
2.2.3.1 Cultivation of cells 
All cell lines used in this study were cultured in 75 cm² cell culture flasks at 37 °C and 5% CO2, 
and passaged every two to three days before reaching 100% confluency. For passaging, the cells 
were washed with DPBS and incubated with 1 mL trypsin to detach the cells. After ~5 min 
incubation at 37 °C, pre-warmed complete cell culture medium was added to the flask to stop 
trypsin digestion. The cell suspension was either seeded in multi-well plates for experiments or 
transferred to a new 75 cm² cell culture flask for further cultivation.  
2.2.3.2 Cell stocks 
Cells were grown in 75 cm² cell culture flasks to 80–90% confluency. The cells were washed with 
DPBS once and then detached by incubation in 1 mL trypsin at 37 °C for ~5 min. After that, 4 mL 
of complete cell culture medium was added and the cell suspension was transferred to 15 mL 
falcon tubes. The cells were pelleted by centrifugation at 600 g for 5 min at room temperature. The 
cell pellet was resuspended in 5 mL pre-cooled cell stocking medium and transferred into cryo 
tubes in 1 mL aliquots. Immediately the cryo tubes were stored at −80 °C in a cell freezing 
container to cool down gradually with rate of −1 °C/min. For longer storage, the tubes were 
subsequently transferred to a liquid nitrogen tank. 
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2.2.4 DNA techniques 
2.2.4.1 Isolation of Neisseria genomic DNA 
Pelleted Neisseria was resuspended in 500 µL GTE buffer containing 200 µg/mL RNase A and 0.1% 
SDS and was incubated at 42 °C for 10 min until the solution was clear. The lysates were 
transferred to a Phase Lock Gel™ tube (5 PRIME GmbH) and mixed with one volume of 
phenol-chloroform (1:1). After shaking vigorously for 30 s, the mixture was centrifuged at 15,000 
rpm for 5 min. The aqueous phase was transferred to a new Phase Lock Gel™ tube and 
phenol-chloroform extraction was repeated. The upper phase was then transferred to a new tube 
and DNA was precipitated by adding 2.5 volumes of cold 100% ethanol and 0.1 volumes of 3 M 
NaAc (pH 5.2) followed by 1 h incubation at −20 °C. The DNA was pelleted by centrifugation at 
15,000 rpm and 4 °C for 15 min and washed with 2 volumes of ice-cold 75% ethanol. After 
centrifugation (15,000 rpm, 4 °C, 5 min) the pellet was air dried and dissolved in 100 µL distilled 
H2O. 
2.2.4.2 Construction of recombinant vector  
To construct a recombinant vector in E. coli, the inserted DNA fragment was amplified from 
recombinant plasmid or Neisseria genomic DNA with PCR (2.2.4.3) and purified with an 
appropriate method (2.2.4.5). The amplified DNA fragments and the target vector were digested 
with appropriate restriction enzymes (2.2.4.6). After purification, the inserts and the vector were 
ligated at a suitable ratio at 16 °C overnight (2.2.4.6). Subsequently, the ligation reaction was 
transformed into competent E. coli DH5α or XL1-blue (2.2.2.3) and plated on appropriate 
selective agar plates. Bacterial colonies were verified by cPCR to contain the recombinant DNA 
(2.2.4.7). Afterwards, plasmids from cPCR-positive colonies were isolated (2.2.4.8) and the 
inserted DNA fragment was confirmed by sequencing (2.2.4.9). 
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2.2.4.3 Polymerase Chain Reaction (PCR) 
A standard PCR reaction was performed in a 0.5 mL PCR tube with 50–100 ng template DNA, 10 
nmol dNTP, 10 pmol forward and reverse primers and 1 U Taq polymerase or 1 U Phusion 
polymerase in a total volume of 50 µL and using the following temperature profile: 30 s at 98 °C 
for Phusion or at 95 °C for Taq, 30 cycles of 10 s at 98 °C for Phusion or at 95 °C for Taq, 20 s at 
56–62 °C (depending on the melting temperature of the primer pairs) and at 72 °C for the time 
based on the length of the template [30 s/1 kb (Phusion); 1 min/1 kb (Taq)], and then 10 min at 
72 °C. PCR products were analyzed on agarose gels and, if required, purified using a PCR 
purification kit.  
2.2.4.4 Agarose gel electrophoresis 
DNA samples were mixed with 6× loading dye (Fermentas) and separated on agarose gels (in 1× 
TAE buffer or 0.5× TBE buffer) containing ethidium bromide (Roth) or Intas HD Green (Intas) by 
applying an electric field of 12 V/cm for about 45 min. DNA fragments shorter than 500 bp were 
separated on 2% agarose gels, longer fragments (500-3000 bp) on 1% agarose gels. DNA bands 
were visualized under UV light. 
2.2.4.5 DNA purification 
DNA fragments from PCR or DNA restriction enzymes digestion were separated on agarose gels, 
were excised with a scalpel under UV light and the DNA was recovered using the GeneJet
TM
 Gel 
Extraction Kit (Fermentas) according to the manufacture’s protocol. The DNA was eluted with 30 
µL dH2O and stored at −20 °C. The concentration of recovered DNA was quantified by a 
NanoDrop 1000 Spectrophotometer (Peqlab Biotechnology). 
2.2.4.6 Restriction and Ligation 
Amplified DNA and target vector were digested with appropriate Type II restriction enzymes 
(Fermentas). If there was no optimal buffer or working temperature for two restriction enzymes, 
  Material and methods 
44 
 
digestions were conducted serially. Generally 1 µg DNA was digested with 1 U of the respective 
restriction enzyme in the buffer system suggested by the supplier for 2–4 h at 37 °C. The digested 
DNA fragments and the linearized vectors were purified using GeneJet
TM
 Gel Extraction Kit 
(Fermentas). The DNA fragments and linearized vectors were quantified by a NanoDrop 1000 
Spectrophotometer (Peqlab Biotechnology) for ligation. 
In the ligation reaction mix, the optimal molar ratio of DNA fragments to linearized vectors was 
from 3:1 to 8:1 in a total volume of 20−30 µL. The ligation reaction was performed by T4 DNA 
ligase (Fermentas) at 16 °C overnight. 
2.2.4.7 Colony Polymerase Chain Reaction (cPCR) 
Colony PCR is a convenient high-throughput method for verifying recombinant plasmids directly 
from E. coli colonies or gene knockout mutants from Neisseria colonies. Each single colony was 
numbered and picked into 20 µL dH2O. Then the bacteria cells were lysed by heating to 95 °C for 
10 min followed by 5 min incubation on ice. The solution was spun down and 2 µL of the 
supernatant was used as the cPCR template. Following the schematic for a standard PCR reaction 
80 µL reaction mixture was aliquoted into ten PCR tubes (8 µL/tube) and 2 µL templates was 
added. The program for cPCR was the same as the standard PCR program. cPCR products were 
analyzed by agarose gel electrophoresis. 
2.2.4.8 Plasmid extraction from E. coli 
Plasmids were isolated from bacterial overnight cultures using AxyPrep
TM
 Plasmid Miniprep Kit 
(Axygen) or NucleoBond® PC 100 plasmid midiprep Kit (Macherey-Nagel) following the 
instructions of the manufacturer. 
2.2.4.9 DNA sequencing and analysis 
All sequencing reactions based on the dideoxy chain termination method according to Sanger [139] 
were performed by Seqlab Biotech. 15 µL sequencing sample containing either 1.2 µg plasmid or 
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22.5 ng/100 bp of PCR products was supplemented with 30 pmol sequencing primer. Sequencing 
data was analyzed by DNAMAN Version 6 (Lynnon Corporation). 
2.2.4.10 DNA analysis by Agilent 2100 Bioanalyzer 
To test the size range of DNA fragments and the amount of DNA fragments in each range, DNA 
fragments were measured on the Agilent 2100 Bioanalyzer using Agilent High Sensitivity DNA 
chip, suitable for separation and detection of DNA segments with size range of 50–7000 bp and 
quantitative range of 5–500 pg/µL. DNA concentrations were first measured with a NanoDrop 
1000 Spectrophotometer (Peqlab Biotechnology) and then diluted to a concentration of 5–500 
pg/µL before measurement on the Bioanalyzer. The Agilent High Sensitivity DNA chip then was 
loaded with DNA gel matrix containing DNA dye. 5 µL of marker and 1 µL of DNA sample were 
added into each well, followed by electrophoresis and measurement according to the 
manufacturer’s instructions. 
2.2.4.11 Site-directed mutagenesis 
In order to introduce the Neisseria DNA uptake sequence (DUS, 5’-atgccgtctgaa-3’) into the Tn5 
transposon, the Tn5 transposon was first inserted into pCR2.1-Topo (Invitrogen). The Tn5 
transposon from EZ-Tn5
TM
 <kan> insertion kit (Epicentre Biotechnologies) was dA-tailed by 
NEB’s dA-tailing module and subsequently cloned into pCR2.1-Topo (Invitrogen) according to 
the manufacturer’s instructions. The DUS was introduced to BamHI site of Tn5 transposon by 
site-directed mutagenesis with the primers EZ-Tn5-Kan2-DUS-F and EZ-Tn5-Kan2-DUS-R. 
Briefly, 25 µL PCR reactions with single primer EZ-Tn5-Kan2-DUS-F or EZ-Tn5-Kan2-DUS-R 
was performed with Phusion Polymerase using the following temperature profile: 30 s at 98 °C, 
followed by 5 cycles of 10 s at 98 °C, 20 s at 50 °C and 2 min at 72 °C, and 5 min at 72 °C. Both 
reactions were combined and a second PCR was performed: 30 s at 98 °C, followed by 18 cycles 
of 10 s at 98 °C, 20 s at 60 °C and 2 min at 72 °C, followed by 10 min at 72 °C. The methylated 
and non-mutated parental DNA templates in the PCR products were digested with 20 U DpnI for 3 
h at 37 °C followed by 20 min at 80 °C for DpnI denaturation. 5 µL of the resulting preparation 
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was transformed to chemically competent E. coli DH5α and the successful mutagenesis was 
checked by sequencing. 
2.2.5 RNA techniques 
2.2.5.1 Isolation of Neisseria total RNA 
Pelleted bacteria (1 mL of OD550 = 1.5) were resuspended in 800 µL lysis buffer containing 1 
µL/10 mL Ready Lyse. 80 µL 10% SDS was added to a final concentration of 1% (w/v) and was 
incubated at 64 °C for 2 min. The samples were supplemented with 88 µL (0.1 volumes) of 1 M 
NaAc (pH 5.2) and 1 mL (one volume) Roti
®
Aqua Phenol (pH 4.5–5) and were incubated at 64 °C 
for 6 min while inverting every 40 s. After chilling on ice for 2 min, samples were centrifuged at 
21,000 g and 4 °C for 5 min. The aqueous layer was transferred to a 2 mL Phase Lock Gel™ tube 
and mixed with 1 mL (one volume) of chloroform and centrifuged at 21,000 g and 4 °C for 5 min. 
The aqueous phase was then transferred to two new 2 mL tubes and mixed with 1 µL GlycoBlue 
(Ambion), 40 µL (0.1 volumes) of 1 M NaAc (pH 5.2) and 1 mL (2.5 volumes) of 100% ice cold 
ethanol and incubated at −80 °C overnight. The RNA was pelleted by centrifugation at 21,000 g 
and 4 °C for 25 min and washed with 1 mL (2.5 volumes) of ice cold 80% ethanol. The RNA 
pellets were air-dried and resuspended in 15.5 µL RNase-free H2O and treated with 2 µL (2 U) 
DNase I (Fermentas), 0.5 µL (20 U) RiboLock RNase Inhibitor (Thermo Fisher Scientific) and 2 
µL 10× DNase I buffer for 30 min at 37 °C. The solution was filled up with 100 µL H2O and 120 
µL (one volume) Roti
®
Phenol Chloroform Isoamylalcohol, mixed extensively and centrifuged at 
13,000 g for 20 min at 4 °C. The aqueous phase was transferred to a new 1.5 mL tube, mixed with 
12 µL (0.1 volumes) of NaAc (pH 5.2) and 300 µL (2.5 volumes) of 100% ice cold ethanol and 
incubated for 2 h at −80 °C, and then centrifuged at 13000 g and 4°C for 30 min. The pellet was 
washed with 70% ice cold ethanol, air dried and resuspended in 50 µL RNase-free H2O followed 
by incubation for 2 min at 56 °C. The RNA quantity and quality was checked by measurements at 
the NanoDrop 1000 Spectrophotometer (Peqlab Biotechnology) or 1% agarose gel, respectively. 
The total RNA was directly used for first-strand cDNA synthesis or stored at −80 °C. 
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2.2.5.2 First strand cDNA (complementary DNA) synthesis  
First strand cDNA synthesis was performed according to the manufacturer’s instructions from 
RevertAid First Strand cDNA synthesis Kit (Thermo Fisher Scientific). Briefly, 2 µg isolated 
RNA was added to 12 µL reaction mix containing 1 µL Random Hexamer primer, incubated at 
65 °C for 5 min and chilled on ice. Then 20 U RiboLock RNase Inhibitor, 1 mM dNTP and 200 U 
RevertAid M-MuLV Reverse Transcriptase were added to the mixture and were incubated in a 
thermocycler with the following temperature profile: 5 min at 25 °C, 60 min at 45 °C and 5 min 
at 70 °C. Controls without the enzyme RevertAid M-MuLV Reverse Transcriptase were prepared 
simultaneously. The cDNA was diluted 1꞉10 and was used as template in RT-PCR (2.2.5.3) or 
qRT-PCR (2.2.5.4). 
2.2.5.3 Reverse transcription PCR (RT-PCR) 
To check the expression of the associated gene in the knockout strains, RT-PCR was 
performed. 1 µl of a 1:10 dilution of the synthesized cDNA (2.2.5.2) was added to the 50 µL 
PCR mixture containing 10 nmol dNTPs, 10 pmol of gene specific forward and reverse primers, 
and 1 U Phusion polymerase. PCR reactions were performed with an initial denaturation step at 
98 °C for 30 s followed by 25 cycles of 98 °C for 20 s, 55 °C for 20 s and 72 °C for 15 s and a 
final incubation for 10 min at 72 °C. The constitutively expressed RNase P gene was used as 
positive control. To check for contaminating genomic DNA within the cDNA sample, the reaction 
was repeated using the Reverse Transcriptase-mock treated control sample (2.2.5.2). PCR 
products were checked on 1.5% agarose gel supplemented with 5% HD Green DNA dye. 
2.2.5.4 Quantitative real-time PCR (qRT-PCR) 
To test transcription levels of some genes, qRT-PCR was performed according to the 
manufacturer’s protocol using PerfeCTa
®
 SYBR
®
 Green FastMix
®
, Rox. Briefly, the synthesized 
cDNA (2.2.4.2) was diluted 1:10, of which 2 µL was used for 20 samples mixed with 98 µL dH2O 
and 200 µL PerfeCTa
®
 SYBR
®
 Green FastMix
®
, Rox. Primers designed by Primer3web were 
diluted to a final concentration of 1 µM. 5 µL primers mix and 15 µL cDNA mix constitute final 
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amplification mix and were added in one well of 96 well PCR plate. Each sample was measured in 
triplicates. PCR reactions were performed in a Step ONE Plus real-time PCR apparatus with 
holding phase of 95 °C for 30 s and 40 cycles of 95 °C for 10 s and 60 °C for 1 min. This was 
followed by determination of melt curves by incubating at 95 °C for 15 s, 60 °C for 1 min, and a 
gradual temperature increase to 95.3 °C with a rate of 0.3 °C/s followed by an incubation at 
95.3 °C for 15 s. In order to normalize the amount of input cDNA for different samples, the 
constitutively expressed 5sRNA was determined in each sample as internal standard. Resulting 
data were analyzed by StepOne v2.3. 
2.2.6 Protein techniques 
2.2.6.1 Expression of recombinant proteins in E. coli 
The full length of NGFG_01605 with stop codon was amplified from N. gonorrhoeae MS11 
genomic DNA with primers 01605-BclI-F and 01605-HindIII-R (Table 2.9) and cloned into 
pET28b at BamHI and HindIII restriction enzymes sites to express His-tag N-terminal fusion 
protein. The recombinant plasmid was transformed to E. coli SoluBL21strain and selected on LB 
agar plates with kanamycin. Single colonies were picked into 5 mL LB medium containing 
kanamycin and incubated overnight (200 rpm, 37 °C). Overnight bacterial cultures were used to 
inoculate fresh kanamycin-containing LB medium at a dilution of 1:20 dilution and were 
incubated at 250 rpm at 37 °C until on OD600 of 0.4–0.6 was reached. Then the cultures were 
induced by addition of a final concentration of 0.25 mM IPTG and were incubated at 25 °C and 
200 rpm for 4 h. Afterwards, the bacterial pellet was collected by centrifugation at 4,000 rpm and 
4 °C for 15 min. The pellet was either used directly for purification or stored at −20 °C. 
2.2.6.2 Ni-NTA purification of recombinant proteins from E. coli 
The bacteria pellets (2.2.6.1) were resuspended in 5.4 mL pre-cooled lysis buffer containing 1 
mg/mL lysozyme and incubated on ice for 30 min. The bacterial suspension was sonicated on ice 
for 10 min (Branson Sonifier 250; 50% duty cycle, output 4), the lysate was transferred in 12 ml 
polypropylene tubes (Greiner bio-one) and centrifuged at 10,000 g and 4 °C for 25 min. The pellet 
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was suspended in Laemmli buffer, whereas the supernatant was used for Ni-NTA His•Bind Resin 
purification. 500 µL Ni-NTA beads were equilibrated with 5 mL lysis buffer and incubated with 
the supernatant at 4 °C for 1 h on a rotary mixer. A purification column was equilibrated once with 
lysis buffer, the Ni-NTA beads were loaded on the column and the residual liquid was drained by 
gravity flow. The flow through was collected. Then the column was washed three times with 5 mL 
washing buffer. Afterwards, 1 mL elution buffer was added to the column to elute the protein. 
Elution was repeated five times. The purified protein was mixed with 100% glycerol to a final 
concentration of 20% and was stored at −20 °C. 
2.2.6.3 Bradford assay 
Concentration of proteins in solution was determined with the Bradford assay. A calibration curve 
was established by a series of BSA samples (0, 1.25, 2.5, 5.0 and 7.5 µg/mL respectively) in a 
final volume of 80 µL in a 96 well plate. 1 µL of the unknown protein samples were mixed with 
79 µL H2O. Every sample was prepared in duplicates. Then 20 µL of Bradford reagent was added 
to each well and mixed gently by pipetting without introducing air bubbles. The plate was 
incubated in the dark for 15 min and then analyzed by measuring the absorption at 595 nm in a 
plate reader (Tecan).  
2.2.6.4 SDS-PAGE and Western blotting 
Protein samples were resuspended in 2× Laemmli buffer and incubated at 95 °C for 5 min to 
denature the proteins. Then the samples were spun down and supernatants were loaded on the 10% 
SDS-polyacrylamide gels and electrophoresed at 12V/cm for 2 h.  
For Coomassie staining, gels were incubated in Coomassie brilliant blue staining buffer at room 
temperature for 45 min and subsequently washed with destaining buffer until the protein bands 
appeared without background.  
For Western blotting, gels were transfered on PVDF membranes using a semi-dry blotting 
chamber (Peqlab Biotechnology). Each PVDF membrane was activated by incubation in 100% 
methanol for 15 s. Then the transfer sandwich was assembled air bubble-free and contained (from 
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cathode to anode) 1 sheet of Whatman paper, the PVDF membrane, the polyacrylamide gel 
followed by 2 sheets of Whatman paper. Proteins were transferred at 0.8 mA/cm
2
 for 2 h. 
Subsequently, the membrane was blocked for 1 h at room temperature in 1× TBST with 3% BSA. 
Blocking buffer was discarded and the membrane was then incubated overnight with diluted 
primary antibody in 3% BSA/ 1× TBST at 4°C, followed by three 10 min washing steps. The 
membrane was then treated with secondary antibody (usually diluted 1:3000 in 1× TBST 
containing 5% non-fat dry milk) at room temperature for 1 h. The membrane was washed three 
times with 1 x TBST for 10 min., Equal volumes of ECL solutions 1 and 2 (Thermo Fisher 
Scientific) were mixed and added to the membrane. Chemiluminescence was detected by an 
INTAS Imager digital system and proteins were quantified by ImageJ (http://imagej.nih.gov). 
To reutilize the membranes for subsequent detections, the PVDF membrane was reactivated by 
incubation in 100% methanol for 5–10 s and washed with 1× TBST for 10 min for 3 times 
followed by incubation in stripping buffer (Thermo Fisher Scientific) for 15 min at room 
temperature. Afterwards, the membrane was washed three times with 1× TBST for 10 min and 
then blocked in 3% BSA in 1× TBST as described above.at room temperature for 1 h. The 
membrane was incubated with the new primary antibody. 
2.2.6.5 Protein precipitation 
In order to precipitate proteins from the supernatant, 1/100 volumes of 2% sodium deoxycholate 
(DOC) was added to the supernatant and the sample was incubated on ice for 30 min. Afterwards, 
1/5 volumes of 72% trichloroacetic acid (TCA) was added to a final concentration of 14.4% and 
the sample was incubated at 4 °C overnight. Then, the sample was centrifuged at 15,000 g at 4 °C 
for 30 min and the resulting protein pellet was washed twice with one volume of ice-cold 100% 
acetone, and re-pelleted for 10 min by centrifugation at 15,000 g and 4 °C. The pellet was 
air-dried and resuspended in a small volume of 2× Laemmli buffer for SDS-PAGE. If sample 
acidification by TCA resulted in a yellow color of the Laemmli buffer, 1 N NaOH or 1 M Tris/HCl 
pH 8.5 was used to neutralize the sample. Before SDS-PAGE analysis, the samples were mixed 
for 15 min at 65°C and 650 rpm and spun down. 
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2.2.6.6 Isolation of bacterial inclusion bodies for immunization 
To isolate inclusion bodies from E. coli protein expression strains, bacteria were harvested by 
centrifugation, the pellet was resuspended in 10 volumes of lysis buffer containing a final 
concentration of 0.5 mg/mL lysozyme and incubated on ice for 30 min. A final concentration of 
0.2% Triton X-100 was added to the sample and again incubated on ice for 30 min. Afterwards, 
the bacterial suspension was lysed by sonication on ice with 3 pulses of 30 s (BRANSON 
SONIFIER 250; 50% duty cycle, output 5) and pelleted by centrifugation at 17,000 rpm at 4 °C 
for 30 min. The pellet was resuspended in 1 M urea in NTE buffer and the sonication and 
centrifugation was repeated. Then, the pellet was resuspended in 7 M urea in NTE buffer. After an 
additional sonication step, the suspension was centrifuged in an ultracentrifuge (Optima Max-xp 
Ultra centrifuger, MLA-80-Rotor, 16×64 mm centrifuge tube) at 80,000 rpm and 4 °C for 15 min. 
The supernatant contained the inclusion bodies. The concentration of proteins within purified 
inclusion bodies was measured by Bradford assay (2.2.6.3). Electro-elution of the purified 
inclusion bodies was performed to remove residual urea. Briefly, 3 mg of the purified inclusion 
bodies was separated in 8% SDS-PAGE and stained with Coomassie brilliant blue for 10 min 
followed by rinsing in destaining buffer for 20 s and three 10 min washes in 1 M Tris/HCl pH 7.5. 
The band was cut out of the gel with a clean scalpel. Immunization of rabbits was performed by 
ImmunoGlobe. Residual amounts of purified inclusion bodies were stored as aliquots at −20 °C.  
2.2.6.7 Antibody purification 
Antibody was purified from rabbit serum by binding to and elution from immobilized antigen. 
First, an immobilized antigen column was generated by coupling of the recombinant protein 
(2.2.6.6) to cyanogen bromide-activated sepharose (CNBr; Sigma). 0.4 mg of recombinant protein 
used for immunization was re-buffered in 2 mL 0.2 M carbonate buffer pH 8.9 by a Vivaspin 6 
column (10,000 MWCO, Sartorius Stedim Biotech GmbH) according to the manufacturer’s 
instructions. 50 mg of CNBr beads (Sigma) were swelled in 10 mL of 1 mM HCl for 20 min, 
washed once with 0.2 M carbonate buffer and then immediately incubated with the recombinant 
protein at room temperature for 1 h and at 4°C overnight. The beads were washed twice with 0.2 
M carbonate buffer and then incubated in 100 mM ethanolamine for 1 h at room temperature to 
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block all the remaining coupling sites. Then the beads were washed three times with 0.2 M 
carbonate buffer and equilibrated with 500 mM NaCl in PBS. Next, the beads were incubated with 
10 mL serum and 15 mL PBS in a 50 mL polypropylene tube (Falcon) at 4°C overnight with slow 
rotation. The beads were harvested by centrifugation at 4,000 g and 4°C for 10 min and washed 
two times with 30 mL 500 mM NaCl in PBS. Then the beads were transferred to a column and 
washed with 500 mM NaCl in PBS continuously until no protein was detected in the flow through. 
For that purpose 1 µL of the wash was spotted onto a piece of nitrocellulose membrane and was 
stained with 0.1% Ponceau red in acetic acid. Subsequently, 1 mL elution buffer (0.2 M acetic acid, 
pH 2.7, 500 mM NaCl) was applied to the column and the eluted antibody was collected in tubes 
containing 200 µL 1 M Tris/Base to neutralize the pH. The presence of eluted antibody was 
checked by Ponceau red staining of 1 µl elute. Eluted antibody was re-buffered in PBS and 
concentrated with a Vivaspin 6 column to a volume of 100 µL. Purified antibody was mixed with 
87% glycerol to a final concentration of 45% and stored in aliquots at −80°C. 
2.2.7 Transposon library construction 
N. gonorrhoeae N2009 genomic DNA (gDNA) was extracted using the NucleoSpin Tissue Kit 
(Machery-Nagel). 0.5 µg gDNA was mutagenized in vitro with 0.12 pmol Tn5 transposon 
(EZ-Tn5
TM
 <KAN-2> Insertion Kit, Epicentre Biotechnologies) and purified by phenol extraction 
and ethanol precipitation. Gaps within the DNA were closed by 20 min incubation with 1 U T4 
DNA polymerase (Fermentas) and 2 nmol dNTPs at 11 °C for 20 min followed by heat 
inactivation at 75 °C for 10 min. After phenol-chloroform extraction and ethanol precipitation, 
nicks in the mutagenized DNA were ligated by treatment with 5 U T4 DNA ligase (Fermentas) at 
16 °C overnight. After precipitation, 0.1 µg mutagenized DNA was mixed with 50 µL N. 
gonorrhoeae N2009 suspension (OD550 = 0.32) and incubated for 24 h on GC agar plates. 
Resulting colonies were transferred to GC agar plates supplemented with kanamycin and were 
incubated for 48 h at 37 °C. The colonies were harvested in PPM medium and stored at −80 °C. 
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2.2.8 DNA sequencing sample preparation and Illumina 
sequencing 
Recombinant Neisseria gDNA was isolated as described (2.2.4.1) and sheared by sonication 
(Bandelin Sonorex RK 255S) with 10 pulses of 60 seconds duration followed by pauses of 30 s. 
Sheared DNA was blunted and A-tailed by NEB’s end repair and dA-tailing modules according to 
the manufacturer’s instructions. Custom adapters were produced by annealing a final 
concentration of 90 µM “Adaptor sense” and “Adaptor antisense” oligonucleotides (Table 2.4) in 
1x Oligo annealing buffer. The mixture was heated for 5 min at 94 °C and was allowed to cool to 
room temperature over 1 h. 0.4 nmol of adaptors were ligated to 0.5 µg A-tailed DNA with T4 
DNA ligase (Fermentas) at 16 °C overnight. The ligation products in a range of 250–400 bp were 
size-selected by gel extraction using QIAquick Gel Extraction Kit (Qiagen). 
Enrichment of DNA fragments containing parts of the transposon was performed by PCR with 
primers complementary to the adaptor and to the transposon mosaic end sequence (“Antisense 
Input” and “P5-ME”; Table 2.4). First, a PCR was performed with 4 nmol dNTPs, 0.05 µg DNA, 
4 pmol P5-ME primer, 2% DMSO, 0.4 U Phusion polymerase (Thermo Fisher Scientific) in a total 
volume of 20 µL and using the following temperature profile: 30 s at 98 °C, followed by 10 cycles 
of 10 s at 98 °C, 20 s at 45 °C and 30 s at 72 °C, and 10 min at 72 °C. In a second PCR, the 30 µL 
reaction volume contained 10 pmol of each primer “P5-ME” and “Antisense Input”, 6 nmol 
dNTPs, 2% DMSO, and 0.6 U Phusion. The following temperature profile was used: 30 s at 98 °C, 
followed by 10 cycles of 10 s at 98 °C, 20 s at 50 °C and 30 s at 72 °C and then 10 min at 72 °C, 
followed by 30 s at 98 °C, 18 cycles of 10 s at 98 °C, 20 s at 55 °C and 30 s at 72 °C and a final 
incubation of 10 min at 72 °C. PCR products of 250–300 bp were size-selected and gel purified 
prior to sequencing. 
Illumina sequencing was performed at the Max Planck Genome Centre Köln by Dr. Bruno Huettel 
and Dr. Richard Reinhardt. DNA was sequenced on an Illumina HiSeq 2000 sequencer using 101 
bp sequence cycles with a sequence primer that binds to the transposon mosaic end (TnSeq; Table 
2.4). The library specific barcode was sequenced by “TnSeq index SP”, which binds to the adaptor 
sequence next to barcode (Table 2.4). 
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2.2.9 Conditional knockout analysis 
Conditional knockout assays [168-170] were performed to validate a subset of candidate essential 
genes. For that purpose we exchanged the promoter of each candidate gene with the 
isopropyl-D-thiogalactopyranoside (IPTG)-inducible Ptrc promoter [171] flanked by a kanamycin 
cassette. Ptrc originated from a Hermes-10 vector [171], was PCR-amplified with primers Ptrc-F 
and Ptrc-R and was subsequently cloned into pGEM-T (Promega) thereby yielding pGEM-T-Ptrc. 
The kanamycin cassette containing a Neisseria DNA uptake sequence (DUS; 5’-atgccgtctgaa-3’) 
[166,167] was amplified from pCR2.1-Tn5-DUS (DUS was introduced in a BamHI site of the Tn5 
kanamycin cassette by site-directed mutagenesis; see section 2.2.4.11) using oligonucleotides 
kan-SpeI-F and kan-SacI-R. The PCR fragment was restricted with the endonucleases SpeI and 
SacI and was inserted in the accordingly restricted pGEM-T-Ptrc resulting in pGEM-T-kan-Ptrc. 
The kan-Ptrc cassette was amplified from pGEM-T-kan-Ptrc by the primers Ptrc-R and 
kan-cassette-R. Approximately 500 bp long regions upstream and downstream of the targeted 
promoter were combined with the kan-Ptrc cassette via fusion PCR. The oligonucleotides rib-up-f 
and rib-up-r as well as rib-down-f and rib-down-r were used for amplification of the upstream and 
downstream region, respectively (Table 2.5). The resulting PCR fragment was purified and used in 
transformation of N. gonorrhoeae MS11. Bacteria were plated on selective GC-plates containing 
with 40 µg/mL kanamycin. Successful promoter replacement was checked by amplifying the 
genomic region via PCR and sequencing of the respective PCR products. Subsequently, the 
mutants were conjugated with N. gonorrhoeae N220, a strain which encodes lac
q
 on the plasmid 
pTH10a (our unpublished results). Conjugants were selected on the GC-plates containing 40 
µg/mL kanamycin, 7 µg/mL erythromycin and 0.5 mM IPTG. Essentiality of the gene was tested 
by comparing bacterial growth in presence and absence of IPTG in GC-plates. 
2.2.10 Genetic footprinting 
Genetic footprinting on Neisseria transposed DNA fragments from in vitro and in vivo libraries 
was performed to validate a subset of the candidate identified essential genes as described before 
[146,172-174]. First, the predicted essential gene regions were amplified from chromosomal DNA 
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of N. gonorrhoeae N2009 by PCR. Purified PCR products were transposed in vitro with the 
EZ-Tn5 transposon and the gaps in transposed products were repaired as described above (chapter 
2.2.7). An aliquot of in vitro transposed DNA was used as control for PCR-based footprinting. 
Then, transposed DNA was transformed into N. gonorrhoeae N2009 and the mutants were 
selected on GC agar plates supplemented with kanamycin (GC-kan). The mutants were collected 
in PPM medium supplemented with 2.5 mM MgCl2 and 0.1 mM CaCl2, and incubate with 1 U/mL 
DNase I (Fermentas) at 37 °C for 30 min to remove remaining extracellular DNA. Subsequently, 
the mutants were passaged to a new GC-kan plate. After several passages on these selective plates, 
genomic DNA of the mutant pool was isolated by phenol-chloroform extraction and ethanol 
precipitation as described above (chapter 2.2.4.1). PCR-based genetic footprinting was carried out 
as described [146,172-174] by using a transposon-specific primer (Tn ME sequence; Table 2.6) 
and primers specific to each chromosomal region (Table 2.6). PCR reactions consisted of 200 ng 
transposed DNA fragments from in vitro or in vivo, 50 pmol of each primer, 10 nmol dNTPs, 2.5 
U Taq DNA polymerase (Genaxxon), and 0.4 U Phusion DNA polymerase in 1× buffer S in a 50 
µL reaction. The PCR program was as follows: 30 sec at 95 °C; 30 cycles of 94 °C for 30 sec, 
58 °C for 30 sec and 68 °C for 30 sec + 10 sec per cycle. PCR products were analyzed by gel 
electrophoresis on 1% agarose gel. 
2.2.11 Screening for virulence factors 
Glycerol stocks of the mutant library were recovered by growth on GC agar plates for 16–18 hours. 
4×10
7 
Chang cell were seeded in 6-well cell culture plates and grown to a confluency of 80–90% 
for infection. Chang cells were washed with HEPES medium twice and incubated in HEPES 
medium for 30 min before infection. Bacteria were collected in warm HEPES medium and added 
to the cells at an MOI of 100. After centrifugation for 3 min at 600 g, the infected cells were 
incubated for 1 h. To select for adherent and invasive cells (“output I library”), infected host cells 
were washed with HEPES medium three times and were lysed by treatment with 1% saponin for 
15 min and subsequent plating on GC agar plates. To select for invasive bacteria (“output II 
library”), infected host cells were incubated with 100 µg/mL gentamicin for 2 h prior to saponin 
lysis and plating. After 16–20 h, the selected mutants were collected from the agar plates, 
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resuspended in PPM medium and aliquots were prepared as glycerol stocks. Another aliquot of 
each library was washed with HEPES medium and used in another round of infection. In total, 
three subsequent infections were performed with each library. 
2.2.12 Quantification of total cell-associated and intracellular 
colony forming units 
Chang cells were grown in 24-well cell culture plates to 80–90% confluency and infected with 
gonococcal strains at an MOI of 50 in HEPES medium for 30 min. For quantification of total 
cell-associated colony forming units (CFU), the monolayers were washed with HEPES medium to 
remove the non-adherent bacteria and then lysed by incubated with 1% saponin for 7 min. Serial 
dilution of the lysates were plated on GC agar plates and the CFU were determined after 24 h 
incubation at 37 °C and 5% CO2. To quantify the intracellular viable bacteria, the infected 
monolayers were incubated with 50 µg/mL gentamicin for 2 hours prior to lysing in 1% saponin 
and plating. Gentamicin protection assay were performed at least three times in duplicate. 
2.2.13 Construction of gene knockout mutants in Neisseria 
Approximately 500 bp long regions upstream and downstream of the targeted gene were 
PCR-amplified from Neisseria genomic DNA (primers are listed in Table 2.7) and combined with 
a kanamycin cassette via overlap PCR (Fig. 2-1). The kanamycin cassette was amplified from Tn5 
transposon (EZ-Tn5
TM
 <kan> insertion kit, Epicentre Biotechnologies) with the primers op_kan_s 
and op_kan_hfq-mut_as (Table 2.7). The overlap PCR fragment was purified and transformed into 
the wild type strain N. gonorrhoeae N2009. After homologous recombination, bacteria were 
selected for successful homologous recombination events on GC plates containing 40 µg/mL 
kanamycin. The gene deletion was verified by amplifying the genomic region via PCR and by 
sequencing of the respective PCR products. 
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Fig. 2-1 Overview of the overlap PCR procedure for targeted gene knock-out in N. gonorrhoeae. 
PCR-amplified upstream and downstream homology regions of the interested gene are combined 
with a kanamycin cassette. The combined fragments are assembled and amplified via overlap 
PCR. 
As shown in Fig 2-1, the upstream and downstream regions and the kanamycin resistance cassette 
were amplified separately. 50 µL reaction mixture contained 10 nmol dNTP, 10 pmol forward and 
reverse primers, 50–200 ng Neisseria genomic DNA or Tn5 transposon and 1 U Phusion 
Polymerase. The program started with an initial step at 98 °C for 30 sec, followed by 30 cycles of 
10 sec at 98 °C, 15 sec at 55–65 °C (depends on the melting temperature of each paired primers) 
and 20 sec at 72 °C, and ended with an final step at 72 °C for 10 min. The PCR products were 
purified prior to fusion PCR. The upstream or downstream region was assembled with the 
kanamycin cassette by 10 PCR cycles without primers. The reaction mix of 20 µL was composed 
of 4 nmol dNTP, 25–100 ng upstream or downstream region, an equal molarity of kanamycin 
cassette, 0.4 U Phusion Polymerase and 0.5 U Taq Polymerase. The program had an initial step at 
98 °C for 30 s, 10 cycles at 98 °C for 10 s, 50 °C for 20 s and 72 °C for 20 s and a final step at 
72 °C for 10 min. Then the two reactions were mixed, aliquoted into two PCR vials and the PCR 
program was repeated. Then the assembled whole fragment was amplified by PCR by adding 30 
µL reaction mixture containing 10 pmol “upstream forward” primer and “downstream reverse” 
primer, 6 nmol dNTP, 0.6 U Phusion Polymerase and 0.5 U Taq Polymerase. PCR reactions were 
performed with an initial denaturation step at 98 °C for 30 s, 20 cycles at 98 °C for 20 s, 60 °C for 
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20 s and 72 °C for 1 min and a final elongation step at 72 °C for 10 min. The fusion PCR products 
were separated on 1% agarose gel and gel purified. The products were verified by sequencing 
(with “upstream forward” and “downstream reverse” primers, respectively) and the fusion 
fragments were transformed into Neisseria.  
2.2.14 Differential immunofluorescence staining 
Chang cells were grown on round glass coverslips (12 mm diameter, VWR) in 12 well cell culture 
plates to 60–70% confluency and infected with Neisseria strains in HEPES medium at an MOI of 
10 for 30 min. After several washes with HEPES medium, the cells were fixed with 4% 
Paraformaldehyd (PFA) for 15 min at room temperature. After washing with phosphate-buffered 
saline (PBS) unspecific antibody-binding sites were blocked with 1% bovine serum albumin (BSA) 
in PBS for 1 h. To stain the extracellular bacteria, the coverslips were incubated with a polyclonal 
rabbit anti-N. gonorrhoeae antibody (1:100 in 1% BSA, US Biological NO600-02) for 1 h, 
washed with PBS and incubated with a Cy2 conjugated goat anti-rabbit immunoglobulin G (1:100 
in 1% BSA, Dianova) for 1 h. After extensive washing with PBS, the cells were permeabilized 
with 0.1% Triton X-100 in PBS for 15 min. Detection of extra- and intracellular bacteria was 
performed as described above, with the exception that a Cy5-conjugated goat anti-rabbit 
immunoglobulin G (1:100 in 1% BSA, Dianova) was used for labeling. To stain host cell actin, 
cells were incubated with Alexa 555-conjugated phalloidin (1:70 in PBS; Invitrogen) for 20 min. 
Subsequently, the coverslips were washed with PBS, mounted on glass slides with Mowiol (Roth) 
and analyzed by confocal fluorescence microscopy on a Leica TCS SPE (Leica) using a 63x oil 
immersion objective (numerical aperture 1.4). Lasers used for detection of Cy2, Cy5 and Alexa 
555 were with the excitation wavelengths of 488 nm, 532 nm and 635 nm. Band-pass filters were 
set 520-550 nm, 570-600 nm and 660-710 nm respectively.  
2.2.15 GP96 knock-down in Chang by RNAi 
Chang cells were grown to 60–70% confluency in 12 well cell culture plates. Before transfection, 
the medium was changed to Opti-MEM
®
 media. The transfection mix was prepared with 100 µL 
Opti-MEM
®
 media, 25 nM siRNA (siluci or siGP96) and 3 µL HiPerFect transfection reagent 
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(Qiagen) in a sterile Eppendorf tube. The sample was mixed by vortexing and incubated at room 
temperature for 5–10 min to allow the formation of transfection complexes. The transfection 
complexes were added to cells dropwise and were distributed by gently swirling the plates. The 
transfected cells were sub-cultured after 24 h and transfection efficiency was analyzed by 
collecting cells at 24 h, 48 h and 72 h post transfection in order to determine the appropriate time 
of gene silencing. 
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3 Results 
3.1 Construction and sequencing of a transposon mutant 
library in Neisseria gonorrhoeae 
3.1.1 Construction of a high-density transposon mutant 
library in N. gonorrhoeae 
With completion of the gonococcal genome sequence (Supplementary Table 6.1) [175,176], the 
study of Neisseria gonorrhoeae has entered the post genomic era. Many of the sequenced and 
predicted genes are still of unknown function and thus genome wide strategies are required to aid 
in annotation of the genome to identify novel drug and vaccine targets as well as virulence factors 
in the pathogen. In this study, a genome-wide high-density random transposon mutagenesis library 
was successfully established in N. gonorrhoeae strain MS11 with Tn5 transposon containing a 
kanamycin resistance marker (Fig. 3-1A). 
Two steps, transposition and transformation, are critical for construction of a high density 
transposon mutant library. Since efficient transformation of N. gonorrhoeae depends on the 
presence of a DNA uptake sequence (DUS), an attempt was undertaken to introduce a synthetic 
DUS into a modified Tn5 transposon (chapter 2.2.4.11). However, usage of the so-called 
Tn5-DUS did not significantly increase the frequency of insertion events (data not shown). Further 
it was observed that DNA isolation by phenol extraction (chapter 2.2.4.1) strongly inhibited the in 
vitro transposition. In order to obtain high-quality chromosomal DNA without phenol 
contamination, Neisseria chromosomal DNA was isolated from MS11 derivative strain N2009 by 
a silica column-based method (chapter 2.2.7). Subsequently Neisseria genomic DNA was 
subjected in vitro to Tn5 transposon mutagenesis.  
Since in vitro transposition of Tn5 leaves 9 bp gaps flanking each side of the inserted transposon, 
the gaps were filled and covalently closed by treatment with T4 DNA polymerase and T4 DNA 
ligase, respectively. Mutagenized DNA was transformed into N. gonorrhoeae N2009 and 
  Results 
61 
 
recombinant bacteria were selected by kanamycin. A single reaction thereby produced about 
20,000 kanamycin-resistant colonies. After a total of six independent repetitions, more than 
100,000 individual colonies were obtained and subsequently pooled.  
 
Fig. 3-1 Generation and sequencing of a transposon mutant library.  
(A) Construction of a genome-wide random transposon mutant library. Neisseria genomic DNA 
is mutagenized in vitro by Tn5 transposon containing a kanamycin resistance marker, and then 
transformed naturally into a Neisseria population. The bacteria are selected on GC agar plates 
with kanamycin and subsequently pooled. 
(B) Preparation of Illumina sequencing sample. Genomic DNA from the pool is extracted, 
fragmented and ligated to Illumina PE adaptors. Transposon junctions are amplified with the 
primers complementary to transposon mosaic ends (ME) and adaptors. The DNA fragments 
carrying terminuses (orange, blue) compatible to the Illumina flow-cell are amplified on a cluster 
station and then sequenced specifically with the sequencing primer (TnSeq Primer) that binds to 
transposon mosaic ends and the library specific barcodes are sequenced by TnSeq index SP. 
3.1.2 Sequencing the transposon mutant library 
To identify transposon insertion sites (TIS) in the mutant library, the DNA sequences adjacent to 
TIS were amplified and sequenced by Illumina sequencing (Fig. 3-1B). Neisseria genomic DNA 
from the mutant pool (chapter 2.2.4.1) was extracted and sheared by a water bath sonication to 
achieve a fragment size distribution of 300–500 bp. The electrophoresis of fragmented Neisseria 
genomic DNA is depicted in Fig. 3-2A (Lane 2, 4 and 6). The results were further confirmed by 
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measurement with an Agilent 2100 Bioanalyzer (Fig. 3-3A). The sheared DNA was blunted and 
A-overhangs were added prior to the ligation of Illumina PE adaptors (chapter 2.2.8). The 
adaptors contained a T-overhang and non-complementary regions resulting in a Y-shaped 
conformation to avoid self-ligation of the adaptors. Selective amplification of the DNA sequences 
adjacent to transposon insertion sites was performed by PCR with primers complementary to the 
adaptor and to the transposon mosaic end sequence (P5-ME and Antisense input, Table 2.4). In 
order to test the specificity of the amplification, control reactions were performed containing 
either only the adaptor-specific primer or only the transposon-specific primer. However, 
non-specific amplification products were not observed (Fig. 3-2B). Further, PCR products were 
cloned into pCR2.1-TOPO vector by TA cloning. The resulting plasmids were verified by EcoRI 
digestion and subsequently the inserts from the recombinant plasmids were sequenced by Sanger 
sequencing (SeqLab). The sequencing results indicated that the inserts were indeed Neisseria 
genomic DNA sequence containing a transposon mosaic end sequence on one end (data not 
shown). PCR products were further analyzed by agarose gel electrophoresis (Fig. 3-2B) and on an 
Agilent 2100 Bioanalyzer (Fig. 3-3B). The gels and electropherograms demonstrated that most 
DNA fragments were in the size range from 200 to 400 bp. The PCR products were size-selected 
by gel extraction and the fragments between 250 and 300 bp were purified and sent for sequencing 
on an Illumina HiSeq 2000 next-generation sequencing platform (Max Planck genome Centre, 
Cologne) using a custom sequencing primer that binds to the transposon mosaic end. Illumina 
sequencing cluster generation was enabled by addition of sequences to the PCR primers that were 
complementary to two specific capture oligonucleotides on the Illumina flow cell. The library 
specific barcodes were sequenced by TnSeq index SP thus enabling multiplexing of the libraries.
1
 
                                                        
1 Dr. Richard Reinhardt and his colleagues (Max Planck Genome Centre, Köln) performed the Illumina 
sequencing and preliminary quality control of the sequencing reads (Fig. 3-4). 
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Fig. 3-2 Quality of DNA fragments obtained in the process of sequencing sample preparation was 
tested by agarose gel electrophoresis.  
(A) Electropherogram of isolated Neisseria genomic DNA before and after sonication. Lane 1, 3 
and 5 indicate complete Neisseria genomic DNA. Lane 2, 4 and 6 indicate the results of 
fragmentation of Neisseria genomic DNA after sonication.  
(B) Enrichment of transposon-chromosomal junctions was performed by PCR amplification with 
primers complementary to transposon mosaic ends (ME) sequence and adaptors sequence (Lane 
1). Lane 2 indicates the PCR amplification products only with transposon-specific primer. Lane 3 
indicates the PCR amplification products only with adaptor-specific primer. M: 100 bp DNA 
ladder. 
 
Fig. 3-3 Size range and the amount of the DNA fragments measured by Agilent 2100 Bioanalyzer. 
The X-axis represents the product size in bp and the Y-axis is the arbitrary fluorescence intensity 
in fluorescence unit (FU). The DNA markers present are the lower marker at 35 bp (left peak) 
and the upper marker at 10,380 bp (right peak). (A) DNA fragmentation. (B) PCR enrichment of 
transposon-chromosomal junctions. 
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3.2 Analysis of sequencing data 
A single sequencing run yielded more than 30 million raw sequencing reads. Firstly, the quality of 
the sequencing reads was checked by the software Fast QC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The evaluation report indicated the 
library was random and diverse (Fig. 3-4). For example, 101 bases sequencing reads were obtained 
with 94 bases high quality and the last 7 bases good quality (Fig. 3-4A). It indicated the quality of 
each base in the sequencing reads was credible. The percent of G, A, T and C appeared in each 
base of the reads should be nearly 25%. The report of Per Base Sequence Content (Fig. 3-4B) 
indicated the percent of G, A, T and C appeared in most bases of the reads except the first 9 bases 
was nearly the same, about 25%. The first 9 bases were the duplication sequences caused by 
transposition, which indicated the position of a transposon insertion site. The analysis report 
showed there may be insertion preference of Tn5 or bad sequencing quality at the beginning of the 
sequencing. Another evaluation index is the GC distribution over all sequences. The GC count per 
read in red nearly coincided with the theoretical distribution shown in Fig. 3-4C. 
  Results 
65 
 
 
Fig. 3-4 Quality control of the sequencing reads made by Fast QC
2
.  
(A) Quality scores across all bases. The X-axis represents the position of the base in the 
sequencing read. The Y-axis represents the quality of the base in −10*lg (p), p: measuring error 
probability. The green background corresponds to high quality reads, the yellow background to 
intermediate quality reads and the red background to poor quality reads. Most bases in the reads 
(93%) were in high quality. 
(B) Sequence content across all bases. The X-axis represents the position of the base in the 
sequencing read. The Y-axis represents the percent of G, A, T and C appeared.  
(C) GC distribution over all sequence. The red line is GC count per read and the blue is the 
theoretical distribution. 
                                                        
2 Quality of the sequencing reads was analyzed by Dr. Richard Reinhardt and his colleagues. 
  Results 
66 
 
All these indexes indicated the sequencing were of high quality and thus were used for mapping to 
the Neisseria genome
3
. For mapping, the primer and adaptor sequences were firstly trimmed from 
the original sequencing reads and all remaining sequences longer than 12 bp (more than 97%) 
were mapped on the ring chromosome (2,233,640 bp) and the plasmid (4,153 bp) of N. 
gonorrhoeae MS11 version 4 (Neisseria gonorrhoeae group Sequencing Project, Broad Institute 
of Harvard and MIT, http://www.broadinstitute.org/) using Bowtie 2.0.2 [177]. The mapping 
demonstrated 87,812 unique transposon insertion sites distributed across the whole genome (Table 
3.1, Fig. 3-5A). This indicated that almost all the genome sequence contained a very high density 
of transposon insertions with an average of one insertion every 25 bp. There was no difference in 
TIS percentages between coding sequences (CDS) and intergenic regions, demonstrating that the 
TIS distribution was random without a bias for either coding or intergenic regions (Fig. 3-5B). 
Also there was no bias in the TIS positions within the CDS (Fig. 3-5C). In order to validate the 
reproducibility of sequencing, genomic DNA was isolated from the same library and two 
additional sequencing samples were prepared. The subsequent two sequence runs yielded 84,335 
(Library 2 or 438_A) and 86,327 (Library 3 or 438_B) transposon insertion sites which were 
identified on the N. gonorrhoeae MS11 ring chromosome. Since reproducibility among the 
technical replicates was very high (Pearson correlation coefficient p=0.994; p-value < 2.2e-16), 
library 2 was chosen for further analysis.  
Table 3.1 Overview of sequencing results 
 
Library 1 Library 2 (438_A) Library 3 (438_B) 
Sequencing reads 31,771,224 
a
 54,346,653 30,541,365 
Processed 
b
 30,888,325 (97%) 40,538,502 (75%) 19,480,906 (64%) 
Mapped 
c
 11,293,160 (37%) 37,835,517 (93%) 17,708,811 (91%) 
Unique TIS 
d
 87,812 125,666 129,055 
Intragenic TIS 66,509 100,791 102,566 
a 
Including internal control sequences from Enterobacteria phage φX174 
b
 Passing primer/adaptor trimming (length ≥ 12 bp) 
c
 Mapping to new assembly of MS 11 genome sequence and its cryptic plasmid 
d
 Unique transposon insertion site (TIS) on the Neisseria chromosome and plasmid 
                                                        
3 Christian Remmele performed raw data processing and mapping. 
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Fig. 3-5 Tn-seq mapping results show that the distribution of Tn5 insertions is random, unbiased, 
and of high density
4
. 
(A) Distribution of transposon insertion sites (TIS) across the whole genome of MS11. The X-axis 
represents the whole genome of MS11 and the Y-axis represents the number of mapped 
sequencing reads in log2 scale.  
(B) Proportion of the counts of the sequencing reads and the TIS demonstrate that there is no 
insertional bias between the coding regions or intergenic regions in the Neisseria genome.  
(C) Positional distribution of TIS in CDS normalized by gene length demonstrates that there is 
no bias in the position of TIS within coding regions. The full gene length is regarded as 100% 
(X-axis) whereas the Y-axis represents the number of TIS identified at the relative position 
within the gene. 
3.3 Identification of Neisseria essential genes 
For the 2526 genes encoded by the N. gonorrhoeae MS11 genome (including 350 newly annotated 
genes)
5
, the counts of the sequencing reads and the number of separate transposon insertion sites 
(TIS) per gene are shown in Table S1. The number of TIS per gene varied between 0 and 506, 
with a median of 31. Up to 81.9% (2069 genes) of the genes have less than 50 TIS and very few 
                                                        
4 Tn-seq mapping was done by Christian Remmele. 
5 The preliminary annotation of the N. gonorrhoeae MS11 genome (version 4) consists of 2185 CDS (2176 CDS 
on the chromosome and 9 CDS on the plasmid) (Neisseria gonorrhoeae group Sequencing Project, Broad Institute 
of Harvard and MIT). Christian W. Remmele et al augmented the MS11 genome annotation. 350 CDS on the 
chromosome and 5 CDS on the plasmid were new annotated (Table S1). 
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genes contain more than 150 TIS (Fig. 3-6A). The mutants with TIS in essential gene are not 
viable and missing in transposon mutant libraries, so these TIS located in the essential genes 
cannot be detected from Tn-seq data. Theoretically, genes without TIS or with strongly depleted 
TIS were considered to be essential for Neisseria survival and growth. However, TIS were 
detected in nearly all the genes with different frequencies which can be evaluated only with the 
statistical analysis. P-value was assigned to assess gene essentiality which assume uniform 
transposon insertion rates across the whole genome and neutral fitness costs of each mutant [152]. 
The P-value of each gene is shown in Table S1. Occasionally, transposon insertions in a 
non-essential gene might disrupt the expression of an essential gene downstream in the same 
operon. This kind of mutants could not survive which might result in false-positive essentiality 
calls. Therefore, the predicted essential genes were divided into two groups, 480 genes of which 
are not contained within operon, whereas 301 genes are within an operon structure (Fig. 3-6B). 
This information is also included in Table S1. Since an unequivocal assignment of sequence reads 
to duplicated genes is not possible, P-values for duplicated genes were adjusted (Table S1).
6
  
 
Fig. 3-6 Distribution of TIS in one gene indicated the essentiality of the related gene. 
(A) Number of transposon insertion site (TIS) per gene. 19 genes have no TIS, 2069 genes (81.9% 
of the total genes) have less than 50 TIS, 102 genes (4% of the total genes) have more than 100 
TIS, and the average TIS per gene is 31. 
(B) Number of the predicted essential genes or non-essential genes belonged to the group of genes 
in operon or genes not in operon. 480 essential genes are not within operon, whereas 301 essential 
genes are within an operon structure. 1204 genes are non-essential and not within operon, while 
541 non-essential genes are within operon structure. 
                                                        
6 Bioinformatics analysis of the data was done by Christian Remmele. 
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In summary, 781 genes with P<0.05 were designated as essential for Neisseria survival and 
growth (Table S2). The list contains some well-known essential genes involved in fundamental 
biological processes, such as DNA replication, DNA recombination, DNA repair, transcription, 
ribosomal structure and biogenesis, as well as translation and energy production. For example, all 
aminoacyl-tRNA synthetase genes and the genes encoding subunits of ATP synthase were 
identified as essential in this study. In addition, seven out of the eight subunits of the multimeric 
DNA polymerase III were identified as essential. The remaining gene NGFG_00714, which is 
annotated as exonuclease and epsilon subunit of DNA polymerase III was unlikely to be essential 
(P=1), whereas NGFG_00762 (P=0.00073) also encodes an epsilon subunit and thus might 
functionally replace NGFG_00714. 
Exemplary, triosephosphate isomerase (TIM, NGFG_00153) was identified as an essential gene. 
TIM plays an important role in glycolysis and is essential for efficient energy production [178]. 
Fig. 3-7 showed the distribution of mapped sequencing reads (black and green lines) in the 
according chromosomal region. Only very few transposon insertions were detected in the coding 
region and also in the promoter region of the gene NGFG_00153 encoded TIM (P=0.00073). By 
contrast, the genes upstream and downstream of TIM, NGFG_00152 and NGFG_00154, displayed 
high insertion density which resulted in P-values of 0.30367 and 0.99151 respectively, thereby 
defining NGFG_00152 and NGFG_00154 as non-essential genes (Fig. 3-7). However, 
NGFG_00152 (encoded preprotein translocase SecG subunit) only shows a lot of reads at the 
C-terminus and the majority of the ORF is not targeted by Tn5. It is possible that the C-terminal 
domain of SecG might not be important for the function and the protein without C-terminal 
domain is still functional, therefore the gene might still be essential. 
The putative essential genes list includes 215 of the 307 essential genes in E. coli MG1655 [179] 
that have orthologs in Neisseria gonorrhoeae MS11 (70%), suggesting that a high percentage of 
essential E. coli genes have orthologs in N. gonorrhoeae that are also essential (Table S3). The rest 
566 genes contain genes involved in fundamental cellular processes, such as ribosomal proteins, 
subunits of ATP synthase and enzymes for DNA metabolism which might be essential in other 
bacteria just not in E. coli. Besides, it shows some species specific essential genes including 
conjugal transfer pilus assembly proteins, irons binding and transport proteins, ABC transporters 
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and also 112 hypothetical proteins and 29 phage proteins. Some of them have been previously 
identified as essential: Omp85 (NGFG_01715, P=0.00073) [180], PorB (NGFG_01725, 
P=0.00073) [181,182] and the alternative sigma factor RpoH (NGFG_00430, P=0.00073) [169]. 
The predicted essential genes especially Neisseria specific essential genes could be putative 
targets for vaccine and antibacterial drug development. 
 
Fig. 3-7 Triosephosphate isomerase (TIM) is an essential gene. Distribution of mapped 
sequencing reads (black and green lines, merger of three libraries) shows transposon insertion 
sites on a segment of the Neisseria gonorrhoeae MS11 genome encoding TIM. The non-essential 
genes NGFG_00152 and NGFG_00154 (grey; P=0.30367 and 0.99151, respectively) have a lot of 
sequencing reads, while TIM encoded by NGFG_00153 (green) does not display such a read 
density and thus constitutes an essential gene (P=0.00073). The predicted promoter region of 
TIM (white box upstream of NGFG_00153) is also essential. 
3.4 Validation of gene essentiality 
Many of the predicted essential genes are required for fundamental biological processes, however, 
more than 15.4% (120 genes) of the putative essential N. gonorrhoeae genes were annotated as 
hypothetical proteins. To test the essentiality of a subset of these candidate drug and vaccine 
targets, mutagenesis of the genes, conditional knockout assays and genetic footprinting studies 
were performed.  
3.4.1 Conditional knockout assay 
Conditional knockout assay was established to test the essentiality of some candidate essential 
genes [168-170] which were listed in Table 3.2. The native promoter sequences of the candidate 
essential genes might be recognized by RpoD (σ70) which represents GC house-keeping sigma 
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factor, so the promoter sequence were predicted by BPROM (a bacterial sigma 70 promoter 
recognition program) [183]. Exemplary, in order to test the essentiality of the putative essential 
genes NGFG_00442 and NGFG_00443 (50S ribosomal protein L35 and L20, with P-values of 
0.00073 and 0.00914, respectively), the predicted native promoter was detected 117 bp upstream 
of the operon. The native promoter was replaced with a kanamycin-Ptrc cassette containing the 
IPTG-inducible promoter Ptrc amplified from Hermes-10 vector [171]. Afterwards, the mutants 
were conjugated with N. gonorrhoeae MS11 N220, a strain containing pTH10a [171] which 
constitutively expresses the repressor lacI
q
. By replacement of the promoter region, the expression 
of the candidate gene was conditional inhibited by omitting IPTG. Accordingly, the conditional 
knockout of NGFG_00442–00443 grew on GC-plates supplemented with 0.5 mM IPTG but did 
not survive on GC plates without IPTG. These data indicated that the ribosomal proteins encoded 
by NGFG_00442 and NGFG_00443 are essential for N. gonorrhoeae growth and that the assay 
was functional. By contrast, for NGFG_01725, NGFG_01315 and NGFG_00686, the 
Ptrc-promoter mutants were not obtained after several attempts of transformations (Table 3.3). It 
may be due to that these genes are so important for Neisseria survival and it is not allowed to 
change their expression pattern. Furthermore, the conditional mutants of NGFG_02103, 
NGFG_04144 and NGFG_00007 grew even in absence of IPTG (Table 3.3). It is possible that 
these gene products still exist in the cells even after several passage growths without IPTG. In 
order to remove the remaining products, the concentration of IPTG was reduced to 0.1 mM to 
maintain the growth of mutants, and then more subsequent passages (about ten passages) of the 
mutants on the plates without IPTG were performed. However, no obvious growth defect was 
found (Fig. 3-8). Further, the expression of these genes in the conditional knockout mutants were 
tested by RT-PCR using RNA isolated from bacteria grown on the plates with or without IPTG. 
Fig. 3-9 shows the expression of NGFG_00007 was strongly reduced in the absence of IPTG 
compared with its expression in the presence of 0.1 mM IPTG, but the detectable expression 
might be sufficient to support Neisseria survival and growth (Lane 1–4 in Fig. 3-9). The same 
situation was found in conditional mutants of NGFG_04144 (data not shown). This suggested that 
the Ptrc promoter is leaky and that a minute amount of protein expression driven by Ptrc even in 
absence of IPTG produces enough gene products to support Neisseria growth. In conclusion, the 
conditional knockout assay based on the leaky IPTG-inducible Ptrc promoter might be suitable for 
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testing essentiality of the candidate essential genes that require a large amount of protein to sustain 
Neisseria growth such as ribosomal proteins. 
Table 3.2 Conditional knockout constructs of candidate essential genes 
Gene ID Annotation Essentiality 
(P-value) 
CDS_ 
Start 
CDS_ 
Stop 
CDS_ 
Strand 
Promoter 
region 
(upstream 
of ATG) 
NGFG_01725 Outer membrane 
protein P.IB 
0.00073 1860158 1861210 + 158 bp 
[184,185] 
NGFG_00442 50S ribosomal 
protein L35 
0.00073 2149030 2151195 + 117 bp 
NGFG_00443 50S ribosomal 
protein L20 
0.00914 2151701 2151991 + within 
operon of 
NGFG_00
442 
NGFG_02103 Hypothetical 
protein 
0.01442 1681299 1681475 - 120 bp 
NGFG_01315 Hypothetical 
protein 
0.00699 1662515 1662916 - 100 bp 
NGFG_04144 Hypothetical 
protein 
0.00073 1421651 1422010 - 2 bp 
a
 
NGFG_00007 Hypothetical 
protein 
0.00177 2119773 2120003 - 210 bp 
NGFG_00686 Hypothetical 
protein 
0.05433 1078088 1078249 + 57 bp 
a
 Ptrc promoter was inserted into the 2 bp region in front of ATG of the gene NGFG_04144  
Table 3.3 Growth phenotypes of conditional knockout constructs 
Gene ID  Annotation 
Mutant 
(available)  
Growth phenotype 
With IPTG Without IPTG 
NGFG_01725 Outer membrane protein P.IB no ND ND 
NGFG_00442 50S ribosomal protein L35 yes Growth Growth defect 
NGFG_00443 50S ribosomal protein L20 yes Growth Growth defect 
NGFG_02103 Hypothetical protein yes Growth Growth 
NGFG_01315 Hypothetical protein no ND ND 
NGFG_04144 Hypothetical protein yes Growth Growth 
NGFG_00007 Hypothetical protein yes Growth Growth 
NGFG_00686 Hypothetical protein no ND ND 
ND: not determined 
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Fig. 3-8 Growth phenotypes of N. gonorrhoeae MS11 wild type N220 and conditional knockout 
mutants on the GC agar plates in the presence (right) or absence (left) of 0.1 mM IPTG. The 
gonococci were grown on GC agar plate containing 0.1 mM IPTG for 16–20 h at 37 °C in 5% 
CO2 in a humidified atmosphere and then collected in PPM medium. Approximately 10
7
 
gonococci were streaked on the GC agar plates with or without IPTG and the phenotypes were 
recorded after 24 h incubation at 37 °C in 5% CO2. Only NGFG_00442 mutants were not able to 
grow on the plates without IPTG, which indicated NGFG_00442 is an essential gene.  
 
Fig. 3-9 Conditional Ptrc-driven expression of NGFG_00007. RNA isolated from NGFG_00007 
conditional knockout mutants grown on GC agar plates with or without 0.1 mM IPTG (as 
indicated) was reverse transcribed using random primers. The subsequent PCR was performed 
with primers specific for NGFG_00007 and RNase P as indicated. Two clones were analyzed. 
Lanes 1, 2, 5, 6, 9 and 10 are derived from clone 1 whereas the other lanes were from clone 2. The 
amplification of RNase P from the cDNA samples without Reverse transcriptase (-RT, lanes 9–12) 
show there are no contaminated genomic DNA in the isolated RNA samples. The amplification 
with H2O (lanes 13 and 14) show there are no contamination in primers mix. M: DNA ladder. 
Results shown are representative of three independent determinations. 
3.4.2 Genetic footprinting assay 
Gene essentiality was further tested by a genetic footprinting assay [146,172-174]. Here the region 
of interest containing the putative essential gene as well as upstream and downstream of the open 
reading frame was amplified by PCR. Subsequently the PCR products were mutagenized in vitro 
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with Tn5 and were transformed in N. gonorrhoeae N2009. Resulting mutants were selected on GC 
agar plates supplemented with kanamycin and were pooled. Afterwards, the bacteria were 
incubated with DNase I to digest the remaining extracellular transposed DNA. gDNA was 
re-isolated and footprinting was performed using a chromosome-specific and a transposon-specific 
primer. As a reference, the PCR was conducted with the mutagenized DNA that had been used for 
transformation. The size of PCR products indicated where the Tn5 insertions occurred within the 
region of interest and thereby allows determination of the transposon insertion sites within the 
locus. Since bacterial mutants with insertions in essential genes are not viable, the Tn5 insertions 
within the essential genes will be lost during cultivation of the bacteria. Essentiality thus can be 
determined by comparing the control samples illustrating all Tn5 insertions after in vitro 
mutagenesis with a selective loss of insertions within in vivo selected mutants. PCR specificity 
was assured by carrying out the PCR with chromosome-specific primers derived from both, the 5’ 
and 3’ direction of the region. As shown in Fig. 3-10, genetic footprinting was performed in the 
genomic regions of NGFG_01063-1068 (722834-725537) and NGFG_01048-01053 
(736587-732215). The functionally uncharacterized genes NGFG_01066, NGFG_01049 as well 
as NGFG_01051 encoding ferredoxin-NADP
+
 reductase were predicted essential genes 
(P=0.04238, 0.00073 and 0.00129, respectively). In vitro transposition of the 4373 bp region 
NGFG_01048-01053 yielded 226 individual mutants, whereas for the 2704 bp region 
NGFG_01063-1068, 495 clones were obtained. PCR products corresponding to an insertion in 
these genes in vivo were rarely detected on an agarose gel when compared to the PCR products 
observed from the in vitro template. By contrast, PCR products corresponding to an insertion in 
the surrounding non-essential genes were detected (Fig. 3-10A). These data are in agreement with 
the insertion patterns detected in the Tn-seq libraries (Fig. 3-10B) and illustrate that the candidate 
genes NGFG_01066, NGFG_01049 and NGFG_01051 are indeed essential. Simultaneously these 
data prove that NGFG_01068, NGFG_01064, NGFG_01063, NGFG_01053, NGFG_01052 and 
NGFG_01048 are non-essential in N. gonorrhoeae under the tested conditions. 
In addition to conditional knockouts and genetic footprinting assays, several putative essential 
genes were validated by inability to produce deletion mutants of whose mutants show strong 
growth phenotypes. Bacteria with disruption of NGFG_01725, NGFG_01315 and NGFG_00686 
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(see also conditional knockout assay; Table 3.3), as well as beta-ketoacyl-acyl-carrier-protein 
synthase II (NGFG_01674, P=0.00385) and uridylate kinase (NGFG_01912, P=0.00177) were not 
viable (Table 3.4). Similarly, gonococci with knockout in the ABC transporter substrate-binding 
protein virulence factor Mce (NGFG_00072, P=0.03377), a phospholipase D family protein 
(NGFG_00827, P=0.00262) and a hypothetical protein (NGFG_01266, P=0.05006) were obtained 
on GC agar plates, but demonstrated a strong growth defect (Table 3.4). By contrast, gene deletion 
experiments were performed with several predicted non-essential genes (Table 3.4) and these gene 
deletions did not influence gonococci survival and growth under the tested conditions. 
 
Fig. 3-10 Genetic footprinting and TIS distribution in Tn-seq libraries indicated gene essentiality. 
(A) Genetic footprinting demonstrates gene essentiality in N. gonorrhoeae. Neisseria PCR 
products are mutagenized with Tn5 in vitro and transformed into bacteria. gDNA is recovered 
from recombinant bacteria and the distribution of Tn5 insertions of in vivo-selected mutants is 
compared to the in vitro template by PCR using a transposon-specific primer (Tn ME sequence) 
and a chromosome-specific primer placed either 5’ (left panel) or 3’ (right panel) from the locus 
NGFG_01048-01053 or NGFG_01063-1068. M: DNA ladder. 
(B) Distribution of TIS in this region in Tn-seq libraries. The mapped sequencing reads from 
library 1 (blue line), library 2 (red line) and library 3 (green line) indicate the insertion patterns 
in this region surrounding the predicted essential genes NGFG_01049, NGFG_01051 and 
NGFG_01066. Grey bar represents non-essential genes and green bar represents putative 
essential genes. 
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Table 3.4 Growth phenotypes of gene knockout mutants in Neisseria gonorrhoeae 
Gene ID Gene function Gene 
name 
P-value Mutant growth 
a
 
NGFG_00042 TonB dependent siderophore receptor  0.12712 Normal 
NGFG_00506 Hypothetical protein  0.07867 Normal 
NGFG_00599 Sulfate ABC transporter  cysW 1 Normal 
NGFG_00859 DedA family membrane protein  0.58067 Normal 
NGFG_00860 Outer membrane protein opcA 1 Normal 
NGFG_01393 Hypothetical protein  0.99247 Normal 
NGFG_01489 TonB-dependent receptor  1 Normal 
NGFG_01605 Predicted protease aif1
b
 1 Normal  
NGFG_01643 ABC transporter 
ATP-binding/permease protein 
 1 Normal 
NGFG_01836 Membrane-bound lytic murein 
transglycosylase A 
mltA 1 Normal 
NGFG_02032 FKBP-type peptidyl-prolyl cis-trans 
isomerase  
fkpA 1 Normal 
NGFG_00072 ABC transporter substrate binding 
protein 
mce 0.03377 Growth defect 
NGFG_00827 Phospholipase D family protein pld 0.00262 Growth defect 
NGFG_01266 Hypothetical protein  0.05006 Growth defect 
NGFG_01674 Beta-ketoacyl-acyl-carrier-protein 
synthase II 
fabH 0.00385 Could not 
obtainable 
NGFG_01912 Uridylate kinase pyrH 0.00177 Could not 
obtainable 
a
 Growth curve was performed in Neisseria growth medium 
b
 aif1 was first named after “Adherence and Invasion-associated Factor 1” in this study 
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3.5 Use of Tn-seq to identify N. gonorrhoeae virulence 
factors in DGI 
The virulence mechanisms involved in disseminated gonococcal infection (DGI) are not well 
understood. Therefore the transposon mutant library in N. gonorrhoeae strain N2009, an MS11 
derivative expressing PorB1A (chapter 3.1) was used to infect the human conjunctiva epithelial cell 
line Chang (ATCC CCL-20.2) due to the high bacterial invasion efficiency of 0.6 invasive 
non-piliated bacteria and 0.015 piliated Neisseria per host cell after 1h infection at a MOI of 100 
(data not shown). Because the library contained about 100,000 mutants and a 100-fold 
representation of the library was used for screening, approximately 10
7
 bacteria from the library 
were recovered on GC agar plates and were used to infect 4 × 10
7
 Chang cells under low 
phosphate conditions. After infection for 1h, the cell-associated or invasive bacteria were selected 
by gentamicin treatment and recovered on agar plates. The recovered bacteria were used in two 
additional infection rounds. Each time the recovered bacteria were pooled thus yielding three 
separate “output” libraries. As control, the mutant library was incubated for the same time in 
infection medium in the absence of host cells and thus constituted the “input” library (Fig. 3-11). 
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Fig. 3-11 Infection and screening for virulence factors involved in DGI. A high-density Tn5 
mutant library was used to infect Chang cells with an MOI 100 for 1 h under low phosphate 
conditions (HEPES medium). After infection, the unattached bacteria were washed away and the 
cells were lysed by incubation with 1% saponin for 15 min. The cell-associated bacteria (adherent 
and invasive bacteria) were recovered on the agar plates for the next round of infection. In order 
to select for invasive bacteria, 100 µg/mL gentamicin was added after the infection to kill all the 
extracellular bacteria. Intracellular bacteria were recovered on agar plates as described above. 
Recovered bacteria were used for two additional subsequent infections thereby increasing 
stringency of the assay. The mutants without infection constitute input library. Chromosomal 
DNA from input and output libraries was isolated and TIS were identified as described. A 
depletion of TIS in the recovered output libraries thus will indicate the factors required for 
adherence or invasion under the low phosphate conditions.  
Chromosomal DNA from input and output libraries was isolated and the sequencing samples were 
prepared for Tn-seq as described (chapter 3.2)
7
.The introduction of different barcodes enabled 
multiplexing of Tn-seq as well as identification of the source of the sequenced DNA. The 
                                                        
7 Dr. Richard Reinhardt and his colleagues performed the Illumina sequencing and preliminary quality control of 
the sequencing reads. Christian Remmele performed raw data processing and bioinformatics analysis. 
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sequencing reads were separated based on the barcodes and then mapped to MS11 genome 
(version 4, Neisseria gonorrhoeae group Sequencing Project, Broad Institute of Harvard and MIT). 
More than 50 million raw sequencing reads were obtained for the output I library and nearly 60% 
were specifically mapped to the genome which indicated 88,625 unique TIS in the annotated CDS 
regions. For the output II libraries, the samples from the second and the third infection round were 
sequenced and the results showed 32,198 and 34,147 intragenic TIS, respectively (Table 3.5). The 
complete data, the distribution of the reads and TIS counts per gene is shown in Table S4. Few 
sequencing reads were acquired from the input library. It might be due to poor-quality sequencing 
sample or technical problems during sequencing which can be ruled out by repeating the 
sequencing of a new prepared sequencing sample of this library. Because the wild-type strain 
N2009 cannot grow in HEPES medium, it is more likely that most mutants cannot survive or grow 
in the incubation of HEPES medium which lead to very few mutants in the input library. 
Table 3.5 Overview of sequencing results of input and output libraries. 
 Input library 
(438_C) 
a
 
Output I library 
(438_D) 
b
 
Output II library 
(438_E) 
c
 
Output II library 
(438_F) 
d
 
Sequenced reads 101,178 50,666,104 14,160,012 19,231,784 
Mapped reads 69,183 
(68.38%) 
30,722,996 
(60.64%) 
8,679,833 
(61.30%) 
10,593,688 
(55.08%) 
Uniquely mapped reads 68,302 
(67.51%) 
30,315,271 
(59.83%) 
8,569,794 
(60.52%) 
10,375,019 
(53.95%) 
Unique TIS 5,980 112,887 42,123 45,321 
Intragenic TIS 4,548 88,625 32,198 34,147 
a
 non-infection library, sample from the second round selection 
b
 output I library, sample from the second round selection 
c 
output II library, sample from the second round selection 
d
 output II library, sample from the third round selection 
3.6 Identification of virulence factors required for DGI 
In order to identify the virulence factors required for Neisseria adherence or invasion during 
phosphate sensitive infection, the P-values of each gene in these three different output libraries 
were calculated based on the TIS counts (Table S4). The depletion of TIS in specific genes during 
the selection indicated the requirement of the corresponding gene products for Neisseria 
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attachment to or invasion into the host cells. The recovered bacteria resulting in the output I 
library adhered to or invaded into the host cells. This illustrates that the genes in which 
significantly reduced numbers of TIS are required for adherence. Conversely, mutants lost in the 
output II library demonstrated factors required for adherence or invasion. By comparing the data 
between libraries DGI invasion factors can be identified. Exemplary, the uncharacterized gene 
NGFG_00506 was predicted as an invasive factor due to a loss of Tn5 insertions lost in the output 
II library when compared with reads originating from either “input” or “output I” library (Fig. 
3-12). In summary, 431 genes with P< 0.05 in the output I library (438_D) indicated that the 
respective mutants were unable to attach to the host cells or were not viable (Table S5). Further 
analysis showed that the list of candidate genes for Neisseria adherence factors contained 333 
predicted essential genes (chapter 3.3; Table S5) and 98 non-essential genes (Table 3.6). In this list 
the genes for the known adhesin type IV pilus as well as its assembly proteins PilP and PilW are 
found. To analyze gonococcal DGI invasion factors, the two output II libraries 438_E and 438_F 
were merged and genes with P< 0.05 in either library were chosen. Table S6 harbors 184 predicted 
essential genes and 43 non-essential genes (Table 3.7). The overlap in both libraries consisted of 
117 genes, 102 of which comprising essential and 15 non-essential genes (Table 3.7). A subset of 
candidate genes was chosen for validation and closer characterization in order to learn more about 
the mechanism of Neisseria phosphate sensitive infection. 
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Fig. 3-12 Distribution of mapped sequencing reads on the DNA segment of NGFG_00506 
indicates involvement of the ORF in DGI invasion. The different coloration indicates the 
different libraries from which the sequencing reads were obtained: red reads originate from the 
“input” library (438_A), green reads from the “output I” library (438_D) and blue reads from 
the “output II” library (438_E).  
Table 3.6 Non-essential candidate genes for Neisseria adherence 
Gene ID Gene function Gene name P-value 
(438_D) 
Adhesion 
NGFG_00608 type IV pilus assembly protein  pilW 0.00795  
NGFG_00233 type IV pilus assembly protein  pilP 0.00643  
NGFG_01202 type IV pilus biogenesis/stability protein  pilW 
(silent 
copy) 
0.02190  
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Transporters 
NGFG_00598 sulfate/thiosulfate import ATP-binding protein  cysA 0.00302  
NGFG_00071 ABC transporter permease   0.04406  
NGFG_02085 histidine-binding protein hisJ 0.02218  
NGFG_04085 cell division ABC transporter ATP-binding protein ftsE 0.00207  
Nucleic acid metabolism  
NGFG_01045 protein RecA recA 0.00384  
NGFG_00705 single-stranded DNA-binding protein ssb 0.04562  
NGFG_01851 DNA recombination protein RmuC rmuC 0.04681  
NGFG_01096 recombination factor protein R   0.04056  
NGFG_01641 Holliday junction ATP-dependent DNA helicase  ruvA 0.03411  
NGFG_01413 Rrf2 family protein   0.02336  
NGFG_02201 transposase   0.00384  
NGFG_04232 transposase   0.01588  
NGFG_01885 transferase   0.01863  
NGFG_02198 replication initiation factor   0.03540  
NGFG_00391 transcription antitermination factor  nusB 0.02038  
Protein metabolism 
NGFG_01644 ribosome small subunit-dependent GTPase A   0.02190  
NGFG_00413 ribosomal RNA small subunit methyltransferase A rsmA 0.02190  
NGFG_01129 ribosomal RNA small subunit methyltransferase B rsmB 0.01985  
NGFG_00566 ribosome-associated protein   0.00207  
NGFG_01786 methionyl-tRNA formyltransferase   0.04416  
NGFG_00172 (Dimethylallyl) adenosine tRNA methylthiotransferase miaB 0.00207  
NGFG_00439 queuine tRNA-ribosyltransferase   0.00207  
NGFG_02117 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate 
N-succinyltransferase 
  0.00384  
NGFG_01618 deoxyribodipyrimidine photo-lyase phrB 0.03823  
NGFG_01692 dihydrodipicolinate reductase   0.01079  
NGFG_02065 2,3-bisphosphoglycerate-dependent phosphoglycerate 
mutase 
gpmA 0.00207  
NGFG_01787 peptide deformylase   0.00207  
NGFG_02048 Imidazole glycerol-phosphate dehydratase   0.00570  
Metabolic enzymes 
NGFG_02228 lacto-N-neotetraose biosynthesis glycosyltransferase  lgtE 0.03091  
NGFG_00164 orotate phosphoribosyltransferase, OPRTase   0.01531  
NGFG_00193 4-hydroxyphenylacetate 3-monooxygenase, reductase 
component 
  0.00207  
NGFG_00187 carbamoyl-phosphate synthase small chain   0.01014  
NGFG_00654 isocitrate dehydrogenase, NADP-dependent   0.00207  
NGFG_00713 2-nitropropane dioxygenase   0.00207  
NGFG_00758 acetate kinase 1 ackA1 0.00570  
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NGFG_00764 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase ispF 0.02218  
NGFG_00888 HAD hydrolase, family IB   0.00643  
NGFG_00895 short chain dehydrogenase   0.02564  
NGFG_00918 dihydroxy-acid dehydratase   0.00207  
NGFG_01074 glucokinase   0.01985  
NGFG_00247 oxidoreductase   0.02872  
NGFG_00338 phosphoglycolate phosphatase   0.02816  
NGFG_00350 phosphate acetyltransferase   0.00207  
NGFG_00390 dihydroorotase   0.03055  
NGFG_01648 NADH-quinone oxidoreductase subunit N nuoN 0.03152  
NGFG_01654 NADH-quinone oxidoreductase subunit J nuoJ 0.04222  
NGFG_01656 NADH-quinone oxidoreductase subunit H nuoH 0.00486  
NGFG_01663 NADH-quinone oxidoreductase subunit B nuoB 0.00725  
NGFG_01329 3-deoxy-D-manno-octulosonate 8-phosphate 
phosphatase, YrbI family 
yrbI 0.03270  
NGFG_01335 shikimate dehydrogenase   0.04790  
NGFG_01499 thiamine biosynthesis lipoprotein apbE 0.01478  
NGFG_01501 Na(+)-translocating NADH-quinone reductase subunit 
F 
nqrF 0.00643  
NGFG_01505 Na(+)-translocating NADH-quinone reductase subunit 
B 
nqrB 0.04633  
NGFG_01542 biopolymer transporter exbD 0.04710  
NGFG_01574 3-octaprenyl-4-hydroxybenzoate carboxy-lyase ubiD 0.02614  
NGFG_01605 protease   0.00795  
NGFG_02134 NADPH-dependent 7-cyano-7-deazaguanine reductase   0.02162  
NGFG_01608 guanylate kinase   0.00384  
NGFG_01791 aspartate carbamoyltransferase regulatory chain pyrl 0.00930  
Others 
NGFG_00049 lipoprotein   0.04847  
NGFG_00141 Lipoprotein Mlp mlp 0.02218  
NGFG_01832 UPF0409 lipoprotein   0.04255  
NGFG_00197 GTP-binding protein  ychF 0.00302  
NGFG_00448 restriction endonuclease   0.04633  
NGFG_00560 type I restriction enzyme, S subunit   0.02237  
NGFG_00901 [2Fe-2S] ferredoxin, ISC system protein   0.04807  
NGFG_04139 bacteriocin resistance protein   0.00795  
NGFG_01630 integral membrane protein, virulence factor MviN mviN 0.00302  
NGFG_01826 mechanosensitive ion channel protein   0.04178  
NGFG_02173 UPF0210 protein   0.00207  
NGFG_00461 UPF0042 nucleotide-binding protein   0.00384  
Phage proteins 
NGFG_00623 phage protein   0.03951  
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NGFG_00632 phage protein   0.02663  
NGFG_00642 phage protein   0.04178  
NGFG_01054 phage protein   0.03750  
NGFG_01283 phage protein   0.02190  
NGFG_01285 phage protein   0.01820  
NGFG_02190 phage protein   0.02283  
Hypothetical proteins 
NGFG_00183 hypothetical protein   0.01768  
NGFG_01157 hypothetical protein   0.00486  
NGFG_04145 hypothetical protein   0.03540  
NGFG_04198 hypothetical protein   0.01820  
NGFG_04225 hypothetical protein   0.03906  
NGFG_01266 hypothetical protein   0.04663  
NGFG_00979 hypothetical protein   0.02564  
NGFG_01031 hypothetical protein   0.03712  
NGFG_01650 hypothetical protein   0.03152  
NGFG_00264 hypothetical protein   0.04489  
NGFG_00591 hypothetical protein   0.03500  
NGFG_00295 hypothetical protein   0.04681  
NGFG_04237 hypothetical protein   0.04790  
NGFG_02177 hypothetical protein   0.00207  
NGFG_02058 hypothetical protein   0.01223  
NGFG_02204 hypothetical protein   0.02190  
NGFG_02108 hypothetical protein   0.02336  
Table 3.7 Non-essential candidate genes for Neisseria adherence or invasion 
Gene ID Gene function Gene 
name 
P value  
(438_E)  
P value  
(438_F) 
Transporters 
NGFG_01643 ABC transporter ATP-binding/permease 
protein 
 0.02700 0.04892 
NGFG_00598 sulfate/thiosulfate import ATP-binding 
protein CysA 
cysA 0.02377 0.04892 
NGFG_04085 cell division ABC transporter ATP-binding 
protein 
ftsE 0.01419 0.08746 
NGFG_00159 iron chelate ABC transporter, periplasmic 
iron chelate-binding protein 
afeA 0.01508 0.09711 
NGFG_00152 preprotein translocase, SecG subunit secG 0.01943 0.35033 
Protein metabolism 
NGFG_01787 peptide deformylase  0.00544 0.03385 
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NGFG_00439 queuine tRNA-ribosyltransferase  0.00544 0.01451 
NGFG_00172 (Dimethylallyl) adenosine tRNA 
methylthiotransferase  
miaB 0.00738 0.02543 
NGFG_01692 dihydrodipicolinate reductase  0.01508 0.01978 
NGFG_02117 2,3,4,5-tetrahydropyridine-2,6-dicarboxylat
e N-succinyltransferase 
 0.03229 0.04067 
NGFG_02065 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
gpmA 0.01508 0.01036 
NGFG_00566 ribosome-associated protein  0.04197 0.07569 
NGFG_01129 ribosomal RNA small subunit 
methyltransferase B 
rsmB 0.02798 0.08402 
NGFG_02048 Imidazole glycerol-phosphate dehydratase  0.0570595
56 
0.01036 
Metabolic enzymes 
NGFG_00350 phosphate acetyltransferase  0.00738 0.01036 
NGFG_00654 isocitrate dehydrogenase, NADP-dependent  0.00544 0.03072 
NGFG_00913 UDP-N-acetylmuramate:L-alanyl-gamma-D
-glutamyl-meso-diaminopimelate ligase 
 0.03563 0.04314 
NGFG_01568 3-oxoacyl-[acyl-carrier-protein] reductase fabG 0.02100 0.04983 
NGFG_01605 protease  0.01327 0.01813 
NGFG_01656 NADH-quinone oxidoreductase subunit H nuoH 0.01145 0.13267 
NGFG_01648 NADH-quinone oxidoreductase subunit N nuoN 0.03229 0.18745 
NGFG_01501 Na(+)-translocating NADH-quinone 
reductase subunit F 
nqrF 0.0141913
04 
0.10362 
NGFG_00193 4-hydroxyphenylacetate 3-monooxygenase, 
reductase component 
 0.04172 0.10362 
NGFG_01574 3-octaprenyl-4-hydroxybenzoate 
carboxy-lyase 
ubiD 0.08188 0.04387 
Phage proteins 
NGFG_04194 phage protein  0.04904 0.05973 
NGFG_00623 phage protein  0.03563 0.09597 
NGFG_00642 phage protein  0.02477 0.09711 
Hypothetical proteins 
NGFG_00506 hypothetical protein  0.00544 0.03510 
NGFG_00574 hypothetical protein  0.03563 0.02919 
NGFG_01157 hypothetical protein  0.01419 0.08063 
NGFG_02058 hypothetical protein  0.03709 0.11198 
NGFG_01266 hypothetical protein  0.00544 0.10312 
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NGFG_00295 hypothetical protein  0.01145 0.18208 
Others 
NGFG_00062 hemoglobin-haptoglobin utilization protein 
B 
hpuB 0.04870 0.13321 
NGFG_01045 protein RecA recA 0.00544 0.06963 
NGFG_01893 Ngo I restriction endonuclease  0.04904 0.10090 
NGFG_00682 5'-nucleotidase surE surE 0.01419 0.12138 
NGFG_02198 replication initiation factor  0.03563 0.19394 
NGFG_04172 cell-surface protein  0.04730 0.25084 
NGFG_00822 toxin component of toxin-antitoxin system  0.03285 0.31050 
NGFG_01630 integral membrane virulence factor MviN mviN 0.06695 0.01978 
P-values < 0.05 in bold. 
3.7 Validation of candidate invasive genes 
In order to validate the involvement of identified candidate genes in Neisseria disseminated 
infection, the respective genes knockout mutants were generated and analyzed for their ability to 
adhere to and invade into the host cells under low phosphate condition. To construct gene 
knockout mutants, about 500 bp upstream and downstream of the target gene were amplified from 
Neisseria gDNA and combined with a kanamycin cassette (chapter 2.2.13). The resulting PCR 
fragments were transformed into N. gonorrhoeae N2009 and the recombinant bacteria were 
selected on GC plates supplemented with kanamycin. The mutants were checked by colony PCR 
and subsequently the correct location of the kanamycin cassette within the genome was confirmed 
by sequencing the PCR-amplified region from 1000 bp upstream to 500 bp downstream of the 
target gene. Furthermore, the lack of expression of the target gene in the gene knockout mutants 
was checked by reverse transcription-PCR (RT-PCR) with cDNA derived from mutants. 
Here, three candidate genes were tested, the hypothetical protein NGFG_00506, NGFG_01605, a 
predicted protease, and NGFG_01643, an ABC transporter ATP-binding/permease protein. The 
gene knockout mutants for each gene were prepared in triplicate. Growth curves of the mutants in 
rich medium showed that the mutants grew similar to the wild type which indicated the loss of the 
genes did not influence the viability of the mutants (Fig. 3-13). However, the mutants within 
NGFG_01605 or NGFG_01643 showed a significantly decreased adherence and invasion in 
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infections under low phosphate conditions (Fig. 3-13B and C) and suggested a function in 
gonococcal adherence and invasion. Mutants within NGFG_00506 showed similar adherence 
when compared to the wild type, but were significantly decreased in their invasion rates (Fig. 
3-13A) which indicated that NGFG_00506 might be an invasion factor rather than an adhesin in 
this process. It is in agreement with TIS patterns described in Tn-seq data (Fig. 3-12). To confirm 
this result, a differential immunofluorescence assay was performed with mutants lacking either 
NGFG_01605 or NGFG_00506. Invasive bacteria in 50 randomly selected cells were counted. 
Whereas in the wild-type about one invasive bacterium per cell was detected, the mutants’ 
infection rates decreased to less than 0.5 bacteria per cell (Fig. 3-15, [163]). This confirmed that a 
loss of either NGFG_01605 or NGFG_00506 was required for efficient host cell invasion.  
With this technique other genes were tested. For example, mutants within the phospholipase D 
family protein NGFG_00827 were defective in adherence and invasion but also showed growth 
defects in rich medium. This was not surprising since NGFG_00827 was predicted to be essential 
in the input library (P=0.00262 in 438_A library, Table S1; Fig. 3-14B). Mutants lacking 
NGFG_01266 (hypothetical protein; P=0.05007 in 438_A library, Table S1) grew very slowly in 
PPM medium and the adherence as well as invasion of the recombinant bacteria were strongly 
reduced when compared to the wild-type (Fig. 3-14A).  
In the MS11 genome there are several duplicated genes. One of the repeated genes, the 
hypothetical protein NGFG_004218 was analyzed since a sequence alignment demonstrates that, 
NGFG_004218 has identical sequences as mafI gene of N. gonorrhoeae strain FA1090. The 
respective gene knockout mutants grew very well under the tested condition but adherence to and 
invasion into the host cells were decreased (Fig. 3-14C).  
In addition, some genes with P > 0.05 in the output libraries (Poutput) were tested as described 
above (Table 3.8). The mutants within these genes grew normally in rich medium and did not 
show any defect in adherence and invasion when compared to the wild type (data not shown).  
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Fig. 3-13 Growth, adherence and invasion phenotypes of mutants within NGFG_00506 (A), 
NGFG_01605 (B) and NGFG_01643 (C).  
Left, growth curves were performed in PPM using strains that were non-piliated and 
Opa-negative. The experiments were repeated two or three times independently with similar 
results and one representative data was shown.  
Right, adherence and invasion of the bacteria were determined by gentamicin protection assays 
under low phosphate conditions with a MOI of 50 for 30 min. The numbers of adherent or 
invasive bacteria were determined with rates of the wild type strain set to 100%. Data represent 
the mean ± SD of three independent experiments. ns: not significant, * p < 0.05, ** p < 0.01 and 
*** p < 0.001. 
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Fig. 3-14 Growth, adherence and invasion phenotypes of mutants within NGFG_01266 (A), 
NGFG_00827 (B) and NGFG_04218 (C). 
Left images show growth curves of the mutants performed in PPM medium using strains with 
colony morphology of non-pili and non-Opa expression. The experiments were repeated two or 
three times independently with similar results and one representative data was shown.  
Right images show adherent and invasive bacteria were determined by gentamicin assays under 
low phosphate conditions with a MOI of 50 for 30 min. The number of adherent or invasive 
bacteria with infecting of wild type strain was set as 100%. Data represent the mean ± SD of 
three independent experiments. ** p < 0.01. The experiment of NGFG_01266 mutants were 
repeated twice and one representative data was shown. 
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Fig. 3-15 Differential immunostaining demonstrates invasion deficiency of mutants within 
NGFG_00506 (A) and NGFG_01605 (B). Number of invasive bacteria was counted from 50 
randomly chosen cells using differential immunostaining and confocal microscopy [163]. 
Table 3.8 Genes tested for adherence or invasion defects, which are not in the candidate list 
Gene ID Gene function P-value 
(438_D)
a
 
P-value 
(438_E)
b
 
Growth 
c
 Adherence 
and invasion 
phenotype 
d
 
NGFG_00042 TonB dependent siderophore 
receptor 
0.68657 0.76619 Normal ns 
NGFG_01393 Hypothetical protein 0.83074 0.56661 Normal ns 
NGFG_01489 TonB-dependent receptor 0.96054 0.95802 Normal ns 
NGFG_01836 Membrane-bound lytic 
murein transglycosylase A 
0.13808 0.40787 Normal ns 
NGFG_02032 FKBP-type peptidyl-prolyl 
cis-trans isomerase FkpA 
0.94414 0.93860 Normal ns 
a 
438_D, output I library 
b 
438_E, output II library
 
c
 Growth curves were determined in PPM medium 
d 
Gentamicin assays were performed to test N. gonorrhoeae adherence and invasion 
ns: not significant, means the mutants did not show significantly defects in the adherence to or invasion 
into the host cells compared to the wild type strain 
3.8 NGFG_01605 is required for gonococcal internalization 
The growth in PPM medium of NGFG_01605 knockout mutants was similar to the wild type 
strain (Fig. 3-13B), however, under low phosphate conditions, the mutants showed a significant 
decrease in the adherence to and invasion into human epithelial cells as evidenced by gentamicin 
assays (Fig. 3-13B). Further, the ratio of invasive to adhesive bacteria was determined which was 
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smaller for the mutants when compared with the wild-type (Fig. 3-16A). This indicated that 
NGFG_01605 not only influences N. gonorrhoeae adhesion but also invasion into the host cells. 
This was further confirmed by differential immunofluorescence assay (Fig. 3-15B; [163]). In order 
to test if NGFG_01605 was required for the initial attachment to host cell, gentamicin assays were 
performed with piliated mutants. Compared to the wild type strain N2009, the mutants showed 
similar number of adherent bacteria, which demonstrated that NGFG_01605 did not affect 
pili-mediated initial attachment of N. gonorrhoeae to the host cells (Fig. 3-16B). 
 
Fig. 3-16 Ratio of invasive/adherent bacteria demonstrates involvement of NGFG_01605 in 
neisserial host cell invasion under low phosphate conditions but is dispensable for pili-mediated 
attachment. 
(A) Ratio of invasive/adherent bacteria was determined by a gentamicin assay. The ratio of wild 
type strain N2009 was normalized to 100%. 
(B) Chang cells were infected with piliated NGFG_01605 knockout mutants and the wild type 
strain N2009 at a MOI 10 for 1 h in HEPES medium.  
The adherent bacteria were quantified by gentamicin assay. The number of adherent wild type 
was set to 100%. The data depict the mean values ± SD of three independent experiments. ns: not 
significant. *** p < 0.001. 
Aside from PorBIA-mediated internalization, N. gonorrhoeae efficiently enters host cells through 
Opa proteins [64,65,69,74,76]. Two distinct Opa groups recognize different receptors on the 
surface of host cells. Opa50 binds to HSPGs and Opa51-60 interacts with CEACAMs (chapter 1.1.3). 
In order to test the involvement of NGFG_01605 in Opa-triggered invasion NGFG_01605 
deletion mutants were constructed that stably expressed Opa proteins. NGFG_01605 knockout 
mutants were conjugated with either N931 harboring pTH6a with an opa50 expression cassette or 
N313 containing an opa57 expression cassette on pTH6a, yielding strains N2020 and N2021, 
respectively (Table 2.1). To test the Opa50-triggered pathway, Chang cells were infected with 
Opa50 expressing NGFG_01605 mutants (N2020) or wild type strain. The numbers of adherent 
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and invasive bacteria were greatly decreased for N2020 (Fig. 3-17A). A similar result was found 
when CEACAM1-expressing HeLa cells were infected with Opa57-expressing N2021 (Fig. 3-17B). 
These results demonstrated that NGFG_01605 is also involved in Opa-triggered neisserial 
invasion of host cells. 
 
Fig. 3-17 NGFG_01605 functions in Opa-triggered N. gonorrhoeae internalization.  
(A) Chang cells were infected with Opa50-expressing strains in the 1640 medium at MOI 5 for 2 h 
for adherence and MOI 50 for 4 h for invasion.  
(B) HeLa CEA cells were infected with Opa57-expressing strains at an MOI of 5 for 2 h for 
adherence and MOI 50 for 2 h for invasion.  
The number of adherent or invasive wild type bacteria was set to 100%. The mean ± SD of three 
independent experiments is shown. ** p < 0.01, *** p < 0.001. 
NGFG_01605 encodes a protein of 451 aa (amino acid), here named AIF1 (Adherence and 
Invasion-associated Factor 1). Further research on the function of the AIF1 necessitated the 
generation of a specific antibody. An antigenicity prediction of AIF1 was performed 
(ImmunoGlobe GmbH) and showed that the C-terminal part of the protein staring from aa185 
(AIF1185-451aa) was optimal for protein expression and subsequent immunization of rabbits. The 
corresponding DNA sequence was cloned into the vector pET28b at BamHI and HindIII 
restriction sites, which fused an N-terminal His-tag to the protein. The vector was transformed in 
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E. coli soluBL21, however, the recombinantly expressed protein was insoluble even after mild 
induction by 0.25 mM IPTG at 16 °C overnight. So the inclusion bodies of recombinant protein 
were purified (chapter 2.2.6.6, Fig. 3-18A) and dissolved in 7 M urea, which was removed prior to 
immunization by electro-elution. The resulting anti-AIF1 serum specifically detected the 
NGFG_01605 protein in the wild type strain N2009 and no protein was detected in the gene 
knockout mutant (Fig. 3-18C). In order to improve the specificity, anti-AIF1 serum was affinity 
purified (Fig. 3-18D). Besides, the whole AIF1 protein fused with His-tag on the N-terminus was 
successfully purified for further study (Fig. 3-18B). 
 
Fig. 3-18 Purification of AIF1185-451aa inclusion bodies (A), recombinant AIF1 protein (B) and 
specificity of anti-AIF1 antibody before (C) and after (D) affinity purification. 
(A) Isolation and purification of AIF1185-451aa inclusion bodies. After induction with 0.25 mM 
IPTG at 16°C overnight, the recombinant E. coli were lysed by sonication. Most of the protein 
was detected in inclusion bodies in the pellet (P1). P1 was suspended in buffer containing 1 M 
urea, sonicated and centrifuged. A fraction of the protein was soluble in the supernatant (S2), 
whereas the majority was still unsoluble (P2). P2 was resuspended in buffer containing 7 M urea. 
After sonication and centrifugation, most of protein was found in the supernatant (S3). All the 
samples were separated by10% SDS-PAGE and stained with Coomassie blue. S: supernatant; P: 
pellet.  
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(B) Purification of recombinant AIF1 protein from E. coli soluBL21. The samples were separated 
by 10% SDS-PAGE and stained with Coomassie blue. S1: supernatant after sonication; P1: pellet 
after sonication; T: flow-through; W1-3: washing samples; E1-3: elution samples.  
(C and D) Specificity of anti-AIF1 antibody before (C) and after (D) affinity purification. 
Bacterial lysates of N2009 (wt) and N2009 ΔNGFG_01605 were separated by 10% SDS-PAGE 
and analyzed by western blotting using anti-AIF1 antibody (C: 1:500; D: 1:1000 dilutions).  
AIF1 functions in gonococcal adherence to and invasion into host cells (chapter 3.8), hence the 
expression dynamics of AIF1 during the infection was analyzed. The wild type strain N2009 was 
used to infect Chang cells at an MOI of 100. After 15, 30, 60 and 120 min, the cell-associated 
bacteria were collected and AIF1 expression was analyzed by Western blotting using 
affinity-purified anti-AIF1 antibody. With increasing infection time, AIF1 expression increased 
about three-fold (Fig. 3-19A). The transcription of NGFG_01605 during the infection was 
analyzed by real-time PCR with NGFG_01605-specific primers (L-01605-rt and R-01605-rt, 
Table 2.9). Contrasting the protein data, the qPCR demonstrated that the transcription of 
NGFG_01605 was nearly unaltered during the course of infection (Fig. 3-19B).  
 
Fig. 3-19 AIF1 expression increases at protein level during the course of infection, whereas 
transcript levels are unaltered.  
(A) Chang cells were infected with N2009 at a MOI of 100 and samples were collected at different 
time points. AIF1 expression was detected by anti-AIF1 antibody and quantified by ImageJ. The 
expression of PorBIA was used as loading control.  
(B) NGFG_01605 transcription during infection was analyzed by real-time PCR. N2009 was used 
to infect Chang cells at MOI 100. Total RNA from the samples was isolated and cDNA was 
synthesized and qPCR was used to determine transcript abundance. 5sRNA was used as internal 
standard. Experiments were repeated twice. 
The sequence analysis indicates no signal peptides in AIF1 (predicted by SignalP 4.1 Server, 
http://www.cbs.dtu.dk/services/SignalP/) [186] and the putative localization predicted by PSORTb 
(http://www.psort.org/psortb/) [187] is cytoplasmic. The amino acid sequence alignment indicated 
NGFG_01605 encoded protein AIF1 is highly conserved in Neisseria spp. and more than 96 % 
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sequence identity are found in most homologues (Fig. 3-20). The database searching using AIF1 
sequence shows its homologues occur in other bacteria of the family Neisseriaceae besides the 
genus Neisseria, such as the genera Kingella (e.g. U32 family peptidase in Kingella kingae ATCC 
23330 with 86%/93% sequence identity/similarity), Simonsiella (e.g. HMPREF9021_00333 in 
Simonsiella muelleri ATCC 29453 with 86%/93%) and Eikenella (e.g. HMPREF1177_00155 in 
Eikenella corrodens CC92I with 86%/92%). Besides the family Neisseriaceae, AIF1 homologues 
are identified in the bacteria belonged to other family in the order Neisseriales, even in other order 
of the class βproteobacteria the identity sequence up to 60%-80% [188,189]. It seems AIF1 is 
highly conserved in the evolution and may have important roles besides of virulence factor in 
gonococcal engulfment into host cells. 
 
Fig. 3-20 Multiple alignments of amino acid sequence of AIF1 with its homologues in Neisseria 
spp by ClustalX2 (Accession numbers of these sequences are in Supplementary Table 6.2).
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4 Discussion 
4.1 Transposon mutagenesis in N. gonorrhoeae 
DNA transposons are mobile DNA sequences in the genome and frequently found in many 
organisms including Neisseria. In Neisseria gonorrhoeae and Neisseria meningitidis, a small 
repetitive element, often called “Correia elements”, has transposon-like properties of 25 bp 
inverted repeats, a TA duplication at the target site and a functional integration host factor binding 
site [190-192]. DNA transposons take up a high percentage in their host genome and are 
considered to play important roles in genetic plasticity during evolution. Besides, the transposition 
achieves the translocation of linear DNA fragment to a new position by recombination process 
which is independent of homologous sequence or any other host factors. These properties enable 
DNA transposons to serve as useful and powerful genetic tool which have been successfully used 
for transgenesis and insertion mutagenesis in a wide variety of organisms in order to identify 
associated genes in pathogenesis of pathogens, analyze the functional and regulatory genome and 
even be suggested novel methods for gene therapy. 
The conjugative transposons Tn916 [193,194] and Tn1545 [195] from Gram-positive bacteria 
were adapted for mutagenesis in N. meningitidis. One study indicated that the conjugative 
transposon Tn916 can be introduced into different sites on the chromosome of recipient 
meningococci [193], but further research showed that in some cases only the tetM determinant 
was inserted [194]. Moreover, Thomas et al. constructed a Tn5 derivative containing a functional 
kanamycin resistance marker to perform in vivo transposon mutagenesis of N. gonorrhoeae [196]. 
The modified Tn5 is successfully integrated into the chromosome randomly but most insertions 
contained only incomplete transposons. Further it was found that the transposition is independent 
of transposase but requires RecA instead. This event was suggested to represent the outcome of 
some type of illegitimate recombination system in Neisseria rather than of transposition [196]. 
Another transposition system is shuttle mutagenesis with mini-transposon (mTn), mini-Tn3 [197]. 
There, neisserial chromosomal DNA is partially digested and cloned into plasmids which 
constitute a gene bank of Neisseria in E. coli. In E. coli, the neisserial DNA is mutated by 
mini-transposons containing an antibiotic marker for selection. Subsequently, the transposed 
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plasmids are isolated from E. coli and transformed into Neisseria where it inactivates the 
corresponding genes via allelic exchange [198]. This technique has been broadly applied in 
Neisseria with construction of a series of mini-transposons derivatives for different purposes, such 
as the creation of lacZ transcriptional fusions [199] in order to understand gene regulation 
mechanisms, or the production of phoA fusions [200] for identification of exported pathogenicity 
factors [201].  
Although complete genome sequences for several gonococcal strains are available [175,176], our 
understanding of gene function remains limited. The lack of a suitable method for saturation 
mutagenesis remains a major obstacle to the unraveling of the pathogenicity of N. gonorrhoeae. 
The methods described above are not suitable, because i) transposition by conjugative transposons 
is not perfectly stable [194] and displays only low transposition frequency, ii) transposition of GC 
with a Tn5 derivative in vivo does not work properly [196], and iii) although shuttle mutagenesis 
can be used for generation of a large pool of mutants, some neisserial genes are difficult to clone 
in or are even lethal for E. coli. 
In vitro transposition systems using DNA transposons like Tn7, Tn5 and Himar1 mariner have 
been successfully applied for the mutagenesis of naturally competent bacteria, such as 
Haemophilus influenza [174,202], Streptococcus pneumoniae [174] and also Neisseria 
meningitidis [203,204]. Thereby a PCR-amplified DNA segment or isolated chromosomal DNA is 
mutated in vitro by transposons and a purified transposase. After mutagenesis, the DNA is 
transformed back to the target bacteria. In the bacteria genes are inactivated via allelic exchange 
with their mutagenized counterpart. This technique makes the transposition stable due to the 
omission of transposase in vivo and does not require the cloning of target DNA in E. coli. 
Therefore it has developed into a standard for the generation of genome-wide mutagenesis 
libraries in many microorganisms [174,202-204]. Combined with PCR-based amplification 
methods and microarrays, such as transposon site hybridization (TraSH) [204] and 
transposon-based genetic footprinting [174,205], or using the NGS-based technologies, such as 
Tn-seq [148] or TraDIS [147], high-through transposon mutant libraries were applied to rapidly 
identify mutants with fitness deficits in various conditions to predict gene function and genetic 
interaction. 
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In this study, Tn5 was used to create a saturated transposon insertion library in N. gonorrhoeae. 
Neisseria chromosomal DNA was isolated and incubated with purified transposase and equal 
molarity of a Tn5 derivative containing a kanamycin resistance selection marker. Transposons 
were randomly inserted into chromosomal DNA. Subsequently, the transposed DNA was 
reintroduced into N. gonorrhoeae by natural transformation and the bacteria were selected for 
kanamycin resistance (Fig. 3-1A). In order to increase the efficiency of mutagenesis in Neisseria, 
the in vitro transposition and natural transformation to Neisseria are critical steps. Attempts with 
fragmentation of genomic DNA for in vitro transposition and/or introduction of Neisseria DNA 
uptake sequence (DUS) in Tn5 element did not improve the efficiency of mutagenesis in Neisseria 
(data not shown). Further it was found that the quality and purity of isolated genomic DNA is 
critical for the efficiency of mutagenesis since purification of genomic DNA with affinity columns 
led to a higher insertion frequency when compared to phenol-chloroform-based DNA extraction 
most likely because of the inhibition of transposition by remaining phenol or ethanol. Another 
important factor is the recover efficiency of the mutated DNA in the steps after transposition in 
vitro as well as after gaps filling up steps. Here, we adopt phenol-chloroform extraction and 
ethanol precipitation instead of column-based method in order to increase the recover efficiency 
(chapter 2.2.7). One round transformation of mutated DNA into N. gonorrhoeae yielded about 
20,000 kanamycin-resistant transformants. By pooling of mutants from six independent 
mutagenesis rounds the final library comprising about 100,000 colonies was obtained. Southern 
blot analysis confirmed that Tn5 transposition in N. gonorrhoeae is random and only one insertion 
site occurs in each bacterial colony [159]. Transposon insertion sites were then identified by 
Illumina sequencing (Fig. 3-5 and Table 3.1) and the data demonstrate that the library is the result 
of saturated mutagenesis in N. gonorrhoeae. Compared with the previous similar works in N. 
meningitidis, 14,000 Tn5 insertional knockouts [204] or 10,000 single colonies with Himar1 
mutagenesis [203] was obtained across the whole genome. In N. gonorrhoeae, Kline, K. A et al 
performed transposon mutagenesis on upstream of pilE gene to identify DNA sequences that 
facilitate pilin antigenic variation [206]. Chen, A et al performed in vitro saturating mutagenesis 
on porB gene to identify essential versus mutable residues in gonococcal porin [207]. However, 
this study is the first time to perform a genomic-scale mutational analysis of this important human 
pathogen N. gonorrhoeae. 
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Further, quality control of the sequencing reads made by Fast QC indicated that the sequence 
quality was sufficient for further analysis (Fig. 3-4). Then the bias of transposon insertions was 
tested by analysis of the distribution of TIS, for example, the distribution across the whole genome 
of MS11 (Fig. 3-5A), on the non-coding region and coding region (Fig. 3-5B), and the distribution 
in the single gene (Fig. 3-5C). All the indexes showed there was no bias of transposon insertions 
in our Neisseria genome library. Therefore, this saturate mutagenesis library combined with 
high-throughput sequencing system will be a powerful tool for the system-level understanding of 
gonococcal physiology and pathogenesis. 
4.2 781 essential genes in N. gonorrhoeae 
The emergence and spread of multidrug-resistant gonococci became a major public health 
challenge as the loss of treatment options will significantly increase morbidity and mortality in the 
future (chapter 1.1.2). A straight forward approach for the identification of potential new drug 
targets is the identification of essential gonococcal proteins. In order to screen the genes which are 
critical to survival of N. gonorrhoeae, the genome-wide transposon mutagenesis library in N. 
gonorrhoeae strain MS11 was screened for genes which demonstrated a relative depletion of TIS 
indicative of important functions for bacterial growth.  
As is shown in Fig. 3-7, almost no insertions were detected in the CDS and promoter of gene 
NGFG_00153, but in contrast the adjacent genes NGFG_00152 and NGFG_00154 displayed high 
insertion density. NGFG_00153 encodes triosephosphate isomerase, which is required for 
glycolysis, the main pathway of energy production [178]. The absence of TIS is the direct result of 
the inability of mutants within the locus to grow on selective agar plates. Hence these mutants are 
lost from the library leading to the absence of Tn-seq reads in this genomic region, and therefore 
demonstrate that NGFG_00153 is essential for Neisseria viability. Genes with strongly reduced 
TIS thus might be necessary for Neisseria growth or survival and therefore comprise candidate 
essential genes. Due to a very high coverage of TIS in most genes, a statistical analysis can clearly 
assess the essentiality of genes, by calculation of a P-value [152]. The algorithm, developed by 
Christian Remmele (Bioinformatics, University of Würzburg) assumes that the transposon is 
randomly and uniformly inserted across the whole genome and every mutant has the same fitness 
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under the selective condition. However, this evaluation does not consider polar effects of the 
transposon insertion on downstream essential genes in operons. Because the transcriptional 
terminator of Tn5 might terminate transcription of the downstream gene, the mutagenized gene 
might be false-positively identified as essential, although the absence of the gene product of the 
essential downstream gene led to the phenotype. To avoid this misclassification, the location of the 
genes in operons was taken into account. Only genes with P < 0.05 not within operon structures 
were analyzed which resulted in a candidate list of 480 genes (Fig. 3-6B; Table S1). Besides, the 
sequencing reads of duplicated genes are randomly and equally mapped to repeated DNA 
sequences on the genome, so the original and true insertion sites on single gene cannot be 
identified by this technology and individual validation is needed.  
Besides of the well-known essential genes required for bacterial fundamental biological processes, 
Neisseria-specific genes which have been previously identified as essential also were identified in 
our dataset, such as outer membrane proteins PorB [181,182], Omp85 [180], and the alternative σ 
factor RpoH [169]. Notably, 120 predicted essential genes are of as of yet unknown function, 
which might be candidates for targets of anti-gonococcal drugs. For testing the essentiality of 
these genes, conditional knockouts were performed. The native promoter of essential gene was 
exchanged with the IPTG-inducible promoter Ptrc and gene expression was conditionally inhibited 
by omission of IPTG in the growth medium. The assay confirmed essentiality of the ribosomal 
protein encoded by NGFG_00442-00443 for Neisseria survival (Fig. 3-8). By contrast, promoter 
replacement failed for the genes NGFG_01725 (PorB), NGFG_01315 and NGFG_00686. Possibly 
the promoter regions themselves could be essential or fulfill other important functions and thus do 
not allow to be exchanged (Table 3.3). Moreover, the mutants in the hypothetical proteins 
NGFG_02103, NGFG_04144 and NGFG_00007 still grew on agar plates lacking IPTG (Fig. 3-8). 
The gene expression of the mutants with or without IPTG induction was determined by RT-PCR 
(Fig. 3-9). The results indicate that the Ptrc promoter is leaky leading to a base level transcription 
of the Ptrc-controlled gene even in absence of IPTG, which in turn might provide be enough gene 
product to support Neisseria survival and growth. In other studies, the conditional knockout of 
Neisseria relA [168] and rpoH [169], employed two tandem lac operator sequences in order to 
enhance the repression of an uninduced promoter [208], but the leakage problem still existed. 
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Thus conditional knockouts can only be used for validation of essential genes whose products are 
needed in a large amount for bacteria survival, such as ribosomal proteins. Since the limitation of 
conditional knockout assay, genetic footprinting (Fig. 3-10) as well as gene knockout trials (Table 
3.4) were performed to experimentally verify essentiality of candidates genes identified by the 
Tn-seq screen. The experimental data were highly coincident with statistic predictions based on 
p-value of the genes for 11 essential genes and 17 non-essential genes with the exception of a 
single non-essential gene, NGFG_01266 (hypothetical protein; P=0.05007). NGFG_01266 
knockout mutants grew well on agar plates. However the growth curve measured in PPM medium 
indicated that the mutants are deficient in growing in liquid medium (Fig. 3-14A). Interestingly, 
this difference was reflected in the p-value, the calculation of which is based on the mutants’ 
growth on agar rather than growth in liquid medium.  
Some predicted essential genes might not only affect gonococcal fitness, but may lead to direct 
killing of the mutagenized bacteria. One example is the antitoxin gene NGFG_00971 (P=0.0011). 
The co-transcribed genes NGFG_00971 (hypothetical protein) and NGFG_00972 (hypothetical 
protein, P=0.13597) were identified as a toxin-antitoxin (TA) pair with the RASTA-Bacteria 
prediction tool (Rapid Automated Scan for Toxins and Antitoxins in Bacteria, 
http://genoweb1.irisa.fr/duals/RASTA-Bacteria) [209]. Inactivation of antitoxin gene 
NGFG_00971 may release the toxic activity of NGFG_00972 which will cause the death of 
NGFG_00971 mutants whereas mutants within the toxin gene NGFG_00972 will grow well. 
Other interesting examples are the predicted essential phage associated proteins, NGFG_00630 
(homologous to NGO0479 located on the prophage island NgoΦ1 of strain FA1090 [210]) and 
NGFG_02188 (homologous to NGO1116 on the prophage island of NgoΦ2 in strain FA1090 
[210]). NGO0479 and NGO1116 are homologues of the lambda repressor cI which reactivates a 
lysogenic phage. When NGO0479 and NGO1116 were expressed in E. coli, the expression 
inhibited the growth of E. coli and the propagation of phage lambda [210]. Besides, it was 
reported that phage repressors can be regulate host genes expression in the lysogenic cells [211]. It 
was found that NGO1116 was able to inhibit transcription of N. gonorrhoeae genes and 
Haemophilus influenzae HP1 phage promoters [210]. NGFG_01287 (homologous to NGO0509 of 
NgoΦ1 in FA1090 [210]) and NGFG_02185 (homologous to NGO1119 of NgoΦ2 in FA1090 
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[210]) belong to the transcriptional regulator family which is critical in the lysogenic stage of 
neisserial phages. Therefore these phage associated genes might regulate lysogenic phages or 
other neisserial genes which lead to death of mutants. 
4.3 Screening for DGI virulence factors 
To screen for N. gonorrhoeae adhesins and invasins involved in gonococcal internalization into 
human epithelial cell during low phosphate-dependent invasion (LPDI), a genome-scale ‘‘negative 
selection’’ technology was applied [146] (Fig. 3-11). A saturated Tn5 mutagenesis library was 
successfully established in N. gonorrhoeae N2009, a MS11 derivative strain expressing PorBIA, 
the hitherto only confirmed factor required for N. gonorrhoeae LPDI. A 100-fold representation of 
each mutant within the library was used for infection of Chang cells at an MOI 100 for 1 h. 
Adherent or invasive bacteria were recovered on agar and the recovered bacteria were used in 
subsequent repetitions of the infection assays in order to deplete mutants from the library that 
were unable to adhere to or invade into Chang cells. The chromosome-transposon junctions from 
these libraries were PCR-enriched, barcoded and sequenced by massively parallel sequencing. The 
sequencing reads were separated according to the barcode and mapped to the genome to identify 
the TIS (Table 3.4). Again, P-values were determined for each gene to evaluate the gene’s 
fitness/essentiality in the adherence or invasion process. Genes with P < 0.05 were hypothesized to 
be functional in LPDI. Among these the candidate essential genes (chapter 3.3) are excluded from 
further analysis, because the essentiality would cause depletion in the output libraries obtained in 
the LPDI invasion screen. Of the remaining 1745 non-essential genes 98 may function in 
gonococcal attachment to host cell under low phosphate condition (Table 3.6). These include type 
IV pilus-associated proteins, lipoproteins, integral membrane protein, diverse enzymes, 8 phage 
proteins and 15 hypothetical proteins. The 43 candidate invasion factors include various enzymes, 
6 unknown proteins, 3 phage proteins and 3 ABC transporter associated proteins (Table 3.7). LPDI 
is a complicated process starting with bacterial attachment to the host cell surface, engulfment by 
the cells and intracellular survival. The identified factors may participate in one of these three 
steps. This hypothesis was confirmed by validating a selection of candidates. Therein the 
candidate gene was deleted via allelic exchange and the resulting mutants were used within 
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gentamicin protection assay to test their adherence and their host cell invasion rates. The results 
indicated the hypothetical protein encoded by NGFG_00506 functions in the invasive process not 
adherent stage or intracellular survival. By contrast another hypothetical protein NGFG_01266 
suggests a more important role in gonococcal survival rather than in infection, whereas genes 
NGFG_01605, a predicted protease, and NGFG_01643, an ABC transporter ATP-binding 
protein/permease, participate in both adherence and invasion (Fig. 3-13 and 3-14).  
It is interesting that phospholipase D (PLD, encoded by gene NGFG_00827) mutants were 
impaired in their ability to adhere to and invade into epithelial cells in LPDI (Fig. 3-14B). A 
previous study showed that N. gonorrhoeae secretes PLD to augment complement receptor 3 
(CR3)-mediated endocytosis of primary cervical epithelial cells [212] by interacting with Akt 
kinase in a PI3 kinase-independent manner [213]. It remains to be elucidated, however, if PLD 
functions in gonococcal LPDI with a similar signaling pathway.  
Another interesting finding is that infection of the host cells with mutants in NGFG_04218 
(hypothetical protein) showed significant decrease in the number of the cell-associated bacteria 
(adherent and invasive bacteria, Fig. 3-14C). NGFG_04218 is a newly annotated gene (our 
unpublished observations) that has many copies in the MS11 genome. Notably, the 
reverse-complementary sequence of NGFG_04218 is homologous to mafI (NGO1066) in FA1090 
and the upstream region of NGFG_04218 is the coding regions of NGFG_04217 (MafA adhesin, 
homologous to NGO1067 in FA1090) and NGFG_00672 (MafB family adhesion protein, 
homologous to NGO1068 in FA1090). The deletion of NGFG_04218 may influence the 
expression of NGFG_04217 and NGFG_00672, but it is difficult to quantify the transcription of 
NGFG_04217 and NGFG_00672 within NGFG_04218 mutants because both genes have many 
copies in the MS11 genome. Multiple sequences homologous to both, mafB and the adjacent gene 
mafA, are present in the pathogenic species N. gonorrhoeae and N. meningitidis, and also in the 
commensal species N. lactamica. A previous study indicates that gonococci bind to 
gangliotetraosylceramide [GgO4, Gal(β1-3) GalNAc (β1-4) Gal(β1-4) Glc(β1-1)Cer], 
isoglobotriaosylceramide [Gal(α1-3) Gal(β1-4) Glc(β1-1) Cer], gangliotriaosylceramide [GgO3, 
GalNAc (β1-4) Gal(β1-4) Glc(β1-1) Cer] and lactosylceramide [LacCer, Gal(β1-4) Glc(β1-1) Cer]. 
The latter two glycolipids are found in glycolipid preparations from ME180 cells, an epithelial cell 
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line derived from a human cervical carcinoma and the glycolipid-binding proteins on the surface 
of GC are distinct from pili and Opa proteins [214,215]. The glycolipids, LacCer, GgO3 and 
GgO4 share lactose as the core sugar moiety. The GC gene encoding the GgO4-binding adhesin is 
identified with a size of 36 kDa [216] which might be MafA according to the molecular weight. 
Research within the laboratory of Thomas F Meyer revealed that the glycolipid adhesin is part of a 
multiple adhesin family (Maf) exhibiting different binding specificities [217]. Further, mafB2 
(NGO1587) was found up-regulated upon adherence to the endocervix-derived cell line A431 
which suggests requirement of mafB2 for infection [169]. A recent study further showed 
repression of MafA1 and MafA2 (encoded by NMB0375 and NMB0652 in MC58) by the 
regulator NadR in N. meningitidis was in response to signals present in human saliva thus enabled 
N. meningitidis to adapt to the relevant host niche [218].  
4.4 Characterization of NGFG_01605 
NGFG_01605 mutants showed strongly diminished adherence to and invasion into human 
epithelial cells in the PorBIA-triggered pathway under low phosphate conditions (Fig. 3-13B) as 
well as in Opa-dependent pathways (Fig. 3-17). In order to check whether the decreased number 
of recovered bacteria in infections was due to a decreased fitness of the mutants, the bacterial 
growth was monitored under different conditions. However, NGFG_01605 mutants did not show a 
growth phenotype in rich media such as GC agar plates (P=1 in the input library; Table S1) or 
PPM liquid medium (Fig. 3-13B). Further, the differential immunostaining assay confirmed that 
the decrease of recovered bacteria was indeed due to the deficiency in invasion rather than 
intracellular survival (Fig. 3-15B). Furthermore, the ratio of invasive to adherent bacteria as 
determined by gentamicin assays was less than half of the wild type strain, which demonstrated 
that NGFG_01605 was involved in gonococcal invasion as well as adherence (Fig. 3-16A). 
Pili-dependent initial attachment to host cells was not disturbed in NGFG_01605 mutants (Fig. 
3-16B), so that the influence of the knockout on neisserial adherence was due to other unknown 
reasons. Further, the transcription of NGFG_01605 at 15, 30, 60 and 120 min post infection was 
analyzed by real-time PCR and was found to remain unaltered at a similar level during the course 
of infection (Fig. 3-19B). By contrast the amount of AIF1 protein encoded by NGFG_01605 was 
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detectably increased (Fig. 3-19A) which suggested an involvement of AIF1 in gonococcal 
infection. The regulation of AIF1 is more likely at post-transcription level. 
AIF1 is annotated as a putative protease or U32 family peptidase with a hitherto unknown 
catalytic type. It is characterized by the consensus sequence 
E-x-F-x(2)-G-[SA]-[LIVM]-C-x(4)-G-x-C-x-[LIVM]-S containing two active site cysteine 
residues [219]. The prototype of this family is PrtC from Porphyromonas gingivalis. It has been 
characterized biochemically as a Ca
2+
-dependent collagenase and degrades type I collagen leading 
to periodontal tissue destruction [220]. Another interesting member of this group is a secreted 
collagenase, encoded by hp0169 in Helicobacter pylori. It has been identified and functionally 
verified as a new essential virulence factor for H. pylori stomach colonization. However, the 
alignment between these two proteins and AIF1 reveals only moderate sequence identity and 
similarity with PrtC (25%, 45%) and with HP0169 (37%, 54%). The predicted protease or 
collagenase activity of AIF1 should be confirmed by experimental verification. The known 
virulence factor with protease activity in Neisseria is IgA1 protease which is a secreted serine 
protease found in all pathogenic Neisseriae. IgA1 protease specifically cleaves mucosal 
immunoglobulin A1 to escape host immune response [100] and degrades LAMP1 to promote 
neisserial intracellular survival within epithelial cells [102,103]. However, a detailed sequence 
analysis indicates the absence of signal peptides in AIF1 and the putative localization predicted by 
PSORTb is cytoplasmic. Therefore, AIF1 is likely involved in gonococcal infection via regulation 
of bacterial intracellular factors.  
4.5 Prospects 
The identified essential genes from this work provide a large list of potential targets for the 
development of vaccines or anti-gonococcal drugs. For example, the candidate essential genes 
with enzymatic functions could be used to develop new drugs to inhibit their activity. Further, it 
will significantly reduce the occurrence of new resistance if the new drugs can target more than 
one essential gene products. In addition, the list of essential genes contains 120 genes with 
hitherto unknown function. Because these genes as of yet have no homologous genes in any 
organisms, their functions can not be predicted from homologues but it can be speculated via 
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structural analysis of purified protein products and also the structural analysis might give some 
hits for new drug design. 
The data sets obtained within the present study revealed gonococcal factors involved in adherence 
to and invasion into host epithelial cells in a phosphate sensitive condition. The candidate genes 
have been validated and NGFG_01605 encoding a predicted protease was confirmed to participate 
in gonococcal engulfment to host epithelia cells not only in PorBIA-triggered pathway, but also in 
Opa50 and Opa57 mediated Neisseria internalization. Therefore, it might be a common and 
important factor involved in various routes of neisserial infections. The putative protease activity 
of AIF1, the NGFG_01605 gene product, should be tested with protease activity assays, such as 
azocasein assays, and gelatin or casein zymography. The localization of AIF1 can be investigated 
through immunofluorescence staining of reporter gene fusion protein or testing AIF1 expression in 
separated cell components. The interaction partner of AIF1 could provide critical information to 
elucidate the molecular mechanism works in the infection process, which may be investigated by 
co-immunoprecipitation. 
Further, the established method of Tn-seq in N. gonorrhoeae can be easily applied to identify 
other novel gonococcal factors in a variety of environments, such as different growth conditions, 
host cell death or some available infection models. The disadvantage of Tn-seq is supposed to be 
the PCR amplification step in template preparation which may introduce amplification bias or 
create mutations. Newly developed sequencing technologies, so called “third generation 
sequencing”, can perform single molecule sequencing to circumvent any amplification step [221]. 
Additionally, a set of improvements to the standard Illumina protocols may reduce bias and 
reliably obtain high yields of data [222]. Finally, the Tn5 transposon and in vitro transposition can 
be used in many other microorganisms, which are refractory to in vivo mutagenesis.
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6 Appendix 
6.1 Abbreviations 
A ampere 
aa amino acid 
Ac activator element 
AHU Arg-Hyx-Ura 
AIF1 adherence and invasion-associated factor 1 
APS ammonium persulfate 
Arg Arginine 
ASM acidic sphingomyelinase 
ATP adenosine triphosphate 
ble bleomycin 
bp base pair 
BSA bovine serum albumin 
C4bp C4b-binding protein 
cDNA complementary DNA 
CDS coding sequence 
CEACAM carcinoembryonic antigen cellular adhesion molecule 
CFU colony forming unit 
CHO Chinese hamster ovary cell 
CNBr cyanogen bromide 
cPCR colony polymerase chain reaction 
CR3 complement receptor 3 
C-terminal carboxy-terminal 
dA deoxyadenosine 
Dam deoxyadenosine methylase 
Dc dissociation element 
ddNTPs dideoxynucleotides 
DGI disseminated gonococcal infections 
dH2O distilled water 
DMEM Dulbecco's modified Eagle medium 
DMSO dimethyl sulfoxide 
DNA desoxyribonucleic acid 
dNTPs deoxynucleotides 
DOC sodium deoxycholate 
DTT dithiothreitol 
DUS Neisseria DNA Uptake Sequence 
E. coli Escherichia coli 
e.g. Example gratia, for example 
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ECL enhanced chemiluminescence 
EDTA ethylenediaminetetraacetic acid 
ES end sequences 
FCS fetal calf serum 
FI-dNTPs fluorescently-labeled nucleotides 
FU fluorescence unit 
GC Neisseria gonorrhoeae, gonococcus 
GC-kan GC agar plates supplemented with kanamycin 
gDNA genomic DNA 
Gp96 glycoprotein 96 
h hour 
H. pylori Helicobacter pylori 
Hepes 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HFF human foreskin fibroblast cells 
His histone 
HIV human immunodeficiency virus 
HRP horseradish peroxidase 
HSP heat shock protein 
HSPG heparan sulfate proteoglycan 
IE inside end sequences 
IF immunofluorescence staining 
IgA1 immunoglobulin A1 
IGB Integrated Genome Browser 
Inh transposition inhibitor 
IP immunoprecipitation 
IPTG isopropyl-D-thiogalactopyranoside  
kan kanamycin 
kb kilobase 
kDa kilodalton 
L liter 
LAMP1 lysosomal-associated membrane protein 1 
LB lysogeny broth 
LINEs long-interspersed nuclear elements 
LOS lipooligosaccharide 
LPDI Low phosphate-dependent invasion 
LPS lipopolysaccharide 
LTRs long terminal repeats 
M mol/L 
maf multiple adhesin family 
ME mosaic end sequences 
min minute(s) 
MOI multiplicity of infection 
MPS massively parallel sequencing 
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mTn mini-transposon 
MWCO molecular weight cut-off 
N. gonorrhoeae Neisseria gonorrhoeae 
N. meningitidis Neisseria meningitidis 
N.lactamica Neisseria lactamica 
NADH nicotinamide adenine dinucleotide 
NGS next generation sequencing 
NIH 3T3 mouse embryonic fibroblast cells 
N-terminal amino-terminal 
OD optical density 
OE outside end sequences 
Omp85 outer membrane protein 85 
OMV outer membrane vesicle 
Opa opacity-associated proteins 
P
-
 non-piliated phenotype 
P
+
 piliated phenotype 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate-buffered saline 
PC-PLC phosphatidylcholine-specific phospholipase C 
PFA paraformaldehyd 
PI(3,4,5)P phosphatidylinositol 3, 4, 5-phosphate 
PI3K phosphatidylinositol-3’ kinase 
PID pelvic inflammatory disease 
pilE pilin expression locus 
pilS silent pilin loci 
PKD1 PKCμ, protein kinase C μ 
PLC ɣ1 phospholipase Cɣ1 
PLD phospholipase D 
PMN polymorphonuclear leukocyte 
PorB outer membrane porin protein B 
PorBIA PorB serotype A 
PorBIB PorB serotype B 
Porin pore-forming proteins 
PPM proteose peptone medium 
P
s
 S-pilin, a soluble form of pilin 
PVDF Polyvinylidene difluoride 
qRT-PCR quantitative real-time PCR 
Rac1 ras-related C3 botulinum toxin substrate 
RNA ribonucleic acid 
rpm revolutions per minute 
RT-PCR reverse transcription PCR 
s second 
SD standard deviation 
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SDS sodium dodecyl sulphate 
SINEs short-interspersed nuclear elements 
siRNA small interfering RNA 
SREC-I scavenger receptor expressed on endothelial cells I 
sRNA small non-coding RNA 
STI sexually transmitted infection 
str streptomycin 
TbpB transferrin receptor protein 
TCA trichloroacetic acid 
TE transposable element or transposon 
TEMED tetramethylethylenediamine 
Tfp type IV pili 
TIM triosephosphate isomerase 
TIRs terminal inverted repeats 
TIS transposon insertion site 
Tn transposon 
Tnp transposase 
Tn-seq transposon sequencing 
TraDIS transposon directed insertion-site sequencing 
TraSH transposon site hybridization 
TSD target site duplication 
U enzyme unit 
UEC urethral epithelial cell 
UV ultra violet 
V volt 
v/v volume per volume 
VDAC mitochondrial voltage-dependent anion channels 
VRPs viral replicon particle 
w/v weight per volume 
WB western blotting 
WHO World Health Organization 
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6.2 Supplementary materials 
Table 6.1 Available N. gonorrhoeae genome sequences 
Strain GenBank ID 
N. gonorrhoeae FA1090 AE004969.1 
a
 
N. gonorrhoeae NCCP11945 CP001050.1 [175] 
N. gonorrhoeae NCCP11945 plasmid pNGK CP001051.1 
N. gonorrhoeae TCDC-NG08107 CP002440.1 [176] 
N. gonorrhoeae TCDC-NG08107 plasmid pNGTCDC08107 CP002441.1 
N. gonorrhoeae MS11 CP003909.1 
b
 
N. gonorrhoeae MS11 plasmid pMS11 CP003910.1 
a
 submitted by University of Oklahoma, unpublished. 
b
 submitted by Broad Institute, release date 10/19/2012. 
Table 6.2 AIF1 homologues from different Neisseria spp used for multiple alignments 
Strain Accession number 
Neisseria mucosa WP_003748589.1 
Neisseria subflava WP_004519683.1 
Neisseria flavescens WP_003684307.1 
Neisseria lactamica WP_004048244.1 
Neisseria meningitidis WP_0022236041.1 
Neisseria cinerea WP_003677710.1 
Neisseria polysaccharea WP_003753715.1 
Neisseria gonorrhoeae  EEZ48438.1 
Neisseria macacae WP_003777098.1 
Neisseria sicca WP_003768744.1 
Neisseria elongata WP_003771571.1 
Neisseria bacilliformis WP_007342950.1 
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Publications 
Christian W. Remmele*, Yibo Xian*, Marco Albrecht*, Michaela Faulstich, Martin Fraunholz, 
Elisabeth Heinrichs, Marcus T Dittrich, Tobias Muller, Richard Reinhardt and Thomas Rudel 
(2014). Transcriptional landscape and essential genes of Neisseria gonorrhoeae. * authors 
contributed equally, Nucleic Acids Research, in revision 
Michaela Faulstich, Franziska Hagen, Elita Avota, Ann-Cathrin Winkler, Yibo Xian, Sibylle 
Schneider-Schaulies and Thomas Rudel (2014). Neutral sphingomyelinase 2 is a key factor for 
invasion of N. gonorrhoeae associated with disseminated infection. Cellular Microbiology, in 
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Patent applications 
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Thomas Rudel (2014). Essential genes of Neisseria gonorrhoeae as candidates for drug or vaccine 
development. patent pending 
Poster Presentations 
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th
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